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TOPIC: LOCAL ANESTHETICS IN DENTISTRY 
 
Local anesthetics produce a reversible loss of sensation in a portion 
of the body. Local anesthetics may be used as the sole form of anesthesia, 
in combination with general anesthesia and/or to provide postoperative 
analgesia.  
 
Mechanism of local anesthetics action 
All local anesthetics are membrane stabilizing drugs; they reversibly 
decrease the rate of depolarization and repolarization of excitable 
membranes (like nociceptors). Though many other drugs also have 
membrane stabilizing properties, not all are used as local anesthetics 
(propranolol, for example). Local anesthetic drugs act mainly by 
inhibitingsodium influx through sodium-specific ion channels in 
the neuronal cell membrane, in particular the so-called voltage-gated 
sodium channels. When the influx of sodium is interrupted, an action 
potential cannot arise and signal conduction is inhibited. The receptor site 
is thought to be located at the cytoplasmic (inner) portion of the sodium 
channel. Local anesthetic drugs bind more readily to sodium channels in an 
activated state, thus onset of neuronal blockade is faster in neurons that are 
rapidly firing. This is referred to as state dependent blockade. 
Local anesthetics are weak bases and are usually formulated as the 
hydrochloride salt to render them water-soluble. At a pH equal to the 
protonated base's pKa, the protonated (ionized) and unprotonated 
(unionized) forms of the molecule exist in equimolar amounts but only the 
unprotonated base diffuses readily across cell membranes. Once inside the 
cell the local anesthetic will be in equilibrium, with the formation of the 
protonated (ionized form), which does not readily pass back out of the cell. 
This is referred to as «ion-trapping». In the protonated form, the molecule 
binds to the local anesthetic binding site on the inside of the ion channel 
near the cytoplasmic end. Most local anaesthetics work on the internal 
surface of the membrane – the drug has to penetrate the cell membrane, 
which is achieved best in the non-ionised form. 
Acidosis such as caused by inflammation at a wound partly reduces 
the action of local anesthetics. This is partly because most of the anesthetic 
is ionized and therefore unable to cross the cell membrane to reach its 
cytoplasmic-facing site of action on the sodium channel. 
All nerve fibers are sensitive to local anesthetics, but due to a 
combination of diameter and myelination, fibers have different sensitivities 
to local anesthetic blockade, termed «Differential Blockade». Type B fibers 
(sympathetic tone) are the most sensitive followed by Type C (Pain), Type 
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A delta (temperature), Type A gamma (proprioception), Type A beta 
(sensory touch and pressure) and Type A alpha (motor). Although Type B 
fibers are thicker than Type C fibers, they are myelinated and thus are 
blocked before the unmyelinated, thin C Fiber. 
The following sequence of the mechanism of the action of local 
anesthetics was proposed by Covino and Vassallo (1976): 
1. Displacement of calcium ions from the sodium channel receptor site. 
2. Binding of the local anesthetic molecule to this receptor sites. 
3. Blockade of the sodium channel. 
4. Decrease in the sodium permeability. 
5. Depression of the rate of the electric depolarization. 
6. Failure to achieve the threshold potential. 
7. Lack of development of propagated action potentials. 
8. Conduction blockade. 
 
Chemical structure 
The basic chemical structure of a local anesthetic molecule consists 
of 3 parts:  
1. Lipophilic group- an aromatic group, usually an unsaturated 
benzene ring.  
2. Intermediate bond- a hydrocarbon connecting chain, either an ester 
(-CO-) or amide (-HNC-) linkage. The intermediate bond determines the 
classification of local anesthetic.  
3. Hydrophilic group- a tertiary amine and proton acceptor.  
 
Classification of local anesthetics 
On the basis of chemical structure: 
1. Esters: 
− Esters of benzoic acid, e.g. cocaine, benzocaine 
(ethylaminobenzoate), butacaine. 
− Esters of para-aminobenzoic acid, e.g. procaine, chloroprocaine, 
propoxycaine. 
2. Amides: articaine, bupivacaine, lidocaine, mepivacaine, prilocaine. 
On the basis of duration of action: 
1. Short-acting: articaine, lidocaine, mepivacaine, prilocaine, etc. 








Properties of an ideal local anesthetic agent 
The properties that are desirable in a local anesthetic solution are as 
follows: 
1. It should be non-irritating and produce no local reaction to the tissues to 
which it is applied. 
2. It should not cause any permanent change in the nerve structure. 
3. It should cause minimal systemic toxicity. 
4. It must be effective when injected into the tissues and should have 
sufficient penetrating properties to be effective as a topical anesthetic, 
when applied topically to the mucous membrane. 
5. It should have a short time of onset, if possible. 
6. The duration of action must be long enough to allow completion of 
procedure. 
Bennett (1974) has added some properties which are as follows: 
1. It should have enough potency to give complete anesthesia without the 
use of harmful concentrated solutions. 
2. It should be relatively free from producing allergic reactions. 
3. It should be stable in solution and readily undergo biotransformation in 
the body. 




It is a diethyl aminoethyl ester of para-aminobenzoic acid (PABA). It 
was first synthesized by Einhorn in 1905. It is non-irritant and as effective 
as cocaine as a local anesthetic agent. It is much less toxic and does not 
produce drug dependence. It is now seldom used in dentistry because of 
availability of more potent local anesthetic agents. 
Procaine can reduce the effectiveness of sulfonamides; because 
excessive amounts of PABA, which is a metabolite of procaine, can reverse 
the action of sulfonamides. Excessive amounts of this entity reverses the 
inhibition and decreases effectiveness of the antibiotic. Procaine is 
compatible in solution with all vasoconstrictors. 
Pharmacology. Procaine had been the standard of comparison for 
potency and toxicity with other local anesthetic agents for over 50 years. It 
has been assigned a potency and toxicity of 1. The vasodilation caused is 
more profound than all other local anesthetic agents. The effect is very 
brief if used without a vasoconstrictor. A major nerve block with procaine 
may have a duration of 5 minutes; however, the duration is extended to 1 
hour if a suitable vasoconstrictor is used. Procaine is readily absorbed when 
injected into the tissues. The ability to diffuse through interstitial tissues is 
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poor. Hence, a good injection technique; particularly an accurate placement 
of needle; is essential to produce profound anesthesia. 
Hydrolysis. Procaine is hydrolysed to PABA and diethyl aminoethan. 
It is a reaction that is catalysed by an enzyme, plasma choli in plasma and 
liver. 
Availability in Dentistry. Procaine is used alone in dentistry as 4% 
solution; and is 2% solution. It is available as 4% solution. It is marketed a 
combination of 0,4% propoxycaine and 1:30,000 levarte levonordefrin. 
Onset and Duration of Action. The onset of action takes 3-5 minutes 
and the duration of is 30 minutes. 
Maximum Recommended Dose. It is 15-20 mg/kg body weight not 
to exceed 1000 mg. 
 
Lignocaine (lidocaine, xylocaine, octocaine, dentocaine) 
It is the most commonly used local anesthetic agent in dentistry. 
Pharmacology. Diffusion: it rapidly diffuses through interstitial 
tissues, into lipid rich nerve, giving a rapid onset of anesthesia. 
Dissociation constant (pKa) = 7.85. It favours deprotonisation and produces 
more available unionised free base for action on the nerve membrane and 
for production of conduction block. 
Biotransformation. Lidocaine undergoes biotransformation in liver. 
Metabolism: it is metabolised in liver by microsomal fixed-function 
oxidases. Lidocaine and other amide-type local anesthetic agents are not 
affected by enzyme plasma cholinesterase. Hence, these are the agents of 
choice in patients with abnormal or insufficient amounts of this enzyme. 
Use of ester-type of local anesthetic agents should be avoided or greatly 
reduced in these patients. Since mechanism for their degradation is  
deficient, excessive amounts could accumulate in blood stream leading to 
toxic manifestations.  
Excretion: lidocaine and its breakdown products are excreted to 
some extent in urine, by kidney; < 10% unchanged, > 80% by various other 
mechanisms. 
Potency: 2 times as potent as procaine. Today, it is taken as the 
standard for comparison of various other local anesthetic agents. 
Toxicity: 2 times as toxic as procaine. Action on blood vessels:  The 
action on blood vessels is less than that of procaine but more than those of 
mepivacaine and prilocaine. 
Time of onset of action: rapid (2-3 minutes). 
Duration of action is depends upon: type of injection (Nerve block 




Effective dental concentration: 2% 
Anesthetic half-life: 1,6 hours. 
Topical anesthetic action: it has topical anesthetic effect. It forms an 
excellent surface anesthetic. It is used in the following forms topically: 
• 2% in the form of jelly 
• 5% in the form of ointment 
• 10% and 15% in the form of spray (aerosol). 
Local Anesthetic Agents 
Maximum Recommended Dose (MRD). Lidocaine is the most 
commonly used local anesthetic agent, hence it is necessary to consider the 
instructions of the manufacturers and the recommendations of American 
Dental Association are worth following. 
Instructions of the Manufacturer. To understand the concept of 
Maximum Recommended Doses, we need to understand the concentration 
of local anesthetic agents. Consider the example of lignocaine which is the 
most commonly used local anesthetic agent. It is used in the concentration 
of 2%. It simply means 2 g of solute is contained in 100 ml of solution, 
which means 2000 mg of the solute are present in 100 ml of solution. 
Hence, it means 20 mg of the solute is contained in 1 ml of solution. In 
other words 1 ml of 2% lignocaine solution contains 20 mg of the local 
anesthetic agent (lignocaine). 
The instructions for the local anesthetic agents with or without a 
vasoconstrictor, are as follows: 
1. Local anesthetic agents with a vasoconstrictor: 
− As per the manufacturer, the recommended dose of lidocaine with a 
vasoconstrictor, such as epinephrine, is 7,0 mg/kg BW, but not to exceed 
500 mg. 
− A 2% lidocaine solution contains 2 g/100 ml or 2000 mg/100 ml or 
20 mg/ml of local anesthetic solution.  
2. Local anesthetic agents without a vasoconstrictor: Similarly, as per 
the manufacturer, the recommended dose of lidocaine, without a 
vasoconstrictor is 4.4 mg/kg BW, but not to exceed 300 mg. A lesser dose 
is recommended because of faster absorption of the local anesthetic agent. 
This dose will be contained in 15 ml or 7½ cartridges of the local anesthetic 
solution. 
Recommendations of the American Dental Association (ADA). 
However, the dosage regimen as suggested by the Council on Dental 
Therapeutics of the American Dental Association and the USP Convention, 
the Maximum Recommended dose for lidocaine with or without a 
vasoconstrictor is 4.4 mg/kg body weight. 
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The Maximum Recommended Doses are mentioned here as shown in 
Table 7,1, for individuals with their body weights ranging from 10 to 70 
kg. 
The dental cartridges contain 2 ml of local anesthetic solution, 1,8 ml 
in USA and France and 2,2 ml in UK and Australia. Other local anesthetic 
agents used in dentistry are in various concentrations.  
 
Mepivacaine hydrochloride stabilizes the neuronal membrane and 
prevents the initiation and transmission of nerve impulses, thereby 
effecting local anesthesia. 
Mepivacaine hydrochloride is rapidly metabolized, with only a small 
percentage of the anesthetic (5 to 10 percent) being excreted unchanged in 
the urine. Mepivacaine because of its amide structure, is not detoxified by 
the circulating plasma esterases. The liver is the principal site of 
metabolism, with over 50 percent of the administered dose being excreted 
into the bile as metabolites. Most of the metabolized Mepivacaine is 
probably resorbed in the intestine and then excreted into the urine since 
only a small percentage is found in the feces. The principal route of 
excretion is via the kidney. Most of the anesthetic and its metabolites are 
eliminated within 30 hours. It has been shown that hydroxylation and N-
demethylation, which are detoxification reactions, play important roles in 
the metabolism of the anesthetic. Three metabolites of Mepivacaine have 
been identified from adult humans: two phenols, which are excreted almost 
exclusively as their glucuronide conjugates and the N-demethylated 
compound (2´,6´- pipecoloxylidide). 
The onset of action is rapid (30 to 120 seconds in the upper jaw; 1 to 
4 minutes in the lower jaw) and Mepivacaine hydrochloride 3% injection 
without vasoconstrictor will ordinarily provide operating anesthesia of 20 
minutes in the upper jaw and 40 minutes in the lower jaw. Mepivacaine 
hydrochloride does not ordinarily produce irritation or tissue damage. 
 
Articaine (Ultracaine and Septocaine). It was prepared by H. 
Rusching et al. in 1969. In USA, it is used in the formulation of 4% 
articaine HCl with 1:100 000 epinephrine bitartarate in 1,7 ml glass 
cartridges. In Canada, it is marketed under the brand names of Ultracaine 
and Septanest; and in USA as Septocaine. US FDA has approved its use in 
USA, in the year, 2000. 
Chemical structure. It is classified as an amide. It is the only amide 
type of local anesthetic agent containing a thiophene (sulphur-containing) 
ring. In addition it also contains an ester group. 
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Onset and duration of action. The time of onset, duration of action 
and depth of anesthesia is similar to 2% lidocaine with 1:100,000 
epinephrine. A 4% articaine solution with epinephrine is reported to have 
an onset of 1,5-3,0 minutes for maxillary infiltrations and slightly longer 
for inferior alveolar nerve blocks. While the duration of soft tissue 
anesthesia ranges from 2-3 hours for maxillary infiltration anesthesia and 
3-4 hours for mandibular block anesthesia. 
Effective dental concentration: 4% with 1:100 000 or 1:200 000 
Epinephrine. 
Indications. It is indicated in cases of extended minor oral surgical 
procedures, or for long appointments for cosmetic dentistry, full mouth 
restoration, full mouth periodontal surgery, or multiple implant placements. 
Adverse effects. Articaine does not have a greater allergenecity than 
other available local anesthetic agents, probably because the ester 
metabolite is not the allergen PABA. Reports of toxic reactions following 
the use of articaine for dental anesthesia are extremely rare. The rapid 
inactivation of articaine by plasma esterases may explain the apparent lack 
of overdose reactions reported following its administration, even though, it 
is marketed as a 4% solution. Articaine and prilocaine have been associated 
with a slightly higher incidence of mandibular and lingual paresthesia. 
 
Vasoconstrictors 
Most LAs (except cocaine) cause blood vessel dilatation and, 
therefore, a vasoconstrictor is added to diminish local blood flow and slow 
absorption of the LA. In practice, LAs still enter the systemic circulation 
quite rapidly but vasoconstrictors are useful to accelerate the onset, lengthen 
the duration and increase the depth of anaesthesia. They also reduce the local 
haemorrhage, which can be very helpful during surgical procedures. 
However, vasoconstrictors should never be used for infiltration of the ears, 
fingers, toes or penis as ischaemic necrosis may result. The concentration 
used is higher in dentistry than in medicine, particularly in the UK.  
It is used along with a local anesthetic agent, as a vasoconstrictor: for 
achieving hemostasis, to decrease the absorption of local anesthetic agent 
into cardiovascular system and to prolong duration of action.  
The selection of an appropriate vasoconstrictor is based on following 
factors: 
1. Length of the surgical or dental procedure 
2. Requirement for hemostasis during the surgical procedure 
3. Requirement for postoperative pain control 




Adrenaline (epinephrine).  
• Natural catecholamine. 
• Constricts arterioles in skin and mucosa. 
• Increases cardiac output by raising stroke volume and heart rate, but 
this effect is difficult to accomplish with the doses in dental cartridges. 
Epinephrine is available in the following dilutions: 1:50,000, 
1:100,000 and 1:200,000 for use in dentistry. 
 
Felypressin (octapressin).  
• Synthetic analogue of naturally occurring vasopressin. 
• Constricts venous outflow and, therefore, is less effective in 
haemorrhage control than adrenaline (epinephrine). 
• Contraindicated in pregnancy as it is similar to oxytocin and there is 
a possibility of uterus contraction, although the dose is actually very small 
compared with the dose of oxytocin used by obstetricians to induce labour. 
Prilocaine with felypressin is often recommended for use in patients 
with ischaemic heart disease rather than lidocaine with adrenaline 
(epinephrine), but there is no evidence that it is any safer.  
The maximum doses of felypressin as recommended by New York 
Heart ssociation and as suggested by Bennette (1983) and Malamed (1997) 
are as follows: 
A. Normal healthy adult patients (0,2 mg per appointment): 
10 ml of a 1: 50,000 dilution (5 cartridges) 
16 ml of a 1: 80,000 dilution (8 cartridges) 
20 ml of a 1: 100,000 dilution (10 cartridges) 
40 ml of a 1: 200,000 dilution (20 cartridges) 
B. Patients with clinically significant cardiovascular disease (0,04 
mg per appointment) (approximately 1/5th of the dose for normal patients): 
2 ml of a 1: 50,000 dilution (1 cartridge) 
3.2 ml of a 1: 80,000 dilution (1,6 cartridges) 
4 ml of a 1: 100,000 dilution (2 cartridges) 
8 ml of a 1: 200,000 dilution (4 cartridges) 
 
The benefits and risks of including a vasoconstrictor in a local 
anesthetic solution in patients who are medically compromised, must be 
weighed against benefits and risks of using plain local anesthetic solution.  
Contraindications. In cases of significant cardiac and non-cardiac 
diseases, it is essential to: 
1. Determine the degree of severity of underlying medical problems. 
2. Determine whether or not vasoconstrictor can be safely included or 
exclude from the local anesthetic solution. 
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3. Obtain a medical consultation and the necessary information from 
the treating physician regarding the existing medical problem. 
Once the medical status of the patient is improved or corrected, 
dental or surgical procedures requiring administration of local anesthetic 
agents with vasoconstrictors are indicated. 
The groups where inclusion of vasoconstrictor is contraindicated are 
given below: 
1. Patients with significant cardiovascular disease such as ischemic heart 
disease, hypertension and cerebral strokes. 
2. Patients with certain uncontrolled non-cardiovascular diseases, such as: 
thyrotoxicosis or hyperthyroid states and diabetes mellitus. 
3. Patients receiving non-specific beta-blockers, monoamine-oxidase 
inhibitors (MAOIs), tricyclic antidepressants (TCAs) and phenothiazines. 
4. Patients with sulfite sensitivity. 
5. Patients who are undergoing general anesthesia with halogenated agents. 
6. Pregnancy. 
Epinephrine and other vasoconstrictors can be used in moderate 
amounts in patients with mild to moderate cardiovascular disease. 
Felypressin has minimal cardiothoracic stimulatory actions and is 
nondysrhythmogenic; it is recommended for patients with significant 
cardiovascular disease. 
Patients with severe cardiovascular diseases are at too great a risk for 
elective dental therapy, such as: 
1. Ischemic heart disease 
− Patients with history of acute myocardial infarction within last six 
months. 
− Patients with history of acute anginal episodes on daily basis or 
where signs and symptoms are increasing in severity (angina pectoris) (pre-
infarction stage or unstable angina). 
− Patients with cardiac dysrhythmias despite appropriate 
antiarrhythmic drug therapy. 
− Post-coronary artery bypass surgery, less than six months. 
2. Hypertension: Patients with systolic BP greater than 200 mm of Hg 
and diastolic BP greater than 110 mm of Hg should not receive any dental 
care unless BP is corrected. 








Local anesthetic cartridges and vials 
It contains primarily the local anesthetic drug and also the other 
ingredients, which are as follows: 
1. Local anesthetic drug 
2. Vasopressor/vasoconstrictor drug 
3. Preservative for vasopressor 
4. Sodium chloride (NaCl) or Ringer's solution 
5. Distilled water 
6. General preservatives. 
 
Local anesthetic drug. It provides pain control during dental therapy. 
It interrupts propagation of impulse preventing it from reaching brain. 
Drugs are listed by their percentage (%) concentration. The number of mg 
of an agent contained in the cartridge can be calculated by multiplying the 
percentage (%) concentration (e.g. 2% = 20 mg/ml) by 2 (the number of ml 
in a cartridge). Thus, a cartridge containing 2 ml of 2% local anesthetic 
solution contains 40 mg of local anesthetic agent. 
The local anesthetic solution is quite stable, capable of being 
autoclaved, heated or boiled without deterioration. However, other contents 
of cartridge, such as vasopressor and cartridge seal are more labile. These 
are broken down easily. 
 
Vasopressor/vasoconstrictor drug. It is added in various 
concentrations, to some dental cartridges to increase safety and prolong 
duration of action of local anesthetic agents. It also helps in controlling 
bleeding. The pH of dental cartridge containing local anesthetic agent with 
a vasoconstrictor is lower (more acidic) than that without a vasoconstrictor 
(pH of 3.3-4.0 v/s 5.5-6.0). Because of this pH difference plain anesthetics 
have somewhat more rapid or clinical action and are more comfortable 
(less burning on injection). 
 
Preservative for vasopressor. Local anesthetic solutions containing 
vasoconstrictors also contain a specific agent, an antioxidant, that acts as a 
preservative for vasoconstrictors. The most frequently used antioxidant is 
sodium-bisulfite or sodium metabisulfite. It prevents biodegradation of 
vasopressor by O2 which might be present in the cartridge either 
introduced during manufacture, or which got diffused through 
semipermeable membrane or the rubber diaphragm after filling at the time 
of storage of the cartridge. Sodium-bisulfite reacts with O2 before O2 can 
destroy vasopressor. Sodium-bisulfite is oxidised to sodium-bisulphate, a 




Sodium chloride (Nacl) or Ringer's solution. It is added to the 
contents of dental cartridge to make the solution isotonic with the tissues of 
the body. Hypertonic solution produces tissue edema, paresthesia, 
sometime lasting for several months following drug administration. 
 
Distilled water. It is used as a diluent to provide the volume of 
solution in the dental cartridge. 
 
General preservatives. A number of chemicals are used as general 
preservatives. These are added to increase the shelf-life and include: 
Methylparaben, Thymol and Chlorbutol. 
Methylparaben: it is a bacteristatic and fungistatic agent. It has been 
excluded from cartridges in USA, from 1st January 1984, following reports 
of allergy. However, it is still used in multidose vials in some countries. 
Thymol: it is antiseptic, fungistatic and antihelminthic. 
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TOPIC: INSTRUMENTS FOR LOCAL ANESTHESIA 
 




3. local anesthetic solution in the form of a cartridge or a multidose 
vial. 
 
Syringe. It is an instrument or a vehicle whereby the local anesthetic 
solution is delivered through the needle into the tissues of the patient. 
The various types of syringes used in dentistry are as follows. 
I. Non-disposable (Reusable) syringes: 
1. Breech-loading, cartridge type syringe.  
These syringes are available in the following forms: 
− metallic or plastic,  
− aspirating or non-aspirating,  
− self-aspirating types. 
2. Side loading, aspirating and non-aspirating syringes. 
3. Pressure syringe. 
4. Jet injector. 
5. Luer-Lock syringes. 
II. Disposable or plastic syringes. 
III. Safety syringes. 
The requirements of an ideal syringe include the following: 
1. It should be durable and be able to withstand repeated sterilization 
without deterioration and it should allow repeated use. 
2. The disposable syringe should be easily sterilizable and be packaged. 
3. It should accept a wide variety of cartridges and needles of different 
manufacture. 
4. It should not be expensive. 
5. It should be light-weight and easy to handle with one hand. 
6. The aspirating type should have effective aspiration and should be so 
designed that the blood may be easily seen in the cartridge. 
 
Breech-loading cartridge type, aspirating syringe. Breech-loading 
implies that cartridge is inserted into the syringe from one end or from the 
top of the barrel of the syringe. Aspirating syringe has a device such as a 
tip or a harpoon, attached to the piston; which penetrates the thick rubber 
silicone stopper at the other end of the cartridge. When negative pressure is 
applied to the thumb ring by the operator, blood will enter the lumen of the 
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needle and is seen in the cartridge; only if the tip of the needle lies within a 
blood vessel and if the needle gauge is adequate. When a positive pressure 
is applied to the thumb ring, it forces the local anesthetic solution into the 
lumen of the needle and in turn, into patient's tissues around the area of the 
tip of the needle. 
 
Breech-loading cartridge type, plastic aspirating syringe. Recent 
advances in the field of plastic industry has led to the production of this 
plastic syringe, which is both autoclavable and chemically sterilizable. 
 
Breech-loading cartridge type, self-aspirating syringe. Aspiration 
test is advisable, prior to administration of local anesthetic drugs. 
These syringes rely on the property of elasticity of rubber diaphragm 
in the cartridge to obtain the required negative pressure for aspiration. The 
self-aspirating syringes allow multiple aspirations to be performed easily 
throughout the period of deposition of local anesthetic solution.  
 
Non-disposable syringe (Metallic and Plastic) (Aspirating) 
Advantages: 
1. Aspiration is possible with one hand 
2. Autoclavable 
3. Long-lasting with proper maintenance 
4. Lower cost in the long run. 
Disadvantages: 
1. Metallic syringes are heavier than plastic disposable syringes 
2. Possibility of infection with improper care 
3. Deterioration of plastic with repeated autoclaving. 
 
Pressure syringes. Used for intraligamentary injection and also for 
pulpal anesthesia of one isolated tooth in mandibular arch. 
 Principle: liquids forced through very small openings called jets, at 
very high pressure can penetrate skin or mucous membrane. 
 Calibration: the syringe is calibrated to deliver 0,05 to 2,0 ml of 
solution at 2000 psi. 
 Primary use: topical anesthesia prior to insertion of a needle. 
 Secondary use: may be used to obtain mucosal anesthesia of the 
palate. 
Regional nerve blocks or paraperiosteal injections are still required 






1. Does not require use of a needle. Hence, recommended for 
needlephobics and especially for young children. 
2. Deposits very small volumes of local anesthetic solution with 
calculated amount of force. 
3. Used in topical anesthesia. 
4. Complete intraligamentary anesthesia can be achieved for individual 
tooth. 
Disadvantages: 
1. Inadequate for pulpal or regional anesthesia. 




Disposable/Plastic syringes. Disposable/Plastic syringes are 
available in variety of sizes and with an assortment of needle gauges. Most 
often used for IM or IV drug administration, but may also be used for 
intraoral injections. 
Advantages: 
1. disposable; meant for single use. 
2. sterile until opened. 
3. light-weight, better tactile sensation. 
4. decreased chances of transmitting infections. 
Disadvantages: 
1. does not accept prefilled cartridges. 
2. difficult aspiration with one hand, requiring two hands 
3. increased cost in the long run. 
 
Safety syringes. These syringes minimise risk of accidental needle-
stick injuries. 
Advantages: 
1. disposable; meant for single use. 
2. sterile until opened. 
3. light-weight, better tactile sensation. 
4. decreased chances of transmitting infections. 
Disadvantages: more expensive than reusable syringes. 
 
Needles.  The needles permit the local anesthetic solution to travel 
from the dental cartridge into the soft tissues surrounding the tip of the 
needle. The needles used for regional analgesia in dental surgery, range 
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from 24, 25, 27 and 30-gauges; and from 25 mm (1") to 38-40 mm (1½ or 
15/8") in length. 
Needles in dental practice are made up of stainless steel, platinum 
and iridium-platinum or ruthenium alloys. The stainless steel needle is most 
commonly used and is highly recommended. Needles currently available 
are usually pre-sterilized and disposable. 
The advantages of this needle are as follows: 
− rigidity: it is rigid and hence can be easily guided into the tissues. 
− sharpness: it maintains the sharpness of the point. 
− cost: it is not expensive and therefore can be discarded after using for 
each patient. 
− breakage: it rarely occurs, if these are handled properly. 
− availability: it is available in variety of lengths and gauges. 
− sterilization: it withstands boiling and autoclaving without corrosion 
and becoming weak. 
 
The needles used for administration of local anesthetic solutions 
have the following components: bevel, shaft or shank, hub, syringe adaptor 
and cartridge-penetrating end. 
Bevel: it defines the point or the tip of the needle. The bevels, as 
described 
by manufacturers are: long, medium and short. 
The recommended bevel is 12° and it influences the degree of 
deflection. The greater the angle of the bevel with the long axis of the 
needle; the greater will be the deflection as needle is passed through the 
soft tissues. Bennett advised that the short-beveled needle is superior to the 
long tapering bevel for regional analgesia, such as block anesthesia as it is 
less likely to be deflected from its intended path during insertion. Needles 
with point centered on the long axis, deflect less than beveledpoint needles 
whose point is eccentric. 
Shank/Shaft: the length of shank is measured from the hub to the 
point of the bevel. 
Hub: it is a plastic or metal piece through which the needle is 
attached to the syringe. The interior surface of plastic syringe adaptor is not 
prethreaded. Therefore, to attach a plastic hubbed needle to a syringe, the 
needle must be pushed onto syringe while being screwed on. Metallic-
hubbed needles are usually prethreaded. 




Cartridge-penetrating end: it is placed into the needle adaptor of 
syringe and perforates the rubber diaphragm of glass cartridge. Its tip rests 
within the cartridge. 
 
Dental needles are available in two lengths: short – 25 mm and long 
– 38-40 mm. Short needles are recommended for paraperiosteal injections 
in entire maxilla; and anterior mandible. Long needles are preferred for all 
injection techniques requiring penetration of significant thickness of soft 
tissues. For example, pterygomandibular block, Vazirani-Akinosi 
mandibular nerve block, Gow-Gate's mandibular nerve block. 
Larger gauge needles have distinct advantages over smaller gauge 
needles: 
1. Less deflection: it occurs as needle passes through tissues. This leads 
to greater accuracy and higher success rates, especially in those techniques 
in which there is significant soft tissue depth, as in Pterygomandibular 
Block, Gow-Gate's Mandibular Nerve Block, Akinosi Mandibular Nerve 
Block and Infraorbital Nerve Blocks. 
2. Needle breakage: it is not common with disposable needles and is 
less likely to occur with larger gauge needles. 
3. Aspiration: it is easier and more reliable through larger lumen. 
 
Local anesthetic solutions are available in the form of multidose vials 
and cartridges. Local anesthetic solutions are available in multidose vials of 
30 ml in different potencies of local anesthetic agents, i.e. 0,5%, 1%, 2%, 
3% and 4%, etc. 
 
Dental cartridge. It is a glass tube sealed at one end by a rubber 
stopper (plunger); while the other end is sealed by an aluminium cap over 
the rubber diaphragm. The rubber stopper is forced into the tube by the 
plunger of the cartridge syringe, while the rubber diaphragm is punctured 
by the cartridge end of the needle. It is available in the form of a 
presterilised glass cylinder. The capacity of cartridges 2 ml, while that in 
USA and France is 1,8 ml and that in UK and Australia is 2,2 ml.  
The local anesthetic cartridge should be stored as aseptically as 
possible. These should be stored dry in their original container and covered 
with a lid all the time; or in another suitable sterile container, that is kept 
covered all the times, preferably at room temperature and in dark place. 
Local anesthetic dental cartridges should not be left exposed to direct 
sunlight, because some contents may undergo accelerated deterioration. 
Cartridge warmers are not necessary. Local anesthetic agents in dental 
cartridge, maintained at room temperature do not cause any discomfort on 
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injection into the tissues, nor do patients complain of solutions being too 
cold. 
Cartridge should not be permitted to soak either in alcohol or other 
cold-sterilising solutions, because the permeable rubber plunger will allow 
diffusion of these solutions into dental cartridge. This leads to 
contamination of the local anesthetic solution resulting in post-injection 
pain, edema and trismus. 
 
The prefilled dental cartridge consists of four parts:  
− cylindrical glasstube,  
− rubber stopper (plunger),  
− aluminium cap,  
− rubber diaphragm. 
Cylindrical glass tube. A small bubble of approximately 1-2 mm is 
frequently seen in the cartridge. It is composed of nitrogen gas, which is 
bubbled into the local anesthetic solution during its manufacture to prevent 
oxygen from being trapped in the cartridge and potentially destroying the 
vasopressor or vasoconstrictor. 
Rubber stopper. It is located at the end of cartridge that receives the 
harpoon of syringe. The harpoon is embedded in plunger by gentle finger 
pressure on thumb ring of syringe. The rubber plunger occupies little more 
than 0,2 ml of volume of entire cartridge. In a normal intact dental 
cartridge, the rubber plunger is slightly indented from lip of the glass 
cylinder. Cartridges that contain plungers, which are equal with or extruded 
beyond the glass of the cylinder should not be used. 
Aluminium cap. It is located at the opposite end of cartridge from 
rubber plunger. It fits snugly around the neck of glass cartridge holding thin 
rubber diaphragm in position. It is silver colored in all cartridges. 
Rubber diaphragm. It is a permeable membrane through which the 
cartridge end of needle penetrates. The permeability of diaphragm allows 
solution in which dental cartridge is stored to diffuse into cartridge, 
contaminating the local anesthetic solution.  
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TOPIC: TYPES OF LOCAL ANESTHESIA 
 
The various types of techniques used for deposition of these agents, 
in dentistry are as follows:  
1. surface or topical anesthesia,  
2. infiltration anesthesia,  
3. field block,  
4. nerve block or conduction anesthesia. 
 
SURFACE OR TOPICAL ANESTHESIA 
By this method small terminal nerves in the surface area of the intact 
mucosa 
or the skin up to the depth of about 2 mm are anesthetised by application of 
a local anesthetic agent directly to the area. 
Nerves anesthetised – superficial nerve endings. 
Indications: 
− prior to the infiltration injection techniques or nerve blocks for 
making the insertion of the needle painless 
− prior to carrying out incision and drainage of abscesses 
− prior to removal of sutures. 
Forms.  
Spray:  
1. The active ingradient is a suitable local anesthetic agent, such 
as 10% or 15% lignocaine hydrochloride in water base. The agent is 
expelled in small quantities from an aerosol container.  
Advantage: rapidity of onset. The onset of time of anesthesia is 
approximately 1 minute and the duration of anesthesia is approximately 10 
minutes.  
Disadvantage: when used as a spray, the solution is spread over more 
extensive area than desired. 
Method of application: it is used as a spray on the area in which the 
needle penetration is proposed to be made; or it can also be sprayed on a 
small cotton pellet or roll and then placed on the proposed site of injection 
for about one minute. 
II. Ethyl chloride spray: it produces anesthesia by refrigeration. 
When sprayed onto either mucous membrane or skin, it gets volatilized 
rapidly and produces rapid anesthesia. 
Method of application: The spray is directed over a limited area until 
"snow" appears. 
Care: undue inhalation of vapours by the patient should be avoided. 
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Use: occasionally used to produce surface anesthesia prior to taking 
an incision for fluctuating abscesses. 
 
Ointment. It is used for similar purposes as spray. The active 
ingredient is a suitable local anesthetic agent, such as 5% lignocaine 
hydrochloride. 
Time of onset: 3-4 minutes. 
Application: ointments are used for application over tender and 
inflamed gingivae prior to deep scaling. 
 
Emulsion. The active ingredient is a suitable local anesthetic agent, 
such as 2% lignocaine hydrochloride. 
Indications: 
− when full mouth impressions are to be taken in patients who are 
prone to retching. 
− relief of postoperative pain or tenderness following mucogingival 
surgical procedures such as gingivectomy. 
Method of application: one teaspoonful of the emulsion is swished 
around 
in the mouth and oropharynx for 1-2 minutes; and later is spat out 
immediately prior to taking impressions. 
 
Jet injection. It is a technique by which a small amount of local 
anesthetic solution is expelled as a jet into submucosa without the use of a 
hypodermic needle. Specialised syringes are used for this technique. These 
techniques depend upon discharge of a small quantity of local anesthetic 
solution from a reservoir. It produces a fine jet of solution which penetrates 
the mucosa through a small puncture wound and produces surface 
anesthesia. The hypodermic needle is then inserted painlessly through the 





TOPIC: INFILTRATION ANESTHESIA 
 
There are various types of infiltration anesthesia depending upon the 
site of deposition of the local anesthetic solution. The solution can be 
deposited below the mucosa or in the submucosal layers, or in the 
subcutaneous connective tissue, just above the periosteum, beneath the 
periosteum, in the periodontal ligament, in the cancellous bone, in the 
interdental septum or in the pulpal tissues of the tooth. On the basis of 
deposition, these techniques can be categorised in the following ways: 
1. Submucosal or subcutaneous anesthesia 
2. Paraperiosteal or supraperiosteal anesthesia 
3. Subperiosteal anesthesia 
4. Intraligamentary 
5. Intrapulpal anesthesia 
6. Intraosseous anesthesia 
7. Intraseptal anesthesia 
 
Submucosal injection 
Technique: the local anesthetic solution is deposited in the 
immediate submucosal tissue layers. The solution diffuses through the 
interstitial tissues and reaches the terminal fibers of the nerve in the area of 
deposition of the local anesthetic solution. 
Procedure: the needle is inserted beneath the mucosal layers. Care 
should be exercised to avoid injecting too superficially. Excessive amounts 
injected superficially may lead to sloughing of the overlying tissues. 
Usually 0,25-0,5 ml of the local anesthetic solution is deposited. 
 
Paraperiosteal or supraperiosteal injection 
It is commonly called the local infiltration and is the most frequently 
used local anesthetic technique. The paraperiosteal injection is commonly 
used injection technique for obtaining anesthesia in the region of all 
maxillary teeth and mandibular anterior teeth because of thin cortical plates 
and abundant cancellous bone. 
Site of insertion: the needle is inserted through the mucosa and the 
solution is deposited in close proximity to the periosteum or along the 
periosteum, in the vicinity of the apex of the tooth to be treated, as close to 
the bone as possible. This facilitates diffusion through the periosteum and 
penetration through the haversian canals of the cortical bone. These canals 
are numerous; near apices of teeth near the surfaces.  
Technique: by this method the local anesthetic solution is deposited 
just above or besides the periosteum. It does not always produce 
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satisfactory anesthesia due to distension of tissues due to superficial 
injection. In this method, the local anesthetic solution is not carried quickly 
from the area of deposition of the local anesthetic solution, through the 
alveolar bone; so that sufficient amount of local anesthetic solution does 
not diffuse through cortical layer into cancellous bone, which is necessary 
to produce satisfactory anesthesia. This is in particular, in cases of 
extirpation of pulp or preparation of a cavity. In these situations, it is 
necessary for the alveolar bone to be anesthetised but the local anesthetic 
solution should diffuse through apical foramen into the pulp chamber. 
Advantages: only two punctures are made labially. Similarly, if it is 
desired to anesthetise all mandibular incisors, only one labial puncture is 
made. The needle insertion takes place well down the vestibular mucosa of 
mandibular labial frenum; and is directed towards one canine fossa. About 
1 ml of solution is deposited. The needle is then withdrawn to a point 
permitting its course to be directed to other canine fossa. Deposit 1ml of 
local anesthetic solution. Massage the solution to enhance absorption 
through numerous foramina. 
Other common names: local infiltration, supraperiosteal injection. 
Nerves anesthetised: large terminal branches of superior dental 
plexus. 
Areas anesthetised: the region innervated by the large terminal 
branches such as the pulps of the maxillary teeth, labial/buccal 
periodontium, supporting alveolar bone and labial/buccal mucoperiosteum; 
that includes labial/buccal periosteum, overlying connective tissue and 
mucous membrane. 
Indications. this method is used for procedures in the entire maxilla 
and anterior mandible. In these areas, the cortical plates are thin and there 
is abundant cancellous bone. The local nesthetic solution penetrates bone 
through Haversian canals. These canals are numerous near the apices of 
teeth near the surfaces. 
1. Pulpal anesthesia when treatment is limited to one or two teeth in 
maxilla and anterior mandible. 
2. Soft tissue anesthesia for surgical procedures in a circumscribed area. 
3. Children and young adults. In children, this technique can be used in 
the posterior mandible to anesthetise deciduous molars as the cortical bone 
is thin in this region. 
Contraindications: 
1. Presence of acute inflammation or infection in the area of injection. 
2. Presence of dense bone covering the apices of teeth, as in maxillary 





1. High success rate 
2. Technically easy injection 
3. Usually atraumatic 
Disadvantages: the technique is not recommended for large areas 
because of: need for multiple penetrations, the necessity to administer 
larger volumes of anesthetic solution and satisfactory anesthesia cannot be 
always produced. 
Technique.  A 25 or 27 gauge short needle is recommended.  
Point of insertion: it is at the height of mucobuccal fold in the 
vicinity of the tooth to be anesthetised. 
Target area: the apical region or above the apex of the tooth to be 
anesthetised. 
Depth of insertion: few millimeters. 
Bevel: the position of the bevel of the needle should be facing the 
bone. 
Landmarks: 
− mucobuccal fold in the region of the tooth to be anesthetised. 
− crown of the tooth. 
− root contour of the tooth.  
Position of the patient: the occlusal plane of maxillary teeth should 
be at an angle of 45° to the floor. 
Position of the operator: 
− for maxillary injections, for the right side, the operator stands by the 
side of the patient; and for the left side, the operator stands in front of the 
patient. 
− for mandibular injections, the operator stands by the side of the 
patient for the left side; and in front of the patient for the right side. 
Preparation of the tissues at the site of injection with an antiseptic. 
Application of topical anesthetic at the site of injection. 
Retract the lip/cheek, pulling the tissues taut. 
Take a preloaded syringe. Initially, hold it at an angle of 45º to the 
long axis of the tooth to be anesthetised, with the bevel of the needle facing 
the bone. Insert the needle at the height of mucobuccal fold, or a few 
millimeters away from the labial cortex. 
Aspirate, if negative, deposit approximately 0,5 ml of the solution 
slowly over 20 seconds. 
Wait for 2-3 minutes, check for the signs and symptoms of 





Signs and symptoms: 
1. Subjective: feeling of numbness in the area of distribution of the nerve 
anesthetised. 




In this method, the local anesthetic solution is injected beneath the 
periosteum. Subperiosteal injection has superiority over supraperiosteal 
injection. It confines the solution below periosteum; obviates permeating 
the pulp. The solution is under pressure enabling it to penetrate the 
cancellous bone, periodontal membrane and finally diffuses through apical 
foramen into the pulp. 
Technique. Needle: recommended length and gauge are 1" and 25 
respectively. The needle is inserted midway between gingival margin and 
the approximate apex of the tooth; and at right angle to the buccal alveolar 
plate, in order to penetrate mucous membrane, gingival tissue and 
periosteum. The needle is then placed at an angle of 45º to the alveolar 
plate, bevel facing the bone and then it is advanced towards the apex of the 
tooth, beneath the periosteum. As the needle progresses, about 0,3-0,5 ml 
of local anesthetic solution is injected slowly. The periosteum will force the 
solution through the cortical plate and into the cancellous bone. 
The same procedure is repeated lingually. The amount of solution 
deposited is 0,5 ml. The diffusion of solution through the lingual alveolar 
plate is faster because of presence of numerous foramina. The length of the 
needle inserted is between 5 and 7 mm. 
Periosteum: there is an aspect, associated with the method of 
subperiosteal injection, which needs discussion. One theory advanced was 
that a subperiosteal injection may produce persistent or prolonged pain due 
to "tearing" of the periosteum from bone. Contrary to general belief, the 
periosteum is not closely attached to bone in the same way a glove covers a 
hand.  
According to Gray, the periosteum in the young bones, is thick and is 
vascular and is less closely connected with the body of the bone from 
which it is separated by a layer of soft tissues containing osteoblasts. Later 
in life, the periosteum becomes thinner and less vascular and the 
osteoblasts are converted into a layer of epithelial cells. Only at the ends of 
bones, the periosteum is closely adherent. This is quite well known that 
there is comparatively more resistance for raising mucoperiosteal flap at 
gingival margins; and once detached at this point, the separation of the rest 
of the mucoperiosteum is comparatively easy. On the other hand, the 
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periosteum and gingival tissues are merged together and cannot be 
separated from one another. 
If deposition of a small amount of the solution tears the periosteum, 
then lifting of mucoperiosteal flap should be considered to be more 
injurious. However, it is well known that the procedure of raising a flap 
causes little pain. 
Advantages: 
1. It is more appropriate, more specific and definite in region. 
2. There is no great trauma, contrary to belief. 
3. It is safe and much more effective than supraperiosteal injection. 
4. Less solution is required to produce the desired results. Total amount 
of solution sufficient to produce satisfactory and profound anesthesia is 
0,3-0,5 ml. 
5. The onset of action is rapid. The depth of anesthesia for extraction is 
achieved immediately, however, for conservative restorative procedures 
such as preparation of cavities and crowns and extirpation of pulps, it is 
advisable to wait for five minutes to allow the solution to reach pulp 
chamber and anesthetise the neural component. 
6. This method greatly reduces the incidence of intravascular 
administration. 
7. Reduces needle punctures. 
Disadvantages: there is theoretical damage to the periosteum. No 




Intraligamentary, intrapulpal, intraosseous and intraseptal injection 
techniques: 
These are the other methods of producing anesthesia. These are 
satisfactory when executed properly. Each has its place of application in 
dentistry. Sometimes, these will produce anesthesia where all other 
methods fail. The abovementioned techniques numbered: 4, 5, 6 and 7 are 
not advised for beginners. These techniques give good results in 
experienced hands. 
 
Intraligamentary (periodontal or peridental) injection 
As the name suggests, the local anesthetic solution is deposited into 
the periodontal ligament or membrane. This injection technique is claimed 
to be safe, provided the point of insertion of the needle is thoroughly 
cleaned and strict aseptic precautions are undertaken. The local anesthetic 
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solution is carried from the alveolar bone and through the apical foramen 
into the pulp chamber. 
Indications: it is a very efficient method of producing anesthesia 
especially for cavity preparation, crown preparation, pulp extirpation, etc.  
Advantages: 
− Rapid onset of action.  
− Specific analgesia to isolated teeth. Single mandibular tooth can be 
anesthetised without performing a pterygomandibular block. This avoids 
numbness of the lip and tongue.  There is less likelihood of inadvertently 
traumatising these structures in the immediate post-injection phase. 
− Useful adjunct to conventional local anesthesia; and in experienced 
hands for minor surgical procedures.  
Disadvantages: 
− Post-injection discomfort due to temporary extrusion.  
−  Apparent increase in the incidence of «dry socket». 
Technique. Needle: 25-gauge is recommended. The local anesthetic 
solution is injected along periodontal membrane of maxillary and 
mandibular teeth, using small amounts of local anesthetic solution, usually 
0,2 ml, delivered via a specifically designed system, which comprises of 
high pressure syringes and ultrafine needles. The high pressure forces the 
solution rather than causing diffusion, through the periodontal ligament to 
the nerves in that area. This technique can also be carried out by the 
conventional syringes, however, care should be exercised to avoid 
shattering of the glass cartridges. The needle is inserted into the gingival 
sulcus and into the periodontal ligament. This technique can anesthetise 
only single individual tooth. The single rooted tooth should be injected on 
the mesial and the distal sides; or buccal and lingual sides; while 
multirooted teeth are injected over each root. The amount of local 
anesthetic solution injected is 0,1-0,2 ml. Some studies have shown that 
application of excessive pressure and the injection of excessive amounts 
can cause avulsion of teeth.  
Procedure: 
1. Strict aseptic precautions. 
2. The needle is inserted on the mesial side of the tooth to be treated, 
beneath the free margin of gingivae, or into the circular ligaments. 
3. A few drops of local anesthetic solution are injected for superficial 
anesthesia. Solution is deposited in tissues to render further insertion of the 
needle painless. 
4. The needle is then forced into periodontal ligament, directing it 
parallel to the long axis of the tooth. 
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5. Usually 0,2-0,4 ml of anesthetic solution is sufficient to achieve 
profound anesthesia (1 ml contains 15,419193 drops). Hold the syringe 
close to needle and reach into the membrane. Needle is held at an angle of 
15º to the long axis of the root and inserted until interdental septum is 
reached at a point midway labiolingually or buccolingually, according to 
the location of tooth. Using the septum as a guide from this point, deflect 
the needle towards the desired tooth to be anesthetised, then force the 
needle into mucous membrane. Solution is deposited with pressure, 
sufficient to rupture tissue and cause leakage of solution. If anesthesia has 
not taken place after 2-3 minutes, the flap on the other side of the tooth 
may be punctured and proceeded as above.  
 
Intrapulpal anesthesia 
This technique is indicated for obtaining anesthesia for procedures 
which require direct instrumentation of the pulpal tissue. First, put a cotton 
ball soaked in local anesthetic solution in the cavity, wait for a minute; and 
then a 25 or 27-gauge needle is inserted directly into the pulp chamber. The 
needle should be held firmly or wedged into the pulp chamber or the root 
canal. Initially, slight discomfort is felt by the patient which subsequently 
gets subsided. Sometimes the needle is bent to get a proper angle for good 
approach.  
 
Intraosseous injection technique 
In this method, the local anesthetic solution is deposited directly into 
the cancellous bone adjacent to the tooth to be anesthetised, between the 
two cortical plates of bone of maxilla and mandible.  
Intraosseous injection is usually an adjunct and is used when 
conventional methods have been tried and failed. Sometimes, it is 
impossible to obtain profound anesthesia of teeth and jaws by ordinary 
methods, not at least of sufficient intensity to allow extirpation of pulp and 
preparation of cavities, etc.  
This may be due to one of the following reasons: abnormal location 
of foramen and unusual density of external cortical plate. These difficulties 
are overcome by intraosseous technique.  
Advantage: it produces profound single tooth anesthesia.  
Disadvantage: specialised equipment and technique is needed.  
Technique: the soft tissues overlying the apex of the tooth are first 
anesthetized with paraperiosteal injections. This injection should be made 
either mesial or distal to the tooth to be anesthetised and slightly above the 
roots, in order to avoid injury to the teeth. An incision is made in the 
mucosa and the periosteum. A small opening or perforation is made in the 
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outer cortical layer of bone with the help of SS White HP-8 round bur. The 
drill is similar to 25-gauge needle. The local anesthetic solution is placed 
through outer cortical plate into cancellous bone with the help of a needle, 
which is inserted through the perforation made in the bone. That allows the 
local anesthetic solution to reach the nerve immediately. The needle with a 
blunt point is used. The needle should not be forced against resistance at 
any time. The needle used should be of such a gauge (usually 23 or 25-
gauge), that it fits snugly into the opening made in the bone to avoid 
possible leakage around the needle, while the local anesthetic solution is 
being injected. Here usually enough anesthesia is present to permit drilling 
through outer cortical plate painlessly. The drilling can be done either on 
the mesial or the distal side of the tooth to be treated.  
Procedure:  
1. Preliminary infiltration: In order to prevent trauma, a preliminary 
injection of a few drops of infiltration is made at the selected site before 
making a perforation. 
2. A small incision is made in the mucosa. The mucoperiosteum is 
elevated and then the buccal alveolar plate is perforated. 
3. The outer cortical plate is perforated at the point with a round bur 
numbered in a straight handpiece. 
4. The drill is directed almost at an angle of 45° to the long axis of the 
teeth directing it slightly palatally or lingually. Drill the external plate until 
it reaches cancellous bone. Stop drilling and withdraw the drill, until a drop 
of blood oozes out. The drill should not enter more than 2 or 3 mm. 
5. The needle is inserted into the opening created; and approximately 
0,5-1 ml of solution is slowly injected under pressure. Anesthesia by 
intraosseous method will not be of very long duration, possibly between 10 
and 20 minutes. If the operation is not completed, inject more solution and 
anesthesia will be re-established immediately. 
Precautions to be taken: 
1. Deposition of too much solution rapidly may produce signs and 
symptoms of toxic reactions, as the solution is rapidly absorbed in the 
cardiovascular system from cancellous bone. 
2. If for any reason, it is necessary to operate on the tooth at a later date, it 
is easy to find the drill hole and inject a small amount of solution. 
3. Never attempt to anesthetise more than one tooth on each side of the drill 
opening. This requires too much of local anesthetic solution which may 
produce toxic symptoms. The technique for intraosseous injection is 
essential in upper jaw, especially in anterior and bicuspid region. The 
beginners should get acquainted with upper anterior region before 
attempting lower teeth. To obtain intraosseous anesthesia in the mandible, 
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It is considered as a variation of intraosseous anesthesia. A needle is 
forced gently into the porous interseptal bone on either side of the tooth to 
be anesthetised. The local anesthetic solution is then forced under pressure 
into the cancellous bone. The solution is taken up by the pericementum and 
the apical nerves. The superficial mucous membrane should be anesthetised 
before the needle is inserted into the interseptal bone. This technique is 
more effective in children and young adults. The interdental septum is of 
cancellous bone and the solution quickly diffuses through the alveolar 
bone.  
Indication: in older patients, there is a great degree of recession of 
gingivae, wherein the intraligamentary anesthesia is not quite effective. 
Technique 1: the injection is given in the septum of two adjoining 
teeth, in between the two cortical plates. 
Procedure: the syringe with the needle is inserted into the interdental 
septum, exerting sufficient pressure on the dense outer layer of bone to 
reach the deeper cancellous structures. 
Technique 2: some operators advocate drilling the outer cortical plate 
similar to that for intraosseous injection. Then the needle is inserted into 
the opening made and then local anesthetic solution is deposited. The few 




TOPIC: NERVE BLOCKS IN THE MANDIBLE 
 
1. Intraoral 
2. Extraoral nerve blocks 
 
Intraoral nerve blocks 
Pterygomandibular block 
Other common names. Inferior alveolar nerve block, mandibular 
nerve block. 
Nerves anesthetised 
• Inferior alveolar nerve, along with its terminal branches such as 
incisive nerve and mental nerve  
• Lingual nerve 
• Long buccal nerve. 
Areas anesthetised 
1. Inferior alveolar nerve 
− pulps of all mandibular teeth from the last molar up to the central 
incisor in the midline 
− body of the mandible 
− inferior portion of the ramus of the mandible 
− buccal mucoperiosteum, in the region of mandibular anteriors, 
anterior to mandibular second premolar or anterior to the mental foramen 
− skin of the chin, skin of lower lip and mucosa of lower lip. 
2.  Lingual nerve 
− mucosa of anterior 2/3rd of the tongue, for both the general sensation 
as well as the special sensation (gustation; sensation of taste) 
− mucosa of floor of the oral cavity 
− lingual mucoperiosteum from the last molar tooth up to the central 
incisor in the midline 
− sublingual and submandibular salivary gland. 
3. Long buccal nerve 
− buccal mucoperiosteum in the region of mandibular molars or buccal 
mucoperiosteum posterior to mental foramen 
− adjacent part of vestibular mucosa 
− adjacent part of buccal mucosa 
− mucosa of retromolar fossa. 
Indications: 
1. Surgical procedures in the region of mandibular teeth in one quadrant. 
2. When buccal soft tissue anesthesia in the region posterior to mandibular 
second premolar is required. 
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3. When lingual soft tissue anesthesia is required. 
4. Restorative procedures in mandibular second premolar and molars. 
Contraindications: 
1. Presence of acute inflammation or infection in the area of injection. 
2. Patients who might bite either the lip or the tongue such as young 
children or mentally handicapped adults. 
Anatomical Landmarks 
• Mucobuccal fold in the region of premolars and molars 
• External oblique ridge 
• Anterior border of ramus of the mandible 
• Coronoid process 
• Coronoid notch 
• Retromolar triangle or fossa 
• Internal oblique ridge 
• Pterygomandibular raphe 
• Pterygomandibular space 
• Sulcus mandibularis 
• Occlusal plane of mandibular molars 
• Contralateral premolars 
• Buccal pad of fat. 
The most important bony landmark in the opinion of the author is the 
internal oblique ridge. The needle has to be on the medial side of the ridge 
to approach sulcus mandibularis or the inferior alveolar nerve; and on the 
lateral side for the long buccal nerve. 
Techniques. There are two techniques practised from time 
immemorial (Halstead). 
1. Direct technique: in this technique the inferior alveolar nerve is 
anesthetised first, hence it is known as «direct technique». 
2. Indirect technique: in this technique the inferior alveolar is anesthetized 
in the third position, hence it is known as «indirect technique» or 
«threepositional block technique». 
It is strongly recommended that the beginners should learn and 
master the indirect technique first; as it is easier, step by step and the 
chances of injury to inferior alveolar nerve are minimized. Further, in direct 
block technique, since the inferior alveolar nerve is anesthetised first, it is 
experienced that if the point of the needle is very close to or touching the 
nerve, the patient tends to jump because of shock-like pain and closes his 
mouth. This creates psychological fear for the later part of the injection 
technique. However, in case of indirect block technique, having deposited 
local anesthetic solution, for the long buccal nerve as well as for lingual 
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nerve, the subsequent penetration of the needle in the third position for 
inferior alveolar nerve is rendered painless. 
Direct technique. The nerves anesthetised are as follows: 
1st position: the direction is from the opposite side – for inferior alveolar 
nerve. 
2nd position: the direction is from the same side or opposite side – for 
lingual nerve. 
3rd position: the direction is from the opposite side – to inject between the 
external and internal oblique ridges-for long buccal nerve with separate 
injection 
Needle: a 25-gauge long needle is recommended. 
Target area: the target area is the inferior alveolar nerve as it passes 
downward through sulcus mandibularis towards the mandibular foramen 
before it enters the foramen. 
Position of the patient: semi-supine with mouth open; and the 
occlusal plane of the mandibular molars is parallel to the floor. 
Position of the operator: for the right inferior alveolar nerve block, 
the operator stands in front of the patient; and for the left inferior alveolar 
nerve block, the operator stands slightly behind and by the side of the 
patient. 
Height of injection 
− Place the index finger or thumb of the left hand on the external 
oblique ridge or the anterior border of the ramus of the mandible.  
− When the finger contacts the anterior border of the ramus, it is 
moved up and down until the greatest depth of the anterior border of the 
ramus is identified. This area is called the coronoid notch.  
− An imaginary horizontal line extends from the coronoid notch to the 
pterygomandibular raphe and determines the height of injection and is 
parallel to and 6-10 mm above the occlusal plane of mandibular molars. 
The palpating finger is then moved lingually across the retromolar 
triangle and onto the internal oblique ridge. 
The finger, still in line with the coronoid notch and in contact with 
the internal oblique ridge, is moved to the buccal side, taking with it the 
buccal pad of fat. This gives better exposure to the internal oblique ridge, 
the pterygomandibular raphe and the pterygotemporal depression. 
When palpating the intraoral landmarks with the thumb, the operator 
may place the index finger extraorally behind the ramus of the mandible, 
thus holding the mandible between the thumb and the index finger. In this 
manner the anteroposterior width of the ramus may be assessed. 
The depth of the needle penetration can be determined by estimating 
anteroposterior width of the mandibular ramus when the needle tip has 
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been advanced half the distance between the palpating thumb and the index 
finger. 
The syringe and the needle is then inserted at the previously 
described height of insertion from the opposite mandibular premolars, at a 
level bisecting the finger and penetrating the tissues of the 
pterygomandibular space. The flaring nature of the ramus of the mandible 
should be kept in mind. 
During insertion, the patient is asked to keep the mouth wide open. 
The needle is penetrated into the tissues until gently contacting bone on the 
medial surface of the ramus of the mandible. 
The needle is then withdrawn about 1 mm, aspiration done, to avoid 
intravascular administration of the local anesthetic solution and 0,8-1.0 ml 
of the solution is deposited slowly. 
The needle is then withdrawn slowly and when about one-half of its 
inserted depth has been withdrawn, 0,5 ml of the solution is injected in this 
area to anesthetise the lingual nerve. 
The long buccal nerve is anesthetised with a separate insertion; and 
is described in the indirect technique. 
Wait for 3-5 minutes and commence with the surgical or the dental 
procedure. 
Signs and Symptoms 
1. Tingling and numbness of the lower lip on the side of injection indicates 
anesthesia of the mental nerve, a terminal branch of inferior alveolar nerve. 
2. Tingling or numbness of one-half of the tongue on the side of injection 
indicates anesthesia of the lingual nerve. 
3. Absence of pain during the surgical procedure or the dental therapy. 
Failure of Anesthesia 
1. Deposition of solution below the level of the mandibular foramen. 
2. Deposition of solution too far anteriorly on the ramus. 
3. Accessory innervation to the mandibular teeth, such as, cervical 
accessory nerve (cutaneous coli), buccal nerve and mylohyoid nerve. 
4. Anatomical aberration, such as a bifid inferior alveolar nerve, with 
second mandibular foramen located more inferiorly, on the medial aspect 
of ramus of the mandible. 
5. Cross innervation: incomplete anesthesia of central incisors due to 
innervation from the contralateral inferior alveolar nerve or mylohoid 
nerve. 
Complications. Hematoma, trismus, transient facial paresis. 
Indirect Technique. This technique of anesthetising the branches of 




1st position: the direction is from the opposite side-to inject between the 
external and internal oblique ridges-for long buccal nerve. 
2nd position: the direction is from the same side-for lingual nerve. 
3rd position: the direction is from the opposite side-for inferior alveolar 
nerve. 
1. Place the index finger in the mucobuccal fold in the region of 
mandibular premolars and molars. 
2. Move the index finger posteriorly, until it is deflected upwards by the 
external oblique ridge and the ascending part of the ramus until the 
coronoid process is reached. 
3. Keeping the ball of index finger in contact with the anterior border of the 
coronoid process, move the finger downward until the deepest part of the 
ascending ramus is located. This is known as «coronoid notch». 
4. Keep the bulbous portion of the index finger in contact with the external 
oblique ridge. At the coronoid notch, rotate the finger so that the fingernail 
is turned towards the sagittal plane. 
5. Maintain pressure against the coronoid notch, slide the index finger 
lingually. First a depression will be felt which is the retromolar triangle; 
and next another ridge, the internal oblique ridge. 
6. Keep the distal phalanx of the index finger in contact with both the 
external and internal oblique ridges and move the finger lingually for about 
½” and then buccally, carrying under the distal phalanx the buccal pad of 
fat back to the cheek, away from the internal oblique ridge, which is 
partially covered. 
7. When the tip of the finger rests over the internal oblique ridge, ask the 
patient to open the mouth as wide as possible. 
8. Take a preloaded syringe with the local anesthetic solution, mounted 
with a 15/8 needle, in a pen grasp, with the barrel over the contralateral 
bicuspid area, insert the needle in the mucous membrane at the center of 
the index finger nail. Keep the syringe parallel to the occlusal plane of the 
mandibular teeth or the mandibular ridge. Again, the flaring nature of the 
ramus of the mandible should be borne in mind. 
9. The tissues should be penetrated in such a way that 1/4th or 1/3rd of the 
needle should remain outside the soft tissues. In majority of patients this 
will result in the tip of the needle resting directly over the sulcus 
mandibularis. In patients with exceptionally large or small skeleton, the 
width of the ramus can be measured by placing the thumb over the 
coronoid notch on the anterior border of the ramus and the index finger on 




10. The patient is asked to keep his mouth open wide until injection is 
completed. The operator must not attempt to contact bone. The operator's 
left index finger is held in position. Deposit local anesthetic solution slowly 
and watch the patient for abnormal reaction. At least 2 minutes should be 
taken to deposit 2 ml of solution for all the three positions (rate of 
deposition: ideal rate: 1 ml/min. recommended rate: 1,8 ml/min). 
11. Withdraw the needle slowly until approximately ¼ of the needle is in 
the tissues. 
12. Deposit 0,5 ml of local anesthetic solution, to anesthetise the lingual 
nerve. Many times the long buccal nerve is also anesthetised at the same 
point. 
13. Long buccal nerve injection: Hold the syringe with a 25-gauge and 1" 
needle, ready to inject at an angle of 45° to the body of the mandible 
keeping the bevel of the needle facing the bone. The tissue in the 
mucobuccal fold is entered just distal to the most posterior tooth or the area 
to be subjected to surgery. About 0,25-0,5 ml of local anesthetic solution is 
deposited. The anesthesia is obtained within 2-3 minutes. 
14. Wait for subjective symptoms. These are: a feeling of warmth or 
tingling sensation in the lip, which starts at the corner of the mouth and 
spreads until it reaches the midline of the lip. The tingling changes into a 
gradually increased feeling of profound numbness; the lip may also feel 
swollen; the tip and side of the tongue tingle and then become numb. For 
profound anesthesia, the operator must wait for 5 to 10 minutes. 
 
Long buccal nerve block 
The long buccal nerve is usually anesthetised as a part of 
pterygomandibular block in indirect technique. 
Other common names. Buccinator nerve block, buccal nerve block. 
Nerves anesthetised. Long buccal branch of the mandibular nerve. 
Areas anesthetised. Mucoperiosteum buccal to the mandibular molar 
teeth, vestibular mucosa, adjacent part of buccal mucosa and mucosa of the 
retromolar fossa. 
Indications. When anesthesia of buccal soft tissues in the mandibular 
molar region is required for oral or periodontal surgical procedures. 
Contraindications. Presence of acute inflammation or infection in the 
area of injection. 
Advantage:  high success rate. Technically easy 
Disadvantag. It has a potential for pain if the needle contacts 






• Ascending ramus of the mandible 
• External oblique ridge 
• Retromolar triangle 
• Internal oblique ridge 
• Last molar tooth. 
Technique 
Area of insertion: it is the area of mucous membrane distal and buccal to 
the most distal tooth or the last molar tooth. 
Target area: the long buccal nerve as it crosses the anterior border of the 
ramus. 
Needle: a 1 inch 25-gauge needle is inserted into the mucosa just distal and 
buccal to the last molar tooth between the external and internal oblique 
ridges and 0,25 to 0,5 ml of solution is deposited in this area. 
Alternative Techniques 
1. Insert the needle and deposit the solution directly into the retromolar 
triangle. 
2. Insert the needle in the mucoperiosteum just buccal to the last molar 
tooth. 
Signs and symptoms. The patient rarely experiences any subjective 




Mental nerve block and incisive nerve block 
Nerve anesthetised. The terminal branches of inferior alveolar nerve: 
Mental nerve and Incisive nerve. 
Areas anesthetised 
1. Labial mucous membrane anterior to the mental foramen, usually 
from the first premolar up to the midline. 
2. Skin of the lower lip and chin. 
3. Pulpal nerve fibers of the first premolars, canines and incisors. 
4. Periodontium and the supporting alveolar bone of these teeth. 
Indications 
1. Dental restorative procedures requiring pulpal anesthesia of multiple 
mandibular anterior teeth. 
2. When inferior alveolar nerve block is not indicated, e.g. when six or 
eight anterior teeth are treated, the incisive nerve block is recommended in 
place of bilateral inferior alveolar nerve blocks. 
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3. When buccal soft tissue anesthesia is required for procedures in the 
mandible anterior to the mental foramen, such as: soft tissue biopsies and 
suturing of soft tissues. 
Contraindications. Presence of acute inflammation or infection in the 
area of injection. 
Advantages 
1. High success rate. 
2. Technically easy. 
3. Usually entirely atraumatic. 
4. Produces pulpal anesthesia, as well as soft and hard tissue anesthesia 
without lingual anesthesia. It is useful instead of bilateral inferior alveolar 
nerve blocks. 
Disadvantages 
1. It does not produce lingual anesthesia 
2. Partial anesthesia may develop at the midline because of the overlap of 
the nerve fibers from those of the opposite side. 
Anatomical landmarks 
Mandibular bicuspids; since the mental foramen usually lies below the 
apex of the second bicuspid or below and between the apices of first and 
second bicuspids. 
Technique  
The positions of the apices of the bicuspid teeth should be estimated. 
A 1 inch, 25, gauge needle is inserted into the mucobuccal fold after the 
cheek has been pulled laterally. 
The tissue is penetrated until the periosteum of the mandible is gently 
contacted slightly anterior to the apex of the second bicuspid. 
About 0,5 to 1,0 ml of local anesthetic solution is deposited in the area. 
Signs and symptoms. Tingling or numbness of the lower lip. Lack of 
pain during the surgical or dental restorative procedure. 
Failure of anesthesia 
1. Inadequate volume of anesthetic solution in the mental foramen, with 
subsequent lack of pulpal anesthesia. 
2. Inadequate diffusion of the solution into the mental foramen. To correct 
this, apply firm pressure over the injection site for 2 minutes, in order to 
force anesthetic solution into the mental foramen. 
Complications. Complications are rare, with rare occurrence of 
hematoma. 
 
Gow-Gates' mandibular nerve block 
Nerves anesthetised. The entire mandibular branch of trigeminal 
nerve is anesthetised, which includes the following: inferior alveolar nerve 
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along with its terminal branches; mental and incisive nerves, lingual, 
mylohyoid,  auriculotemporal and long buccal nerves. 
Areas anesthetised 
1. All mandibular teeth up to the midline on the side of injection 
2. Buccal mucoperiosteum on the side of injection 
3. Mucosa of the anterior 2/3rds of the tongue and floor of the mouth 
4. Lingual mucoperiosteum from the last standing molar tooth up to the 
central incisor in the midline 
5. Body of the mandible and inferior portion of the ramus, etc. 
6. Skin over the zygoma, posterior portion of the cheek and temporal 
regions, etc. 
Indications 
1. Surgical procedures on mandibular body and the ramus. 
2. When buccal soft tissue anesthesia from the third molar up to the 
midline is required. 
3. Surgical procedures in the tongue and the floor of the mouth. 
4. When conventional inferior alveolar nerve blocks are unsuccessful. 
5. Restorative procedures on multiple teeth. 
Contraindications 
1. Presence of infection or acute inflammation in the area of injection. 
2. Patients who might bite either their lip or the tongue, such as young 
children and mentally challenged adults. 
Anatomical landmarks 
Extraoral landmarks: external ear, intertragic notch of the ear, corner 
of the mouth. 
 Intraoral landmarks: ANTERIOR border of the ramus of the mandible, 
tendon of temporalis muscle, mesiopalatal cusp of maxillary second molar. 
Technique  
Target area: LATERAL side of the condylar neck, just below the insertion 
of the lateral pterygoid muscle. 
Procedure 
Position of the patient: the patient is placed in semi-supine position. 
Position of the operator: the operator stands in front of the patient for right-
sided block; and by the side of the patient for left-sided block. 
Identification of the landmarks: 
The operator visualises the landmarks and an imaginary line is drawn 
from the corner of the mouth to the intertragic notch of the ear. 
The anterior border of the ramus and the coronoid process is palpated 
with the help of the thumb of the left hand. This helps in retraction of 
tissues and determination of the site of nerve penetration. 
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Configuration of the needle: the recommended gauge and length of 
the needle are 25 and 40 mm respectively.  
The patient is advised to keep mouth widely open and to remain in 
that position until the injection is completed. This position moves the 
condyle anteriorly, thus facilitating the injection. 
The operator takes a preloaded syringe and aligns the barrel of the 
syringe with the plane extending from the corner of the mouth to the 
intertragic notch directing the syringe from the corner of the mouth on the 
opposite side. 
The needle is gently inserted into the mucous membrane just distal to 
the last maxillary molar tooth present, at the height of the mesiopalatal cusp 
of maxillary second molar. When the third molar is present, the site of 
penetration is distal to the third molar lateral to pterygotemporal depression 
and medial to the tendon of temporalis muscle. 
Site and height of penetration: depth of penetration: the needle is 
advanced slowly until bone is contacted at the neck of the condyle. The 
average depth of soft tissue penetration is 25 mm. 
If bone contact is not established, the needle should be withdrawn 
slightly and redirected until the bone contact is made. 
If aspiration is negative, then 3 ml of local anesthetic solution is 
deposited slowly over 60-90 seconds. 
Withdraw the syringe and keep the needle covered. 
Ask the patient to keep the mouth open for 2-3 minutes to allow 
adequate diffusion of local anesthetic solution and bathing of the nerve 
trunk with the solution. 
The onset of anesthesia with this technique is somewhat slower, 
requiring 5-7 minutes. 
Signs and symptoms 
1. Numbness or tingling sensation of the lower lip 
2. Numbness or tingling sensation of the tongue 




3. Temporary paralysis of cranial nerves II, IV and VI. 
 Failure of anesthesia: 
1. Too little volume of local anesthetic solution is deposited. 






Akinosi (closed mouth) mandibular nerve block 
It was described by Joseph Akinosi in 1977. 
Nerves anesthetised 
The entire mandibular branch of trigeminal nerve, comprising of inferior 
alveolar nerve along with its terminal branches; mental and incisive nerves, 
lingual and mylohyoid nerves are anesthetised, except the long buccal  
nerve. 
Areas anesthetised 
1. All mandibular teeth on the side of injection up to the midline. 
2. Body of the mandible and inferior portion of the ramus. 
3. Buccal mucoperiosteum and mucous membrane in front of the 
mental foramen. 
4. Mucous membrane of the anterior 2/3rd of the tongue and floor of 
the oral cavity. 
5. Lingual soft tissues and periosteum. 
Indications 
1. Limited mandibular opening. 
2. Multiple procedures on mandibular teeth. 
3. Inability to visualise the landmarks for inferior alveolar nerve block. 
Contraindications 
1. Presence of acute inflammation or infection in the area of injection. 
2. Patients who might bite their lip or tongue, such as young children and 
mentally challenged adults. 
3. Inability to visualize or gain access to the lingual aspect of the ramus. 
Advantages 
1. Relatively atraumatic. 
2. Patient need not be able to open his mouth. 
3. Fewer postoperative complications (i.e. trismus). 
4. Lower aspiration rate than with inferior alveolar nerve block. 
5. Provides successful anesthesia where a bifid inferior alveolar nerve and 
bifid mandibular canals are present. 
Disadvantages 
1. Difficult to visualise the path of the needle and the depth of insertion. 
2. No bony contact, so the depth of penetration is somewhat arbitrary. 
3. Potentially painful if the needle is too close to periosteum. 
Anatomical Landmarks 
1. Occlusal plane of teeth in occlusion. 
2. Mucogingival junction of maxillary molar teeth. 
3. Anterior border of ramus of the mandible. 





Needle: the recommended length is 1½” or 38-40 mm and the gauge 
is 25. 
Bevel: the position of the bevel of the needle in the closed mouth 
mandibular block is very significant. It must be facing away from the bone 
of mandibular ramus and towards the midline. 
Height of injection: with Akinosi's technique it is below that of Gow-
Gates' technique but above that of inferior alveolar nerve block. 
Target area: the soft tissues on the medial border of ramus of the mandible 
in the region of inferior alveolar nerve as it travels towards the mandibular 
foramen, lingual nerve and mylohyoid nerves and vessels.  
Procedure 
Position of the patient: the patient is seated in semireclining position 
with head, neck and shoulder adequately supported. 
Position of the operator: the operator stands in front of the patient for both 
right-sided as well as left-sided block. 
Preparation of the tissues: the site of penetration is prepared by topical 
application of antiseptic and anesthetic solutions. 
The patient is asked to bring teeth in occlusion. This aids in 
relaxation of cheek musculature and helps in good visualization of the 
landmarks. 
The operator retracts the patient's lips and cheek exposing the maxillary 
and the mandibular teeth on the ipsilateral side. 
The preloaded syringe with the recommended needle is taken and the 
barrel of the syringe is aligned parallel to the occlusal and sagittal plane but 
positioned at the level of the mucogingival junction of the maxillary 
molars. 
The needle penetrates the mucosa in the embrasure just medial to the 
ramus lateral to maxillary tuberosity and is inserted approximately 1½ or 
25-30 mm. The tip of the needle lies in the target area in the midportion of 
pterygomandibular space, close to the branches of mandibular nerve. 
Following negative aspiration, about 2 ml of local anesthetic solution 
is slowly deposited approximately 1 minute. 
Motor nerves paralysis will develop as quickly or more quickly than 
sensory anesthesia. The patient with trismus will begin to notice increased 
ability to open the jaws shortly after the deposition of local anesthetic 
solution. 
Anesthesia of the lips and tongue will be noticed in 40-90 seconds 
and the surgical procedures can be usually started within 5 minutes  




Failure of anesthesia 
1. Failure to appreciate the flaring nature of the ramus which deflects the 
needle more medially if, internal oblique ridge is not negotiated by keeping 
the syringe nearly at an angle of 90º (perpendicular) to the medial surface 
of ascending ramus. This can be easily achieved by retracting the angle of 
the mouth posteriorly with the barrel of the syringe. 
2. Point of needle insertion is too low. 
3. Underinsertion or overinsertion of the needle as no bone is contacted in 
this technique, the depth of soft tissue penetration is somewhat arbitrary. 
Akinosi recommended a penetration depth of 25 mm in the average sized 
adult measuring from the maxillary tuberosity. 
Complications 
1. Hematoma, rarely.  
2. Trismus, rarely.  
3. Transient facial nerve paresis due to overinsertion of the needle and 
deposition of the solution into the body of the parotid gland, near the 
posterior border of the ramus of the mandible. 
 
Extraoral techniques  
Anesthetic technique for mandibular nerve 
Nerves anesthetised. Mandibular nerve and its subdivisions; 
composed of branches from the anterior trunk and branches from the 
posterior trunk. 
Areas anesthetised. The entire region innervated by mandibular 
nerve and its subdivisions. Temporal region, auricle of the ear, external 
auditory meatus, temporomandibular joint, salivary glands, anterior 2/3rd 
of the tongue, floor of the mouth, mandibular teeth, gingivae, buccal 
mucosa, lower portion of the face (except the angle of the jaw). 
Indications 
1. Presence of acute inflammation or infection at the site of injection for the 
subdivisions of mandibular nerve. 
2. Presence of trauma that would contraindicate or make it difficult or 
impossible to anesthetise the subdivisions of mandibular nerve. 
3. Whenever there is need to anesthetise the entire mandibular nerve and its 
subdivisions, with one single penetration and minimum of local anesthetic 
solution for extensive surgical procedures. 
4. For diagnostic and therapeutic purposes. 
Anatomical Landmarks 
These are common to those for extraoral maxillary nerve block; and are as 
follows: 
− Midpoint of zygomatic arch. 
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− Coronoid process of the ramus of the mandible; and prominence of 
the lateral pole of the condyle; which is located by having the patient open 
and close his mouth. 
− Lateral pterygoid plate. 
Technique 
The technique for mandibular nerve block is essentially the same as 
that for maxillary nerve block. The difference is that the marker is placed 
on the needle at a distance of 5 cm. 
The needle contacts the lateral pterygoid plate, then it is withdrawn 
exactly in the same way as in the maxillary nerve block; however, when it 
is reinserted, the needle is directed upward and slightly posteriorly; in order 
for the needle to pass posterior to lateral pterygoid plate. The needle 
should not be introduced to a depth greater than measured 5 cm.  
Structures. The structures through which the needle passes and the 
structures adjacent to the needle when it is in contact with the lateral 
pterygoid plate are: 
a. Structures through which the needle passes: skin, subcutaneous tissue, 
masseter muscle, sigmoid notch, lateral pterygoid muscle. 
b. Structures in the vicinity of the needle when the needle is in contact with 
lateral pterygoid plate. 
Superiorly: base of the skull. 
Internal maxillary artery; as it crosses inferiorly and curves upwards 
anterior to it, entering the lower part of pterygomaxillary fissure. 
Temporal vessels for internal maxillary artery that may lie on either side of 
it. 
Superficially: the transverse facial artery which may lie above or below it. 
Posteriorly: foramen ovale and posterior to it foramen spinosum. 
Anteriorly: pterygomaxillary fissure through which the needle may pass 
into pterygopalatine fossa. 
Signs and Symptoms 
Subjective: tingling sensation and numbness of lower lip and anterior 2/3rd 
of the tongue. 
Objective: 
− Demonstration of difference in feeling of lower teeth while opening 
and closing the jaws. 
− Lack of demonstration of pain with instrumentation. 
− Absence of pain during surgical procedure. 





TOPIC: NERVE BLOCK ANESTHESIA IN THE MAXILLA 
 
1. Intraoral nerve blocks: 
− infraorbital nerve block,  
− posterior superior alveolar nerve block,   
− nasopalatine nerve block,  
− greater palatine nerve block,  
− maxillary nerve block. 
2. Extraoral blocks. 
 
Intraoral nerve blocks 
Infraorbital nerve block 
There are two approaches to execute the infraorbital nerve block; the 
bicuspid and the central incisior. The nerves and the areas anesthetised, 
indications, contraindications and advantages are same for both the 
approaches. A good knowledge of anatomical landmarks and adherence to 
injection protocol are essential for this procedure. 
Other names. Anterior superior alveolar nerve block. 
Nerves anesthetized 
1. Anterior superior alveolar nerve. 
2. Middle superior alveolar nerve. 
3. Infraorbital nerve-along with its terminal branches on the face: Inferior 
palpebral, lateral nasal and superior labial nerves. 
Areas anesthetized 
The following structures, on the side of injection, are anesthetized: 
1. Pulps of maxillary central and lateral incisors and canine. 
2. Pulps of maxillary premolars and mesiobuccal root of first molar. 
3. Supporting alveolar bone and the labial or buccal periodontium of these 
teeth. 
4. Overlying labial or buccal mucoperiosteum in the region of incisors, 
canine and premolars. 
5. Skin of lower eyelid and both surfaces of conjunctiva, skin of lateral 
aspect of the nose and skin and mucosa of upper lip. 
Indications 
1. Oral and periodontal surgical procedures in the soft and hard tissues 
involving more than two maxillary teeth, such as apicoectomies, 
alveolectomies of maxillary anterior regions, impacted canines and cysts. 
2. Restorative and endodontic procedures involving more than two 
maxillary teeth. 
3. Presence of acute inflammation or infection at the site of injection. 
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4. Presence of dense cortical bone that makes any infiltration technique 
ineffective. 
Contraindications 
1. Discrete treatment areas (one or two teeth only). 
2. When hemostasis in the area of surgery is desirable. In such situations, 
an additional local infiltration into the area is indicated. 
Advantages 
1. The techniques are comparatively simple, easy and safe. 
2. The techniques minimize the volume of solution to be injected and the 
number of needle punctures to be made in order to achieve the desired 
anesthesia. 
3. The incisor approach lessens possibility of inadvertently entering the 
orbit. 
4. It permits deeper penetration into the infraorbital canal, since the 
direction of the needle is parallel to the direction of the canal. 
Disadvantages 
Bicuspid approach: 
1. Psychological: fear of injury to the patient's eye 
2. Anatomical: difficulty in defining landmarks. 
Incisor approach: 
1. There are higher chances of injuring the infraorbital neurovascular 
bundle with deeper penetration into the infraorbital canal. 
Anatomical Landmarks 
Bicuspid approach: all the following structures on the ipsilateral side, such 
as (1) infraorbital margin, (2) infraorbital depression, (3) infraorbital 
foramen, (4) first bicuspid, (5) mucobuccal fold in the region of this tooth, 
(6) pupil of the ipsilateral eye in the forward gaze, (7) angle of the mouth 
and (7) mental foramen. 
Incisor approach: other additional landmarks: (1) central incisor and 
canine on the ipsilateral side and (2) mucobuccal fold in the region of 
canine. 
Approximating structures with the tip of the needle in the final 
position 
The structures in the vicinity of the tip of the needle in the final 
position when the infraorbital nerve comes out of infraorbital foramen are: 
(i) the infraorbital head of quadratus labii superioris muscle is above and 
(ii) the origin of levator anguli oris (caninus) muscle is below. 
Approaches 
Bicuspid approach: THIS technique is comparatively easy and is 
recommended for the beginners. The bicuspid approach is simple and 
causes minimal complications. The needle passes through the mucosa and 
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areolar tissue and during insertion should pass beneath and lateral to the 
facial artery and facial vein. 
Technique: 
Position of the patient: the patient is placed comfortably in the chair so that 
the maxillary occlusal plane is at an angle of 45° to the floor. 
Position of the operator: the operator stands on the right side of patient for 
right-sided block; and stands in front of the patient for the leftsided block. 
Preparation of the tissues: the tissues at the site of injection are prepared 
with an antiseptic. 
Needle: long and 25-gauge needle is recommended. 
Bevel: the bevel is positioned in such a way that it is facing the bone.  
Depth of penetration: 3/4th of an inch of the needle penetrates the soft 
tissues. 
Area of insertion: At the height of mucobuccal fold, or 4-5 mm away from 
the buccal cortex of maxilla in the region of first bicuspid. 
Target area: infraorbital nerve as it comes out of infraorbital foramen. 
Procedure 
Palpation of the anatomical landmarks: locate the infraorbital 
margin. 
Move your finger downward from the margin, applying gentle pressure to 
the tissues. As the finger continues inferiorly, a concavity will be felt. This 
is the infraorbital depression. The deepest part of the depression is the 
infraorbital foramen. 
Maintain your finger on the foramen or mark the skin at the site. 
Retract the lip, pulling the tissues in the mucobuccal fold taut, thus 
increasing the visibility. 
Take a preloaded syringe and insert the needle into the height of the 
mucobuccal fold over the first bicuspid with the bevel facing the bone. 
Orient the syringe towards the infraorbital foramen. 
The needle should be held parallel to the long axis of the tooth as it is 
advanced to avoid premature contact with the bone, initially. 
Advance the needle until bone is gently contacted. 
Care should be taken to protect the eye with thumb/finger to limit the 
passage of the needle towards the eye. 
Central incisor approach: The needle passes through mucosa and 
areolar tissue and beneath the levator labii superioris (angular head of the 
quadratus labii superioris) muscle. It then passes anterior to the origin of 
levator anguli oris (caninus) muscle and beneath the facial artery and facial 
vein. 
Technique. There are certain steps which are common to both the 
approaches, such as position of the patient, position of the operator, 
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preparation of the tissues, configuration of the needle and palpation of the 
anatomical landmarks; and are mentioned with the bicuspid approach. 
Area of insertion: In the central incisor approach, the direction of the 
needle is such that it bisects the crown of the ipsilateral central incisor from 
the mesioincisal angle to the distogingival angle. The area of insertion is at 
the height of mucobuccal fold, or 4-5 mm away from the labial cortex of 
maxilla in the region of ipsilateral canine. The needle is inserted about 5 
mm from the mucobuccal fold in the region of ipsilateral canine. 
Target area: Infraorbital nerve, as it comes out of infraorbital foramen, 
between levator labii superioris muscle above and levator anguli oris 
muscle below. 
Procedure: 
Palpation of the anatomical landmarks: this is done in the same way 
as for the bicuspid approach. 
The needle is guided into the position by the thumb pressing over the 
infraorbital depression and marking the location of the infraorbital 
foramen). 
In either approach, the needle should not penetrate more than 3/4th of 
an inch. Approximately, 1 ml of solution is slowly deposited in this area 
and the thumb is held in position until the injection is completed. 
The surgeon will be able to feel the anesthetic solution, as it is 
deposited beneath the finger on the foramen, if the needle tip is in the 
correct position. 
Maintain firm pressure with the finger over the injection site both 
during and for at least one minute after the injection. 
Massage the tissue postero-superiorly so that the solution can easily 
diffuse through into the infraorbital foramen. 
Wait for 3-5 minutes after completion of the injection before commencing 
the dental procedure. 
Signs and symptoms: 
1. Subjective: Tingling and numbness of the lower eyelid, side of the 
nose and upper lip. 
2. Objective: comparing the sensation produced with tapping of 
anesthetized and adjacent unanesthetised teeth with an instrument; no pain 
during oral surgical or periodontal surgical procedures or dental therapy. 
Complications.  
1. Hematoma: it may rarely develop.  
2. Paresis of face: it occurs when the injection is given superficially, when 
the needle lies in the vicinity of muscles of facial expression or the nerves 




Failure to obtain anesthesia: 
1. Poor injection technique: 
− needle contacting bone below the infraorbital foramen. to correct, 
withdraw the needle a little, keeping the tip of the needle inside the soft 
tissues, redirect upwards towards the infraorbital foramen. 
− needle deviation medial or lateral to the infraorbital foramen. to 
correct, withdraw the needle a little, keeping the tip of the needle inside the 
soft tissues, redirect towards the infraorbital foramen. 
2. Intravascular administration: Deposition of the local anesthetic 
solution into a vessel. 
 
Posterior superior alveolar nerve block 
Factors to be considered. The factors to be considered prior to giving 
a posterior superior alveolar nerve block are as follows: 
1. Nerve supply of first molar: the posterior superior alveolar nerve block is 
effective for the anesthesia of maxillary third, second and first molar. 
However, the mesiobuccal root of the maxillary first molar is not 
consistently innervated by the posterior superior alveolar nerve. 
Therefore, a second injection, usually a paraperiosteal, is indicated 
following the Posterior Superior Alveolar Nerve Block, when effective 
anesthesia of the first molar does not develop. 
2. Risk of hematoma formation: in the target area, the needle lies in close 
proximity with the pterygoid plexus of veins. In order to reduce the 
incidence of hematoma, the following measures are recommended: 
− Use short needles (1" or 25 mm in length). With this length 
overinsertion is avoided. 
− Always aspirate before deposition of the solution to avoid 
inadvertent intravascular injection. 
− Use 25-gauge needle, as it facilitates aspiration. 
− The needle should be oriented at an angle of 45° to the maxilla, in 
posterior, superior and medial direction. 
3. Patient's skull size: this gives an idea of the depth of soft tissue 
penetration. 
Other Names. Tuberosity block, Zygomatic block. 
Nerves Anesthetised Posterior superior alveolar nerves and its 
branches. 
Areas Anesthetised 
1. Pulps of maxillary third, second and first molar (except the mesiobuccal 
root). 




3. Adjacent lining of maxillary sinus. 
Indications 
1. Oral surgical or periodontal surgical procedures in the area of maxillary 
molars. 
2. Restorative procedures involving two or more maxillary molars. 
3. When paraperiosteal injection is contraindicated as in the presence of 
acute inflammation or infection. 
4. When paraperiosteal injection has failed. 
Contraindication 
When the risk of hemorrhage is high, as in a case of hemophilic. In such 
cases, a paraperiosteal or intraligamentary injection is recommended. 
Advantages 
− atraumatic,  
− high success rate,  
− minimizes the number of penetrations required,  
− minimizes the total volume of anesthetic solution injected. 
Disadvantages 
− risk of hematoma,  
− technique is somewhat arbitrary, as there are few bony landmarks 
during insertion,  
− second injection is required for anesthetising the first molar. 
Technique  
Needle: a 25-gauge, short needle of 25 mm in length is recommended. 
Bevel: the position of the bevel of the needle should be facing the bone. 
Point of insertion: it is at the height of mucobuccal fold in the region of the 
distal surface of maxillary second molar. 
Depth of insertion: it is approximately 16 mm. 
Target area: the posterior superior alveolar nerve as it enters the posterior 
or the infratemporal surface of maxilla. This nerve is located 
posterosuperior and medial to maxillary tuberosity.  
Anatomical landmarks: 
− mucobuccal fold in the region of maxillary second molar 
− maxillary tuberosity 
− zygomatic process of maxilla or the buttress of zygoma 
− infratemporal surface of maxilla 
− anterior border and coronoid process of the ramus of the mandible. 
Procedure 
Position of the patient: the patient is placed in semi-supine position with 




Position of the operator: 
− for right-sided injection the operator stands by the side of the patient. 
− for left-sided injection the operator stands in front of the patient. 
Preparation of the tissues: The site of injection is prepared with the 
application of an antiseptic, followed by application of a topical anesthetic. 
Partially open the patient's mouth, pulling the mandible to the side of 
injection and maxillary occlusal plane at an angle of 45° to the floor. 
Retract the cheek, pulling the tissues taut. 
Palpation of the landmarks. 
Technique I 
Place the index finger in the mucobuccal fold in the region of 
bicuspids and move it in the posterior direction till the prominence of the 
buttress of the zygoma is reached, which is approximately located above 
the first molar. At this point the index finger is rotated so that the fingernail 
is facing the attached gingiva, but the finger tip is still in contact with the 
prominence of the buttress. Pass the finger over the prominence and it will 
dip superiorly in the sulcus posterior to the buttress. 
Retract the finger laterally to expose the depth of the sulcus posterior 
and superior to the buttress. Adjust the finger so that it is in a plane at right 
angle to the occlusal plane of the maxillary teeth and at an angle of 45º to 
the patient's sagittal plane, posterior to the buttress of the zygoma. 
The point of the needle in this position should be located in the depth 
of the sulcus, above the roots of the third molar and anterior to the 
maxillary tuberosity close to the lateral surface of the maxilla. 
The needle of the preloaded syringe is inserted into the tissue in a 
line parallel to the index finger and bisecting the fingernail with the bevel 
of the needle facing the bone. 
Technique II 
Take a preloaded syringe. Insert the needle at the height of the 
mucobuccal fold, in the region of maxillary second molar. 
Advance the needle slowly superiorly, posteriorly and medially, in 
one movement. 
Superiorly: At an angle of 45° to the occlusal plane. 
Medially: At an angle of 45° to the sagittal plane. 
Posteriorly: At an angle of 45° to the coronal plane. 
In an adult of normal size, penetration to a depth of 16 mm will place 
the needle tip in the target area, in the immediate vicinity of the foramina 
through which the posterior superior alveolar nerves enter the posterior 
surface of maxilla. 
Aspirate, if negative, deposit approximately 0,5-1,0 ml of local 
anesthetic solution slowly. 
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Withdraw the syringe slowly. 
Cover the needle with its sheath and keep it in a safe place. 
Wait for 3-5 minutes and start the procedure. 
Signs and symptoms of anesthesia 
1. Subjective: it is difficult to determine the extent of anesthesia 
subjectively. Feeling of numbness in the area of distribution of posterior 
superior alveolar nerve. 
2. Objective: absence of pain with instrumentation and during the 
procedure. 
Failure to Achieve Anesthesia 
1. Poor injection technique: 
− needle too lateral: to correct, withdraw a little and redirect the needle 
tip medially. 
− needle too low: to correct, withdraw a little and redirect the needle tip 
superiorly. 
− needle too far posterior: to correct, withdraw the needle and redirect it 
anteriorly. 
2. Intravascular administration: Deposition of the local anesthetic solution 
in pterygoid plexus of veins and in posterior superior alveolar artery. 
Complications. Hematoma: it is due to insertion of the needle too far 
posteriorly into the pterygoid plexus of veins. It is recommended that we 
use short needles to minimise the risk of puncturing the pterygoid plexus of 
veins and posterior superior alveolar artery. This can be seen immediately 
with the appearance of bluish swelling at the puncture point or copious 
bleeding on withdrawal of the needle. 
Mandibular anesthesia: the mandibular division of trigeminal nerve 
is located lateral and posterior to posterior superior alveolar nerves. 
Deposition of local anesthetic agent lateral to the desired location can 
produce varying degrees of mandibular anesthesia. In such situations 
patients will complain of anesthesia in the lip and tongue. 
 
Nasopalatine nerve block 
It is a potentially painful injection. 
Other common names. Incisive nerve block, sphenopalatine nerve 
block. 
Nerves anesthetised. Nasopalatine nerves bilaterally. These nerves 
emerge from incisive foramen beneath the incisive papilla 1 cm behind 
maxillary central incisors in the midline. 
Areas anesthetised. Anterior portion of the hard palate (palatal 
mucosa) from the mesial of the 





1. Oral surgical or periodontal surgical procedures involving palatal soft 
and hard tissues. 
2. When anesthesia of palatal soft tissues is required for any restorative 
procedure on more than two teeth. 
Contraindications 
1. Presence of acute inflammation or infection at the site of injection. 
2. Whenever there are smaller areas of dental or surgical procedures (one or 
two teeth). 
Advantages 
1. It minimises multiple needle penetrations and reduces the volume of 
local anesthetic solution to be deposited. 
2. It minimises patient discomfort from multiple needle penetrations.  
Disadvantages 
1. There is no hemostasis except in the immediate area of injection. For 
achieving hemostasis in the areas away from deposition of the solution 
additional infiltration has to be given in the area of surgery. 
2. It is potentially the most painful intraoral injection, if the preliminary 
preparatory injections are not employed. 
Anatomical Landmarks 
• Maxillary central incisor teeth 
• Incisive papilla in the midline of the palate 
• Incisive foramen. 
Technique 
Needle: the recommended gauge is 25 or 27 and the recommended length 
is 1" or 25 mm. 
Area of penetration: the palatal mucosa or the halo surrounding the incisive 
papilla. 
Target area: the nasopalatine nerve as it comes out of incisive foramen, 
beneath the incisive papilla. 
Path of insertion: making an angle of 45º to the incisive papilla, 
approaching from the side. 
Bevel: it is facing the palatal soft tissues or facing the palatal bone. 
Procedure. The nasopalatine nerve block is an extremely painful 
injection and hence a preparatory injection is necessary. It is recommended 
that the needle should not penetrate incisive papilla directly. 
Preparatory injections. There are two methods of giving preparatory 
injections. These make the entrance into papilla less painful. 
Labial approach: the preparatory injection is made by inserting the 
needle into the labial intraseptal tissues in between the maxillary central 
54 
 
incisors. The needle is inserted at a right angle to the labial cortical plate 
and passed into the tissues until resistance is felt. Then 0,25 ml of local 
anesthetic solution is deposited.  
Palatal approach: the tip of the needle should be placed in the halo 
or the depression surrounding incisive papilla and a small amount or a few 
drops of local anesthetic solution is injected until papilla blanches. In both 
the palatal and labial approaches, it is advisable to start injecting slowly as 
soon as the needle enters the mucosa. The palatal preparatory injection is 
preferred as the second injection needle prick is avoided. After the 
preparatory injections are over, the needle is then withdrawn and reinserted 
slowly into the crest of the papilla. The needle is advanced slowly into the 
incisive foramen to an extent of about 0,5 cm into the canal and about 0,25 
to 0,5 ml of local anesthetic solution is injected.  
Signs and symptoms 
1. Numbness in the anterior portion of the palate. 
2. No pain during surgical procedures or dental therapy. 
Complications 
1. Necrosis of soft tissues is possible, if highly concentrated vasoconstrictor 
solution is used for hemostasis repeatedly. 
2. The local anesthetic solution may «squirt» back out of the needle 
puncture site either during administration or after needle withdrawal, 
because of the density of soft tissues. 
 
Greater palatine nerve block 
Other common names. Anterior palatine nerve block. 
Nerves anesthetised. Greater palatine nerve (anterior palatine nerve). 
Areas anesthetised. The posterior part of the hard palate and its 
overlying soft tissues, anteriorly as far as the canine/first premolar and 
medially upto the midline or the median palatine raphe. 
Indications 
1. For pain control during oral surgical or periodontal surgical procedures 
involving the palatal soft and hard tissues. 
2. When palatal soft tissue anesthesia is required for restorative therapy on 
more than two teeth. 
Contraindications 
1. Presence of acute inflammation or infection at the site of injection. 
2. Smaller areas of surgical procedures or restorative therapy. 
Advantages 
1. It minimises the volume of solution to be deposited and the number of 
needle penetrations. 
2. The technique is simple and easy. 
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3. Success rate is very high. 
Disadvantages 
1. It is a potentially painful injection technique. 
2. No hemostasis. Hemostasis occurs only in the immediate area of 
injection. Additional infiltration will have to be given in the area of surgery 
for achieving hemostasis. 
Anatomical landmarks 
• Greater palatine foramen 
• Maxillary second and third molars 
• Palatal gingival margin of second and third maxillary molars 
• Median palatine raphe 
• An area, approximately at a distance of 1 cm from the palatal gingival 
margin towards the median palatine raphe. 
Technique 
Needle: a needle of 25 or 27-gauge and 25 mm in length is recommended. 
Point of insertion: it is in the palatal soft tissues slightly anterior to the 
greater palatine foramen.  
Target area: the greater palatine nerve as it comes out from the greater 
palatine foramen and passes anteriorly between the palatal mucoperiosteum 
and the bone of the hard palate. 
Bevel of the needle: it is facing the palatal soft tissues. 
Location of anatomical landmarks: locate the greater palatine foramen with 
a cotton swab which is most frequently located distal to the maxillary 
second molar about 1 cm from the palatal gingival margin towards the 
midline. 
Path of insertion: the greater palatine foramen is approached from the 
opposite side at right angle to the curvature of the palatal bone. 
Procedure 
The needle is inserted slowly until the palatal bone is contacted. 
Aspirate, to avoid inadvertent intravascular injection. 
Deposit 0,25-0,5 ml of local anesthetic solution very slowly. 
Withdraw the needle slowly and cover it with its sheath. 
The nerve may be blocked at any point along its anterior course after 
emergence from the foramen. 
Signs and symptoms 
1. Numbness in the posterior portion of the palate. 
2. No pain during dental surgical procedure. 
Complications 
1. Ischemia and necrosis of soft tissues: when highly concentrated 
vasoconstrictor is used for hemostasis, or if excessive amount of local 
anesthetic solution is used. 
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2. Discomfort: it can cause discomfort to the patient if the soft palate 
becomes anesthetised. 
3. Hematoma: it is rare, as the palatal mucoperiosteum is firmly adherent to 
the bone of the hard palate. 
4. Failure to obtain anesthesia:  
Poor injection technique: if the local anesthetic solution is deposited too far 
anterior or too far posterior to the greater palatine foramen. In the area of 
the maxillary first premolar there is overlapping of fibers from the 
nasopalatine nerve. 
 
Nerve blocks for maxillary nerve 
A. Intraoral Maxillary Nerve Block 
B. Extraoral Maxillary Nerve Block. 
These blocks are used for achieving anesthesia of half of the maxilla. 
Indications 
− Extensive oral and periodontal surgical procedures. 
− Restorative procedures involving a quadrant of maxilla. 
 
Intraoral Nerve Blocks 
Approaches. There are two approaches: 
− High tuberosity approach,  
− Greater palatine canal approach. Both the approaches are considered 
to be technically difficult. These should be attempted only if definitively 
indicated; and by experienced hands. 
Major Difficulties 
1. The difficulty encountered with greater palatine canal approach is in 
locating the canal and negotiating it completely. 
2. The difficulty encountered with the high tuberosity approach is the 
higher incidence of hematoma. This occurs as a result of damage to the 
pterygoid plexus of veins with the needle. 
Other names. Second division (VII) Nerve Block 
Nerves anesthetised. Maxillary division of trigeminal nerve and its 
branches. 
Areas anesthetised. The block anesthetises all the following 
structures on the ipsilateral side of the block. 
1. The pulps of all maxillary teeth and the buccal periodontal tissues, 
supporting alveolar bone and the overlying soft tissues on the side of 
injection. 
2. The bone of the hard palate and part of the soft palate, maxillary sinus 
and the lateral wall of nasal cavity. 




1. Control of pain during extensive oral surgical and periodontal surgical 
procedures and restorative dental procedures to be carried out in the 
ipsilateral maxilla. 
2. Presence of inflammation or infection at the site of injection that 
contraindicates the use of other regional block techniques, such as 
infraorbital nerve block, or posterior superior alveolar nerve block 
techniques. 
3. Diagnostic and therapeutic procedures for trigeminal neuralgias 
involving the second division of trigeminal nerve. 
Contraindications 
1. When the administrator is inexperienced. 
2. Child patients. 
3. Uncooperative patients. 
4. Presence of acute inflammation or infection at the site of injection. 
5. Increased possibility of hemorrhage, especially in a hemophilic. 
Advantages 
1. The high tuberosity approach is less painful. 
2. Success rate is high. 
3. It minimises the number of needle penetrations. 
4. It minimises the total volume of local anesthetic solution injected. 
Disadvantages 
1. Increased risk of hematoma, especially with high tuberosity approach. 
2. The high tuberosity approach is a little arbitrary, as there is absence of 
bony landmarks. 
3. Lack of hemostasis: There is no hemostasis at the site of surgery. It 
requires deposition of additional amount of local anesthetic solution at the 
site of surgery. 
4. The greater palatine approach is painful. 
Technique 
High tuberosity approach: 
Needle: The recommended gauge of the needle is 25 and the length is 1 1/2 
of an inch or 38-40 mm. 
Bevel of the needle: It should be facing the bone. 
Point of insertion: It is at the height of mucobuccal fold above the distal 
aspect of maxillary second molar tooth, as for posterior superior alveolar 
nerve block technique. 
Depth of insertion: 1 ¼ of an inch 
Target area: It is the maxillary nerve as it passes through the 
pterygopalatine fossa. It is superior and medial to the target area of 




− maxillary second molar tooth 
− height of mucobuccal fold above the distal aspect of the crown of 
maxillary second molar tooth 
− maxillary tuberosity 
− zygomatic process of maxilla or buttress of the zygoma. 
Procedure 
Marking the length of the needle: mark the length of the needle to be 
inserted in the soft tissues (about 30 mm). 
Position of the patient: supine or semisupine, the latter is preferable. 
Position of the operator: for the right-sided block, the operator stands on 
the side of the patient; and for the left-sided block, the operator stands in 
front of the patient. Request the patient to keep the mouth partially open. 
Preparation of the tissues: prepare the tissues in the region of the height of 
mucobuccal fold above the distal aspect of maxillary second molar tooth, 
by application of topical antiseptic and topical anesthetic agents. 
Retract the cheek to increase visibility of the area. 
Take a preloaded syringe and place it in the soft tissues at the height of 
mucobuccal fold above the distal aspect of maxillary second molar tooth. 
Advance the needle slowly in a superior, medial and posterior direction as 
previously described for posterior superior alveolar nerve block, to a depth 
of 30 mm. At this depth the tip of the needle lies in pterygopalatine fossa in 
proximity to the maxillary division of trigeminal nerve. 
Aspirate and deposit about 1-1,5 ml of local anesthetic solution slowly. 
Withdraw the needle slowly. 
Wait for 3-5 minutes and commence with the oral surgical or dental 
procedure. 
Greater palatine canal approach: 
Location of greater palatine foramen: It is at the junction of horizontal and 
vertical processes of hard palate in the area of distal surface of the crown of 
maxillary second molar. 
Needle: the recommended gauge of the needle is 25; and the recommended 
length is 11/2 ” or 38-40 mm. 
Bevel of the needle: it should be facing the palatal soft tissues. 
Point of insertion: the palatal soft tissues directly over the greater palatine 
foramen. 
Palpation of the area of insertion: palpate the area with a slight depression 
directly over the greater palatine foramen with index finger. Needle is 
inserted into palatal mucosa in a posterolateral direction at a level of distal 
half of maxillary first molar. 
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Target area: It is the maxillary nerve as it passes through the 
pterygopalatine fossa. The needle passes through the greater palatine canal 
to reach pterygopalatine fossa. 
Anatomical landmarks: 
− greater palatine foramen (junction of maxillary alveolar process and 
palatine bone) 
− maxillary second molar tooth 
− palatal gingival margin in the area of this tooth 
− median palatine raphe. 
Procedure: 
Length: mark the length of the needle (30-35 mm). 
Position of the patient: the patient is positioned in such a way that the 
occlusal plane of maxillary teeth is at an angle of 45º to the floor, when the 
mouth is fully opened. 
Position of the operator: for the right-sided block, the operator stands in 
front of the patient and for the left-sided block, the operator stands by the 
side of the patient. 
Mouth: request the patient to keep the mouth wide open and the neck 
extended. 
Location of the foramen: Locate the greater palatine foramen at the distal 
aspect of maxillary second molar tooth. 
Preparation of the tissues: prepare the tissues directly over the foramen 
with application of topical antiseptic and topical anesthetic agent. 
Take a preloaded syringe and direct it into the mouth from the opposite side 
with the needle at an angle of 45° to the palatal bone, posteriorly and enter 
the greater palatine foramen. 
Bevel: orient the bevel of the needle against the soft tissues over the 
foramen. 
Penetrate the needle into the mucosa. Deposit a small volume of local 
anesthetic solution. 
Advance the needle slowly into the greater palatine canal to a depth of 30-
35 mm. Do not attempt to force the needle against resistance. If resistance 
is felt, withdraw the needle slightly and change the angle slightly and 
advance it further into the canal. Always keep a few mm of needle outside 
the tissues. 
Aspirate and deposit about 1 ml of local anesthetic solution slowly. 
This will anesthetise greater palatine nerve almost immediately and 
maxillary nerve later, allowing for relatively painless probing of greater 
palatine foramen. 
Withdraw the needle slowly and keep it safe. 
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Wait for 3-5 minutes and commence with the oral surgical or the dental 
procedure. 
Signs and symptoms 
1. Numbness of lower eyelid, side of the nose and upper lip. 
2. Numbness in the teeth, buccal and palatal soft tissues on the side of 
injection. 
3. Absence of pain during the procedure. 
Failures of anesthesia 
1. Partial anesthesia: it is due to underpenetration of the needle. To correct, 
withdraw the needle a little and readvance the needle into the greater 
palatine canal up to a proper depth and deposit the local anesthetic solution. 
2. Inability to negotiate the greater palatine canal. In the presence of 
obstruction in the canal, it is advisable to try with tuberosity approach. The 
greater palatine canal approach can be successful if the needle has 
penetrated at least 2/3rd of its length into the canal. 
Complications 
1. Hematoma: it occurs due to the injury to the maxillary artery and injury 
to the pterygoid plexus of veins, via the tuberosity approach. 
2. Penetration of orbit: it is very rare. It may occur in patients with 
smallsized skulls. 
3. Penetration of the nasal cavity: the needle may penetrate the thin medial 
wall of the pterygopalatine fossa and thus the needle enters the nasal cavity. 
 
Extraoral nerve blocks 
Indications 
There are various occasions, when an operator has to resort to extraoral 
injections. In these situations, the opening of the mouth is either very 
painful or impossible. These are as follows: 
1. Wounds sustained due to accidents. 
2. Swellings of head and neck, etc. 
3. Presence of trismus due to various reasons. 
Extraoral injections 
1. Are not difficult than intraoral injections 
2. The technique can be mastered easily 
3. Have easier accessibility 
4. Have easier achievement of asepsis 
5. Larger areas can be anesthetised. 
 
Infraorbital nerve block 
The nerves and the areas anesthetised are the same as that for the 




1. When the anterior and middle posterior superior alveolar nerves are to be 
anesthetised; and the intraoral approach is not possible either because of 
presence of infection or trauma or any other reason. 
2. When attempts to achieve anesthesia by the intraoral methods have been 
ineffective. 
Anatomical Landmarks.  
− infraorbital margin,  
− infraorbital depression,  
− infraorbital foramen,  
− pupil of the ipsilateral eye. 
Technique 
Aseptic precautions: the procedure should be carried out under strict 
aseptic conditions. 
Preparation of skin: the skin is prepared with an antiseptic. 
Location of the infraorbital foramen: with the help of the anatomical 
landmarks the foramen is located. 
Anesthesia of the skin and the subcutaneous tissue: it is achieved by 
deposition of a few drops of local anesthetic agent below the skin. 
Needle: long or short 25-gauge needle is used. 
Procedure 
It is introduced through the marked anesthetised area into infraorbital 
canal. The needle is inserted at an angle of about 45° through the skin 
medially and inferiorly to the foramen to compensate for the thickness of 
overlying tissues.  
With a slight probing action with the tip of the needle, the opening of 
the foramen is located. It is directed slightly upward and laterally to 
facilitate its entry into the foramen. Once found, needle is slowly advanced 
into the canal, to a depth not to exceed 1/8th, keeping in mind their 
orientation. The foramen and the canal, normally open downwards, 
forwards and medially. Incisors and canine are most easily anesthetised, as 
solution is injected close to anterior superior alveolar nerves. 
Carefully aspirate and slowly deposit 1 ml of local anesthetic 
solution. 
Subsequently, withdraw the needle slowly, wait for about 10 minutes 
and begin with the procedure. 
Advantages. It is more precise; since anesthesia does not depend on 







• when the infraorbital nerve block by means of extraoral approach is 
being performed, the needle passes through the following structures: Skin, 
subcutaneous tissue and quadratus labii superioris muscle. 
• when the needle is in final position for this injection the important 
structures in the vicinity of the tip of the needle are: Facial artery and vein. 
Since these vessels are tortuous, they may lie on either side of the needle. 
When the tip of the needle is in the canal, it is very close to the infraorbital 
nerve and vessels. 
Infrequent Occurrence 
There is spasm of internal maxillary artery, resulting in blanching of 
face over the area of distribution of lateral nasal, inferior palpebral and 
superior labial arteries. This condition does not cause any discomfort to the 
patient and it passes away in short time. 
Signs and Symptoms 
Subjective: tingling and numbness of the lower eyelid, side of the nose and 
upper lip. 
Objective: demonstration of absence of pain with instrumentation and no 
pain during the surgical procedure or the dental therapy. 
 
Maxillary Nerve Block 
Nerves anesthetised. Maxillary nerve and all of its branches 
peripheral to the site of injection. 
Areas anesthetised 
Anterior temporal and zygomatic regions, lower eyelid, side of the nose, 
upper lip, maxillary teeth, maxillary alveolar bone and overlying structures, 
hard palate and part of soft palate, tonsils, part of the pharynx, nasal septum 
and floor of the nose and mucosa of the posterolateral part of the lateral 
wall of the nose and turbinate bones. 
Anatomical landmarks 
• midpoint of zygomatic arch 
• zygomatic notch 
• coronoid process of the ramus of the mandible 
• lateral pterygoid plate. 
Indications 
1. Where anesthesia of the entire distribution of the maxillary nerve is 
required for extensive surgery. 
2. When it is desirable to block all the subdivisions of the maxillary nerve 
with only one needle insertion; and with a minimum of anesthetic solution. 
3. When local infection, trauma, or other conditions make nerve blocks of 
the more terminal branches difficult or impossible. 
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4. For diagnostic or therapeutic purposes, such as tics or neuralgias of the 
maxillary divisions of the fifth cranial nerve. 
Technique 
Asepsis: this procedure should be carried out under strict aseptic 
conditions. these include preparation of the hands of the operator, including 
scrubbing and gloving; and surgical preparation of the field of surgery. 
Palpation of the landmarks: the midpoint of the zygomatic arch is located 
and the depression in its inferior surface is marked. The coronoid process 
of the ramus of the mandible is located by opening and closing the lower 
jaw. 
Needle: with a 25-gauge needle, a skin wheal is raised just below this mark 
in the depression, which the operator identifies by having the patient open 
and close the jaw. 
Mark the needle: using a 4” (8,8 cm), 22-gauge needle attached to a 
leuerlock type of syringe, the operator measures 4,5 cm and marks with a 
rubber marker. 
Insertion of the needle: The needle is inserted through the skin wheal, 
perpendicular to the skin surface and to the median sagittal plane. Inject a 
few drops of local anesthetic solution as the needle penetrates deeper into 
the tissues, until the needle point gently contacts the lateral pterygoid plate. 
The needle should never be inserted beyond the depth of the marker. 
The needle is withdrawn, with only the point left in the tissues and 
redirected in a slight forward and upward direction until the needle is 
inserted to the depth of the marker.  
After careful aspiration, 1-2 ml of local anesthetic solution is slowly 
injected. Care should be exercised to aspirate after each 0,5 ml of the 
solution is injected. 
Relations 
During the injection by means of an extraoral approach the needle passes 
through the following structures: Skin, subcutaneous tissue, masseter 
muscle, sigmoid notch and lateral pterygoid muscle. 
When the needle is in contact with the lateral pterygoid plate; the following 
structures are in its vicinity: 
− Superiorly, the base of the skull. 
− Internal maxillary artery that crosses inferiorly and curves up 
anteriorly, entering the lower part of pterygomaxillary fissure. 
− Temporal vessels from the internal maxillary artery, which may lie 
on either side of the artery. 
− Superficially, transverse facial artery. 
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− Posteriorly, the mandibular nerve which passes through foramen 
ovale; and posterior to that, middle meningeal artery, which passes through 
foramen spinosum. 
− Anteriorly, the pterygomaxillary fissure, through which the needle 
may pass into pterygopalatine fossa. 
Signs and symptoms 
1. Subjective symptoms: tingling and numbness of upper lip, side of the 
nose, lower eyelid and in some instances anesthesia of soft palate and 
pharynx, with gagging sensation. 




TOPIC: LOCAL COMPLICATIONS OF LOCAL ANESTHESIA 
 
Complications arising from drugs or chemicals used for local 
anesthesia 
1. Soft tissue injury 
2. Sloughing of tissues (Tissue ischemia and necrosis) 
Complications arising from injection techniques 
1. Breakage of anesthetic cartridge 
2. Breakage of needle 
3. Needle-stick injuries 
4. Hematoma 
5. Failure to obtain local anesthesia 
Complications arising from both 
1. Pain on injection 




6. Mucosal blanching 
7. Persistent paresthesia or anesthesia 
8. Persistent or prolonged pain 
9. Post-injection herpetic lesions or post-anesthetic intraoral lesions 
10. Bizarre neurological complications 
− Facial nerve paresis or paralysis 
− Visual disturbances: 
• Diplopia, or double vision 
• Amaurosis or temporary blindness 
• Permanent blindness 
 
COMPLICATIONS ARISING FROM THE DRUGS OR 
CHEMICALS USED FOR LOCAL ANESTHESIA 
Soft Tissue Injury 
Causes 
It is seen in the form of self-inflicted trauma to lips, tongue and cheek.  
It is common in children and mentally retarded adults. 
Prevention 
1. Use minimum effective dose of local anesthetic agent 
2. Warn the patient's guardians or parents against biting of lips and tongue; 
and also against eating and drinking hot fluids; while the effect of 





1. Symptomatic: it comprises of analgesics and if necessary antibiotics. 
2. Topical application of petroleum jelly, or local anesthetic or antibiotic 
cream. 
 
Sloughing of Tissues (Tissue Ischemia and Necrosis) 
Various Forms 
• Epithelial desquamation or ulceration. 
• Sterile abscess. 
• Tissue necrosis or sloughing. 
Causes 
1. Predisposition: commonly seen in hard palate, as in the region of 
distribution of nasopalatine and greater palatine nerves, because the 
mucoperiosteum is firmly attached to the bone. It occurs at the site of 
injection. Necrosis leads to painful ulceration and sloughing. 
2. Deposition of excessive volume of local anesthetic agent with a 
vasoconstrictor. 
3. Rapid deposition of the local anesthetic solution with undue pressure. 
4. Application of topical local anesthetic agent for prolonged period 
(epithelial desquamation). 
5. Use of high concentration of vasoconstrictors (usually epinephrine), 
resulting in tissue ischemia and necrosis. Sterile abscess occurs secondary 
to prolonged ischemia, resulting from epinephrine. 
Prevention 
1. Avoid using excessive amounts of local anesthetic agent (minimal 
effective dose). 
2. Avoid using vasoconstrictors of high concentration.  
3. Avoid rapid deposition and with excessive pressure. Excessive volume 
may have reaction secondary to excessive pressure. 
4. Warn the patient against application of hot items; while the tissues are 
still anesthetised. 
Management 
Symptomatic: the management depends upon the extent of injury; 
and consists of analgesics, topical anesthetics and bland diet, etc. It usually 









COMPLICATIONS ARISING FROM INJECTION TECHNIQUES 
Breakage of Anesthetic Cartridge 
Causes 
It occurs when there is resistance to flow of local anesthetic solution into 
the tissues. 
It occurs due to following reasons: 
• blockage of the needle. 
• too rapid injection; especially during administration of palatal 
injection. it is due to the palatal mucoperiosteum which is firmly bound 
down to the underlying bone.  
• point of the needle in close contact with bone. 
Management 
In case, the glass of the cartridge breaks while injection, care should be 
taken to ensure complete removal of all broken pieces from the mouth; so 
as to avoid risk of ingestion and injury to the soft tissues of the oral cavity. 
 
Breakage of Needle 
With the introduction of sterile, stainless steel disposable needles, the 
incidence of needle breakage within the tissues has become considerably 
less. 
Causes 
Primary cause: sudden unexpected movements by the patient, as the needle 
penetrates muscle or contacts periosteum. It is basically because of sudden 
pain on injection. 
Secondary or other causes: 
• size/diameter of the needle. Breakage is common in smaller (larger 
gauge, e.g. 27 G) needles. Smaller needles are more likely to break than 
larger needles. Gauge of the needle is inversely proportional to size or the 
diameter of the needle; e.g. 25 G is less in diameter than 22 G. It is a 
mistake to think that a needle, of a slightly lesser gauge will produce 
trauma or that trauma is proportional to gauge of a needle. The sharpness of 
the point is of more importance than the actual gauge of the needle. It is not 
the thickness of needle that creates trauma, but rather the blunt point and 
the barbs. 
• previously bent needles. These are weak; and hence more likely to 
break. 
• redirection of needles once inserted inside the tissues. 
• needles with defect in the manufacture (poor quality needles). 
• forcing needles against resistance. 
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• needle engaging the periosteum while giving nerve blocks, especially, 
the indirect pterygomandibular block technique with the bevel facing the 
bone. 
Prevention 
The following principles should be followed to prevent the possibility of 
breakage of a needle. 
1. Inform the patient about the technique and the procedure. Avoid a 
sudden unexpected needle insertion. An informed patient is always a better 
patient and is much more co-operative. The patient should be warned not to 
move, as needle touches the mucous membrane. Injection of a small 
amount of LA solution in the tissues, slowly and carefully, in advance of 
needle, tends to lessen the pain associated with the insertion and injection. 
2. Selection of proper gauge of needles. 
- A needle of a very fine gauge (27 or 30) should not be used for nerve 
blocks. For nerve blocks, such as pterygomandibular block, posterior 
superior alveolar nerve block, maxillary nerve block, mandibular nerve 
block, use 25-gauge needles. For nerve blocks, especially mandibular 
injections, it is strongly recommended that 25-gauge needles should be 
used. 
- For infiltration anesthesia: 25, or 27, or 30 G and 1” needles may be used. 
The use of fine gauge needles should be restricted to superficial injections. 
3. Use presterilized disposable needles. Do not use resterilisable needles. 
These become dull and the shaft becomes weak. 
4. The entire length of the needle should not be inserted into the tissues. 
Insertion of the needles must be up to a few mm away from the hub. In the 
past, when reusable needles were used; the junction of the shaft with the 
hub formed the weakest point of needle and therefore, was the site where 
breakage usually occurred. The needle should be long enough (adequate 
length) so that a sufficient portion will be allowed to project beyond tissues 
when the point of the needle reaches its final destination. This helps the 
operator, in case of breakage of  the needle, to remove the broken needle by 
holding the portion of the needle outside the soft tissues. Therefore, in 
nerve blocks, 1½ (38-40 mm) needles should be used. The needle should 
not be embedded into the tissues up to the hub. It is vulnerable to breakage 
in this position. The average insertion/penetration in nerve blocks seldom 
exceeds one inch (25 mm). 
5. Do not redirect the needle once completely embedded inside the tissues. 
Excessive lateral force on the needle is an important factor in breakage. 
Always withdraw the needle almost completely, to the submucosal layers 
and then redirect it. 
6. Use needles of good quality and of a good manufacturer. 
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7. Gentle manipulation: At no time should there be any resistance to 
progress of needle during injection. If resistance is encountered, the 
technique of insertion is modified accordingly. Never force needles against 
resistance. 
8. Do not permit the needle to engage the periosteum while giving a nerve 
block. There is always a danger of engaging the periosteum in mandibular 
injection, especially, if indirect approach is used. The needle may penetrate 
periosteum at the internal oblique ridge and when the syringe is swung to 
opposite bicuspids, the needle thus bound to bone may bend and break. 
This is the most frequent cause 
of needle breakage in mandibular injection. 
9. Stabilization of the jaw: Mandible should always be supported by fingers 
or thumb at the inferior border of mandible during the procedure of 
injection. 
10. Needle point should be inserted in the shortest and the most direct line 
to mandibular foramen. In other words, needle should always be kept 
straight during injection procedure. 
11. Thorough knowledge of anatomy of the region involved. Do not 
attempt injections if you are not well aware of the anatomy of the area of 
the technique employed. Familiarise yourself with all the necessary 
anatomical landmarks of the area. 
12. Avoid multiple penetrations with the same needle. 
Management 
Information and reassurance 
1. remain calm and do not panic. 
2. inform the patient of the situation. Make an attempt to allay patient's fear 
and apprehension. 
Localization of the broken needle 
Various radiographs are taken in two different angles to localize the 
position of the broken needle, such as PA view, lateral view, or OPG, etc. 
Use of pilot needle/localizers or a radiopaque localizer or another needle 
can be used to facilitate localization or to pinpoint the site of the retained or 
the broken fragment. Once this relationship between localizing needle and 
the broken fragment is established radiographically, dissection is carried 
out to retrieve the broken needle under local or general anesthesia. 
In case, the needle has broken and is not completely buried in the 
soft tissues: if the needle is visible and is outside the soft tissues, hold it 
with a hemostat and remove it. When giving injection, it is wise to have a 
pair of mosquito forceps, hemostat, or curved Spencer Well's forceps at 
hand so that if the needle breaks and the broken end is visible in the tissues, 
then without shifting the gaze, or the steadying finger, the operator can 
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pickup one of the above mentioned instruments and grasp the broken end 
of the needle to remove it slowly. When the patient moves or swallows 
then the broken fragment may shift deeper into the tissues and set out of 
sight. 
In case, the needle has broken and is completely buried in the soft 
tissues: if the needle is not visible, inform the patient of the situation and 
give assurance. The patient should be advised not to move the jaw. The  
patient should be referred to Oral and Maxillofacial Surgeon for its 
removal. Usually the needle breaks when the tip of the needle is in contact 
with the bone. In case, if the needle end is buried, then use the curved 
hemostat, open it and press the convex tip of the hemostat above and below 
the bleeding point present where the needle is broken, there is a 
good chance that the broken end will emerge out of soft tissues, grasp with 




Accidental injuries occurring to dental staff caused by sharp instruments 
such as needles, blades, scalpels, explorers, root canal instruments and 
wires, etc. These injuries are not usually serious, unless, the instruments 
used were contaminated by blood from patients with conditions such as 
Hepatitis B virus (HBV) infection, Hepatitis C virus (HCV) infection, 
AIDS or AIDS Related Complex (ARC). 
Causes. Careless technique. 
Prevention 
1. Careful handling of sharp instruments, needles and wires. 
2. Prophylactic vaccination of HBV infection taken and maintained.  
Management 
If the injury involves a patient with HBV or HCV infection the following  
management protocols should be followed. The management depends upon 
immune status of the Health Care Worker (HCW). 
• HCW who never took vaccination should receive Hepatitis B 
immunoglobulins (HBIG) within 48 hours of exposure and a course of 
HBV vaccination should be started as soon as possible. 
• HCWs who have been vaccinated, the management depends upon the 
antibody titre. If the titre is more than 100 mu/ml within the previous year, 
no further treatment is required. If antibody titre was not done in the 
previous year, or if the titre is low; then a booster dose of the vaccine is 
taken, followed by testing of the antibody titre. Those HCW who fail to 
respond to the vaccine should be given protection by giving Hepatitis B 
immunoglobulins (HBIG). Presently, there are no guidelines for the 
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prophylaxis for HCV infection. The management, however, consists of 
monitoring liver functions and testing for anti-HCV antibodies. Interferon α 
is being used in such cases. If the injury involves a patient with HIV 
infection or AIDS or AIDS related complex, then the post-exposure 
prophylaxis (PEP) for HIV, as recommended by National AIDS Control 




Effusion of blood into extravascular spaces. Blood effusion continues until 
extravascular pressure exceeds intravascular pressure or until clotting 
occurs. Certain regions have a greater incidence of hematoma. The 
incidence is more in posterior superior alveolar nerve block and 
pterygomandibular block. The possible complications include pain, 
trismus, swelling and discoloration of the region. The density of the tissues 
surrounding the injured vessel is an important factor. 
• secures withy adhesive strips (included) 
• syringe is held ready for use in a convenient position and after use, 
syringe is replaced for recapping 
• made with microban protection 
• available in two sizes (standard – for X-short and short needles; long – for 
long needles) 
• a disposable device, that securely holds a needle-cap in a ready position 
• used to safely uncap and recap needles using onehanded technique 
Causes 
Nicking of blood vessels (artery and vein; usually an artery) during 
injection of local anesthetic solution. 
Prevention 
1. Good knowledge of anatomy. 
2. Use short needle for posterior superior alveolar nerve block. It decreases 
the risk of hematoma. 
3. Adherence to the protocol for the injection technique. 
4. Minimise the number of needle penetrations. 
5. Never use needle as a probe in the tissues. 
Management 
Explanation of the condition and assurance to be given to the patient. The 
swelling and discoloration usually resolve within 7 to 14 days. 
Immediate treatment  
In the immediate phase the hematoma manifests as swelling and 
discoloration. Hence, the following guidelines will be helpful: 
72 
 
Application of direct pressure: if the area is accessible, application of 
mechanical pressure at the site of bleeding for a few minutes will be 
helpful. In most instances, except for posterior superior alveolar nerve 
block, the blood vessels lie between skin and bone, on which pressure 
should be applied for at least 2 to 3 minutes. This effectively stops 
bleeding. 
External application of ice: for a few hours will also control further 
formation of hematoma. 
Delayed Treatment. Advise the patient of possible pain and 
limitation of movement. Pain is to be treated by analgesics. Treat the 
trismus with anti-inflammatory drugs and muscle relaxants. Do not apply 
heat to the area in the early phase as it produces vasodilatation and may 
lead to increase in the size of hematoma. External ice application is advised 
for at least one day, as it causes vasoconstriction. Later, heat application is 
indicated for vasodilatation to absorb the hematoma. Avoid dental 
treatment until there is resolution of symptoms. 
 
Failure to Obtain Local Anesthesia 
Causes 
1. Operator-dependent 
• selection of local anesthetic agent (type and dose; too small a dose). 
• use of a local anesthetic solution which has crossed its date of expiry 
as recommended by the manufacturer. 
• improper injection technique: 
− wrong technique: inaccurate placement of solution (deposition of 
solution far away from the nerve). 
− not waiting long enough for anesthesia to act; before commencing  
the surgery. 
− injection of wrong solution 
− intravascular administration 
− intramuscular administration 
2. Patient-dependent 
• anatomical: 
− barriers to diffusion 
− anatomical aberrations 
− additional innervation 
• psychological:  
− fear and apprehension 
− unco-operative patient, inadequate opening of the mouth, movement 





− presence of infection: it is widely believed that there is alteration in 
the pH of tissues in the presence of infection; which leads to acidic 
environment. The local anesthetic solutions are not effective as these agents 
are alkaloids and are not dissociated in an active state there is an increased 
vascularity of acutely inflamed tissues, which may also be a factor 
− presence of trismus. 
Prevention 
1. Good knowledge of anatomy. 
2. Good injection technique: 
− accurate placement of solution. 
− deposition of adequate dose. 
− wait for sufficiently long enough for anesthesia to act; and then 
commence surgery. Check for subjective and objective signs and 
symptoms. 
− consider using aspiration technique. 
Management 
1. Repeat the injection. 
2. Consider giving additional injections such as intraligamentary, 
intraosseous or intrapulpal injections; unless there is presence of infection 
surrounding the tooth. 
3. Consider anesthetising additional nerves. 
4. Avoid injection of a wrong solution. 
Prevention. To avoid injection of a wrong solution, the following 
measures are recommended: 
− multidose vials. All the local anesthetic solutions and other injectable 
drugs in the similar containers, should be adequately labeled; or the other 
injectable drugs should not be kept on the same trolley, or in the vicinity of 
local anesthetic agents. 
− cartridges. Encourage use of cartridges. Now, with the introduction 
of cartridges universally, the injection of solutions other than local 
anesthetic agents is avoided. There  hould be identifying marks on 
individual cartridges for easy identification by the dental practitioner. 
Management. Antibiotics, local dressings, oral hygiene instructions, 
anti-inflammatory/ analgesics and diet restrictions. 
 
COMPLICATIONS ARISING FROM BOTH 
Pain on Injection 
This increases patient's anxiety; and may lead to a sudden unexpected 





1. Careless injection technique. 
2. Dull needles: Needles become dull due to multiple injections. 
3. Rapid deposition of local anesthetic solution. 
4. Needles with barbs: There is pain while withdrawal of the needle from 
the tissues. 
5. Temperature: Extremes of temperature such as warm or hot or very cold 
(refrigerated) local anesthetic solution. 
Prevention. Every effort should be taken to administer local 
anesthetic solution as painlessly as possible. 
1. Proper injection technique. The basic principles of injection should be 
followed. The lip or the cheek is properly reflected so that the tissues are 
tensed, the sharp point of the needle is placed at right angle to the mucosa 
and the puncture is effected. The insertion of the needle should be slow and 
as atraumatic as possible. Multiple penetrations or insertion in the same 
area should be avoided. 
2. Use sharp needles. Use good quality disposable needles supplied by a 
reputable manufacturer. 
3. Use sterile local anesthetic solutions. 
4. Apply topical local anesthetic agent prior to injection to the site of 
injection. 
5. Inject local anesthetic solution slowly. 
6. Temperature of local anesthetic solution should be the same as room 
temperature and hence, the local anesthetic solutions should be stored at 
room temperature. 
Management. Not required. However, steps should be taken to avoid 
pain associated with njection of local anesthetic agent. 
 
Burning on Injection 
Causes 
1. Altered pH of the solution 
a. Presence of vasoconstrictor: The pH of local anesthetic solution without 
the vasoconstrictor is approximately 5 to 5.5; and that with a 
vasoconstrictor is approximately 3 to 3.5. It is more acidic. 
b. Old solution: The end result of oxidation of Na-bisulfite is Na-bisulfate 
which is more acidic. 
2. Non-isotonic local anesthetic solution. 
3. Other causes: 
• Rapidity of injection: Especially in adherent tissues and confined 
areas, such as palatal mucoperiosteum. 
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• Contamination of local anesthetic solution, especially when cartridges 
are stored in alcohol or other cold sterilizing solutions; leads to diffusion of 
these solutions into the cartridge. 
• High temperature of local anesthetic solution. Solutions warmed to 
body temperature are usually considered to be "too hot" by the patients. 
• Deposition of excessive amount of local anesthetic solutions. 
Prevention 
1. Slow injection. Ideal rate is 1 ml/min; while recommended rate is 1.8 
ml/min. 
2. Cartridges should be stored in a suitable container at room temperature 
without alcohol or any other cold sterilizing solutions. 
3. The excess of cold sterilising solution should be removed by dipping the 
cartridge in sterile water or normal saline. 
4. Use recently manufactured cartridges, as far as possible, to circumvent 
the problem of increased acidic medium of the solution, because of 
oxidation of vasoconstrictor. 
Management. The tissue irritation caused due to the high pH of local 
anesthetic agent, usually, does not require any treatment, as most instances 
are transient and do not cause tissue damage. It disappears as the action of 
local anesthetic agent takes place. Usually, there is no residual pain or 
burning after the action of local anesthetic agent subsides. With rapid 
injection, or injection of a contaminated or a warm solution, there is a 
greater chance of tissue damage, which subsequently may lead to other 
complications such as trismus, edema and paresthesia. In such situations, 
management of the specific individual problem is required. Persistent 
irritation or burning during or after the injection warrants an investigation 
of the local anesthetic solution. The matter should be brought to the notice 
of the concerned manufacturer. 
 
Infection 
The incidence of injection-related infection has become less 
following introduction of pre-sterilised disposable needles and cartridges. 
Causes 
1. Contamination of the needles. Needles touching mucous membrane other 
than the area of insertion of the needle result in contamination of the 
needle. It is the major cause of post-injection infection. 
2. Contamination of the local anesthetic solution. It is also rare, as the 
solutions are pre-sterilized. Contamination of needles or solutions may 
cause a low-grade infection, if placed in the deeper tissues, which may lead 
to trismus. Low-grade infection is not recognized immediately. The patient 
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usually complains of pain and dysfunction in the immediate post-injection 
phase. 
3. Improper injection technique: It includes the following: 
a. Improper handling of local anesthetic equipment (storage of the 
cartridges). 
b. Improper preparation of the site. 
c. Inadequate washing of operator's hands. 
d. Needle passing through an area of infection. It may disseminate 
infection. 
4. Local anesthetic solution deposited under pressure; as in 
intraligamentary injection. It is claimed to deposit bacteria, in healthy 
tissues and thus spreading the infections. 
Prevention. Take measures for complete asepsis, as far as possible, 
which are as follows: 
1. Preparation of the site prior to needle penetration: Apply antiseptic, dry 
the area and then apply topical anesthetic agent. 
2. Careful handling of the needles. Avoid contamination of needles through 
contact with non-sterile surfaces. 
3. Avoid multiple penetrations with the same needle. 
4. Use pre-sterilized disposable needles. 
5. Proper cleansing of operator's hands. 
6. Avoid passing the needles through infected areas. 
7. Proper handling of dental cartridges: 
• Store cartridges aseptically, as far as possible, in a container covered 
with a lid all the time. Once the container is opened, cartridges should be 
stored dry in their original container or in another suitable sterile container 
that is kept covered at all times. 
• Avoid contamination of plunger and the diaphragm prior to their use. 
The diaphragm-end of cartridge should be wiped with a sterile disposable 
sponge soaked with an antiseptic prior to its insertion into the syringe and 
fixing of the needle. 
• Use cartridges available in blister packing. 
• Use cartridges only once (one patient). An attempt to use a portion for 
one patient and the remaining for another patient increases the possibility 
of cross-infection. 
Management 




• heat therapy 
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• anti-inflammatory drugs 
• muscle relaxants and 
• incision and drainage, if necessary. 
Trismus 
It is a fairly common complication of regional anesthesia, 
particularly while giving pterygomandibular block. 
Causes 
Primary cause 
• trauma to muscles (medial pterygoid, temporalis and masseter), blood 
vessels in infratemporal and pterygomandibular fossae during insertion of 
the needle. It is the most commonest cause. 
Secondary causes 
• the following factors cause varying degree of trismus. 
• injection of local anesthetic solutions containing irritating solutions, 
such as, alcohol or other cold-sterilizing solutions, which diffuse into the 
muscle tissue, producing irritation of the muscle leading to trismus. 
• local anesthetic solutions have mild myotoxic properties on skeletal 
muscles. Injection of local anesthetic solutions intramuscularly, or 
extramuscularly leads to progressive necrosis of the exposed muscle fibers. 
• hematoma (large volume of extravasated blood) leads to irritation of 
muscles fibers. 
• low grade infection following injection. 
• deposition of excessive amounts of local anesthetic solutions into a 
particular area. This occurs following multiple failed pterygomandibular 
blocks and which lead to distension of the tissues and may result in post-
injection trismus. 
Prevention 
1. Use sharp, sterile and disposable needles. This avoids the trauma of 
injection and prevents subsequent low grade infection. 
2. Proper handling of local anesthetic cartridges. 
3. Proper handling of needles. Avoid contamination of needles. 
4. Avoid multiple penetrations into the same area. It increases the incidence 
of post-injection trismus. 
5. Use minimum effective volumes of local anesthetic solutions. Avoid 
deposition of excessive amounts of local anesthetic solutions into a 
restricted area. It produces distension of tissues. This may lead to 
postinjection trismus. 
6. Good knowledge of anatomy of the region and fascial spaces. 
7. Follow proper injection technique. 
8. Use aseptic technique. Topical application of antiseptics. 
9. Use atraumatic technique. 
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Management. It depends on the cause of trismus and consists of the 
following: 
• heat therapy 
• warm saline rinses 
• analgesics 
• anti-inflammatory 
• muscle relaxants  
• physiotherapy and, if necessary 
• antibiotics. 
Heat therapy: it includes application of heat, in various ways to the 
affected area, three to four times a day. For example, application of moist 
compresses for 15 to 20 minutes/hour for several days until the symptoms 
are relieved. 
Warm saline rinses: these are made by adding a teaspoonful of salt to 
a glass of water. It is held in the mouth on the involved side for a few 
minutes and is spat out. 
Analgesics. 
Anti-inflammatory drugs: THE analgesics used belong to the group 
of non-steroidal anti-inflammatory agents (NSAIDs) such a aspirin, 
ibuprofen, codein (30-60 mg q6h), etc. which have both analgesic as well 
as anti-inflammatory actions. 
Muscle relaxants: the commonly used muscle relaxants are 
Chlorzoxazone (250 mg in 2 to 3 divided doses, in combination with 
NSAIDs and Diazepam (5-10 mg bid), or any other benzodiazepines. 
Meprobamate 1,2 g in 3 to 4 divided doses can also be used. 
Physiotherapy: it includes mouth opening exercises, as well as, 
lateral excursions (side to side movements), for 5 to 10 minutes every 3 to 
4 hours. 
Antibiotics: if the cause of the trismus is hematoma or low grade 
infection, suitable antibiotics should be prescribed. If the condition is due 
to trauma, mild physiotherapy, analgesics and muscle relaxants are 
advocated. If hemorrhage or low grade infection is the cause, then, 
antibiotics, anti-inflammatory drugs and warm saline mouthwashes are 
indicated. Avoid further dental treatment in the involved region until 
symptoms resolve and the patient is comfortable. If for any reason, the 
dental care has to be continued, an alternate method or technique for 
achieving local anesthesia may be employed. The Akinosi mandibular 
nerve block provides relief from the motor dysfunction and allows the 
patient to open the mouth and permits administration of an appropriate 
additional injection, if required. Complete resolution of post-injection 
trismus takes approximately 
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6 weeks, with a range of 4 to 20 weeks.  
 
Edema 
Edema of tongue, pharynx and larynx may develop into potentially 
lifethreatening situations. 
Causes 




5. injection of irritating solutions such as cold-sterilising solutions. Each 
factor should be considered with regard to its prevention and management. 
Prevention 
1. Preoperative assessment: Complete medical evaluation of the patient, 
particularly history of allergy to any drug.  
2. Careful handling of local anesthesia armamentarium. 
3. Atraumatic anesthetic technique. 
Management. Find out the cause. 
1. In cases of traumatic injection and introduction of irritating solutions, the 
edema is minimal and resolves in a few days and therapy is sometimes not 
required. 
2. Analgesics for pain. 
3. In case of infection, start suitable antibiotics. 
4. If allergy: administer antihistaminics orally and/or IM; sometimes it can 
be life-threatening. Consultation with an allergic specialist is mandatory. If 
breathing is compromised because of edema the following steps are taken: 
• Patient is placed in supine position. In case of tongue or 
oropharyngeal region, right or left lateral position is taken. 
• Institute Basic Life Support (BLS); Airway, Breathing and Circulation 
(ABC). 
• Emergency Medical Services (EMS) are summoned. 
• Administer O2. 
• Administer epinephrine: 0,3 mg (adults), 0,15 mg (child) IM/IV every 
5 minutes until respiratory distress resolves. 
• Administer antihistaminics. 
• Administer corticosteroids. 
5. Refer to oral and maxillofacial surgeon. 
6. Life-threatening situations may require cricothyroidotomy. Transfer the 






It is caused by the spasm of the artery accompanying the nerve at the 
point of injection. 
Causes 
1. Use of excessive amount of vasoconstrictor in the local anesthetic 
solutions. 
2. Deposition of excessive volume of local anesthetic solution in firm or  
tight tissue. 
Prevention 
1. Good knowledge of anatomy. 
2. Adherence to the anesthetic protocol. 
3. Use of aspiration technique; and avoid intra-arterial administration of 
local anesthetic agents. 
Management. Usually a transient phenomenon and no treatment is 
necessary. 
 
Persistent anesthesia or paresthesia (nerve injuries) 
Nerve injuries could be Post-injection, or Postoperative. 
It is the prolonged loss of sensation (hypoesthesia or anesthesia) of 
the part of soft tissues of face, (including tongue and lip), for days, weeks, 
or months, following injection of local anesthetic agent or removal of 
tooth/ root. Paresthesia is altered sensation and may be with partial 
anesthesia. It is a disturbing and sometimes unpreventable complication of 
local anesthetic administration. The most common sites are lips and tongue 
in their descending order of frequency. Paresthesia is more common with 
prilocaine, followed by other injectable local anesthetic agents. When 
lingual nerve is involved, sense of taste may also be affected (chorda 
tympani). Persistent paresthesia can lead to self-inflicted injury. Biting, or 
thermal or chemical insults can occur without the patient's awareness. The 
condition  is more frequent as a result of operative procedure than injection 
itself. The sensory nerves most frequently traumatised are inferior alveolar 
nerve, lingual nerve and mental nerves in lower jaw; and infraorbital nerve 
in upper jaw. Prolonged anesthesia of lip, tongue or nose and cheek follows 
injury to these nerves; the part affected depending upon which nerve is 
injured. The duration of anesthesia depends on severity and extent of nerve 
injury. 
Causes 
1. Injection of local anesthetic solution contaminated with cold-sterilising 
solution, such as alcohol, near a nerve. It produces irritation, resulting in 
edema and increased pressure in the region of the nerve, leading to 
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paresthesia. Alcohol is neurolytic; and may cause paresthesia lasting for 
months and years. 
2. Injection of a wrong solution. It may result from injection of a solution 
other than a local anesthetic solution, such as alcohol or other 
coldsterilising solutions. Only in severe cases the damage is permanent. In 
the absence of a known cause for prolonged anesthesia, this factor should 
always be considered, if cold-sterilizing solutions are used, at any time. 
3. Trauma to a nerve: It is usually due to lack of knowledge of anatomy and 
faulty technique. It may lead to following situations: 
• Trauma to a nerve or the nerve sheath: Initially the patient gets a 
feeling of an «electric shock» to the area innervated by the nerve. Insertion 
of the needle into a foramen also increases likelihood of nerve injury. 
• Complete severing of the nerve fibers/trunk with a needle is extremely 
rare. The damage from the needle is hyperalgesia and not anesthesia. 
4. Hemorrhage into or around the nerve sheath caused by mild trauma of 
the needle. The resultant hemorrhage is reabsorbed very slowly as a result 
of poor circulation in this area. This prolonged pressure may lead to 
degeneration of some of the nerve fibers and may lead to transient 
decreased sensation. 
Prevention 
1. Strict adherence to injection protocol. 
2. Careful injection technique. 
3. Proper handling of local anesthetic cartridges. 
4. Good knowledge of anatomy. 
Management. Most paresthesias resolve within 8 weeks without 
treatment.  
Rare, only if the damage to the nerve is severe, then only the paresthesia 
may be permanent. 
1. Reassurance to the patient. 
2. Administer neurotropic vitamins (Vitamins B1, B6 and B12), parenteral 
and oral; or vitamin B12, oral and parenteral. Presently, the use of 
methylcobalamine, which is an active form of vitamin B12, which has got 
better absorption than other forms like cyanocobalamine, (also hydroxyl-, 
adenosyl-) and hence it is preferable to administer, in case of nerve injuries. 
3. If dental treatment is to be continued, avoid readministration of the local 
anesthetic agent into the same region of traumatised nerve. Use alternate 
local anesthetic technique, if necessary and if possible. 






Persistent or prolonged pain 
Causes 
1. Poor injection technique. Subperiosteal injection of local anesthetic 
agent and tearing of the periosteum by the tip of the needle. 
2. Needle tip with barbs. 
3. Ischemic necrosis (use of vasoconstrictors: Excess amount, higher 
concentration). 
4. Multiple penetrations. 
Prevention 
1. Good injection technique: avoid subperiosteal injection and tearing of 
periosteum. Infiltration anesthesia should be given paraperiosteally or 
supraperiosteally, but not subperiosteally. 
2. Avoid needles with barbs. 
3. Use vasoconstrictors with higher dilution. 
4. Avoid multiple penetrations. 
Management. It is symptomatic and comprises of analgesics. 
 
Post-injection herpetic lesions or post-anesthetic intraoral lesions 
Patients' reporting of development of ulcerations around the site of 
injection a few days after intraoral injection of local anesthetic agent. 
Patient complains of intense pain. 
Causes 
Recurrent aphthous stomatitis (RAS): it is a frequent manifestation, 
developing in gingival tissues (movable part, i.e. not attached to the bone) 
such as buccal vestibule.  
Herpes simplex/herpes labialis: it is related to reactivation of dormant 
Herpes Simplex Virus (HSV) particles by the trauma of injection. It is 
usually seen in patients with history of recurrent herpes labialis, 
particularly, in the terminal area of distribution of trigeminal nerve (inferior 
alveolar nerve, or superior labial branch of infraorbital nerve), in a 
previously anesthetized nerve. HSV can develop intraorally, although it is 
commonly observed extraorally. It is manifested as small bumps on tissues 
attached to underlying bone; such as soft tissues of the hard palate. Trauma 
to the tissues by a needle, local anesthetic agent, cotton swab, or any other 
instrument, may activate the latent form of the disease process. 
Prevention 
1. Pre-anesthetic assessment: history of recurrent herpetic infections. 
2. Delay surgical intervention in the active stage. In susceptible patients, 
intraoral lesions cannot be prevented from developing. Intraoral Herpes 
Simplex, may be prevented, or its manifestations may be minimized, if 
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treated in its prodromal phase (Prodrome: mild burning or itching sensation 
at the site where the virus is 
present, e.g. lip.) 
Management 
Explanation and assurance are integral parts of the management. The 
management, otherwise is symptomatic and includes: analgesics, topical 
anesthetics, e.g. viscous lidocaine, applied topically to affected/ painful 
areas and antiviral agents, (acyclovir) applied QID over the affected area. It 
minimizes the acute phase. 
 
Bizarre neurological symptoms 
It is seen in the form of facial nerve paresis and visual disturbances. 
Facial nerve paresis 
Paresis of some of the muscles of facial expression which are supplied by 
some of the terminal branches of facial nerve, when the solution is 
deposited in their vicinity. 
a. Directly: In the vicinity of terminal branches of facial nerve as (i) in 
infraorbital nerve block, or (ii) while giving a paraperiosteal injection for 
maxillary canine. 
b. Indirectly: Into the deep lobe of parotid gland as in the 
pterygomandibular block. It is a transient phenomenon and lasts for a few 
hours; depending upon: The agent used, its volume injected and the 
proximity to the branches of facial nerve. There is usually minimal or no 
sensory loss. 
Manifestations 
• Face: It results in unilateral loss of motor function of the muscles of 
facial expression. The face appears to be lopsided; there is drooping of lips, 
etc. 
• Eyes: It manifests in the form of inability to voluntarily close the 
ipsilateral eye. The protective lid reflex of the eye is abolished. Winking or 
blinking becomes impossible. Cornea, however, retains its innervations. 
Thus, if irritated, the corneal reflex is intact and tears will lubricate the eye. 
• There will be no anesthesia in the area of injection. 
Causes 
1. Injection of local anesthetic solution in the capsule of, or the deep lobe 
of parotid gland, during a pterygomandibular block. 
2. Injection, superficially, into the muscles of facial expression, or in the 
vicinity of the nerves innervating them, as in infraorbital nerve block. 
Prevention 
1. Good knowledge of anatomy. 
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2. Adherence to the standard protocol for local anesthesia technique, 
particularly, pterygomandibular block and infraorbital nerve block. In the 
pterygomandibular block, if the needle is advanced posteriorly and bone is 
not contacted, the needle should be withdrawn almost completely from the 
soft tissues; the barrel of syringe is shifted posteriorly, the needle is then 
advanced more anteriorly, until it contacts the bone. 
 
Management 
It does not require any treatment. The effect is transient and lasts as long as 
the effect of anesthesia. 
1. Explanation of the situation, that it is transitory phenomenon; (as it lasts 
for a few hours) and reassurance given to the patient. 
2. Eye dressing to be given over the affected eye. Until muscle tone returns, 
or ask the patient to close the eye manually; close the eyelids periodically 
to keep cornea lubricated. 
3. Contact lenses, if any, should be removed, until muscular movements 
return. 
Visual Disturbances 
These complications are rare and difficult to explain. These 
complications are usually seen as unilateral or bilateral disturbances of 
vision; and are seen in the following forms: 
• squint. 
• diplopia or double vision. 
• transient amaurosis (blindness without a demonstrable lesion in the 
eye). 
• permanent blindness. 
The probable explanations of the associated phenomena of these situations, 
are as follows: 
• It is possible that vascular spasm. 
• The accidental intra-arterial injection is most likely cause. In such 
situations, an unusual vascular distribution can be assumed to be the likely 
situation. 
• It may be due to inadvertent anesthesia of the nerves in the region. 
Diagnosis. These complications have to be diagnosed on the basis of 
clinical manifestations. 
Prevention. Sound knowledge of anatomy and the landmarks for the 
injection technique. Strict adherence to the injection protocol. 
Management. The best method is to prevent these complications. 
Reassurance: the patient is assured that a normal region will be 
restored within 30 minutes. 
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Diplopia or double vision. The resultant disturbance in the vision 
will return back to normal as the solution gets diffused, usually within 
about 3 hours. 
Example: the injection which may cause diplopia is infraorbital 
nerve block. 
Explanations 
• The most likely explanation given is that some of the maxillary 
injections may result in local anesthetic solution infiltrating into the orbit to 
anesthetise the extrinsic ocular muscles of the eye. 
• An accidental intra-arterial injection of local anesthetic solution in 
patients with uncommon vascular patterns. In these situations, it is 
presumed that the orbit is supplied either wholly or partly by middle 
meningeal artery, a branch of internal maxillary artery. 
Management. No treatment is necessary; other than reassurance. The 
vision usually returns to normal at the end of the anesthetic effect. 
Transient squints and double vision. These complications have 
occurred following posterior superior alveolar nerve block and maxillary 
nerve block injections. These complications are due to paralysis of extrinsic 
muscles. The most likely explanation is that the local anesthetic solution 
gets diffused into the orbit from the pterygopalatine ganglion and 
infratemporal fossa via the infraorbital fissure. By these routes, the local 
anesthetic solution, may affect the oculomotor, trochlear and abducens 
nerves, which innervate the muscles attached to the eyeball. 




TOPIC: GENERAL ANESTHESIA IN MAXILLOFACIAL 
SURGERY 
 
General anaesthesia is a medically induced coma and loss of 
protective reflexes resulting from the administration of one or more general 
anaesthetic agents.  
A variety of medications may be administered, with the overall aim 
of ensuring unconsciousness, amnesia, analgesia, relaxation of skeletal 
muscles and loss of control of reflexes of the autonomic nervous system.  
The optimal combination of these agents for any given patient and 
procedure is typically selected by ananaesthesiologist or another provider 
such as an anaesthesiologist assistant or nurse anaesthetist, in consultation 
with the patient and the medical or dental practitioner performing the 
operative procedure. 
 
Methods of anxiety and pain control: 
1. Analgesia – the diminution or elimination of pain. 
2. Conscious sedation – a minimally depressed level of consciousness 
that retains the patient’s ability to independently and continuously maintain 
an airway and respond appropriately to physical stimulation or verbal 
command and that is produced by a pharmacological or non-
pharmacological method or a combination thereof. In accord with this 
particular definition, the drugs and/or techniques used should carry a 
margin of safety wide enough to render unintended loss of consciousness 
unlikely. Further, patients whose only response is reflex withdrawal from 
repeated painful stimuli would not be considered to be in a state of 
conscious sedation.  
3. Combination inhalation – enteral conscious sedation (combined 
conscious sedation) – conscious sedation using inhalation and enteral 
agents. When the intent is anxiolysis only and the appropriate dosage of 
agents is administered, then the definition of enteral and/or combination 
inhalation-enteral conscious sedation (combined conscious sedation) does 
not apply. 
4. Local anesthesia – the elimination of sensation, especially pain, in 
one part of the body by the topical application or regional injection of a 
drug. Note: Although the use of local anesthetics is the foundation of pain 
control in dentistry and has a long record of safety, dentists must be aware 
of the maximum, safe dosage limits for each patient. Large doses of local 
anesthetics in themselves may result in central nervous system depression, 
especially in combination with sedative agents.  
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5. Minimal sedation – a minimally depressed level of consciousness, 
produced by a pharmacological method, that retains the patient’s ability to 
independently and continuously maintain an airway and respond normally 
to tactile stimulation and verbal command. Although cognitive function 
and coordination may be modestly impaired, ventilatory and cardiovascular 
functions are unaffected. 
 
Routes of administration: 
• enteral – any technique of administration in which the agent is 
absorbed through the gastrointestinal (GI) tract or oral mucosa (oral, rectal, 
sublingual).  
• parenteral – a technique of administration in which the drug bypasses 
the gastrointestinal (GI) tract ( intramuscular (IM), intravenous (IV), 
intranasal (IN), submucosal (SM), subcutaneous (SC), intraosseous (IO).  
• transdermal – a technique of administration in which the drug is 
administered by patch or iontophoresis through skin.  
• transmucosal – a technique of administration in which the drug is 
administered across mucosa such as intranasal, sublingual, or rectal.  
• inhalation – a technique of administration in which a gaseous or 
volatile agent is introduced into the lungs and whose primary effect is due 
to absorption through the gas/blood interface. 
 
General anaesthesia has many purposes including: 
1. Analgesia – loss of response to pain, 
2. Amnesia – loss of memory, 
3. Immobility – loss of motor reflexes, 
4. Unconsciousness – loss of consciousness, 
5. Skeletal muscle relaxation. 
 
The Guedel's classification by Arthur Ernest Guedel described four 
stages of anaesthesia in 1937. Despite newer anaesthetic agents and 
delivery techniques, which have led to more rapid onset and recovery from 
anaesthesia, with greater safety margins, the principles remain. 
Stage 1. Stage 1 anaesthesia, also known as the «induction», is the 
period between the initial administration of the induction agents and loss of 
consciousness. During this stage, the patient progresses from analgesia 
without amnesia to analgesia with amnesia. Patients can carry on a 
conversation at this time. 
Stage 2. Stage 2 anaesthesia, also known as the «excitement stage», 
is the period following loss of consciousness and marked by excited and 
delirious activity. During this stage, respirations and heart rate may become 
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irregular. In addition, there may be uncontrolled movements, vomiting, 
breath holding and pupillary dilation. Since the combination of spastic 
movements, vomiting and irregular respirations may lead to airway 
compromise, rapidly acting drugs are used to minimize time in this stage 
and reach stage 3 as fast as possible. 
Stage 3. Stage 3, «surgical anaesthesia». During this stage, the 
skeletal muscles relax, vomiting stops and respiratory depression occurs. 
Eye movements slow, then stop, the patient is unconscious and ready for 
surgery. It has been divided into 4 planes: 
− eyes initially rolling, then becoming fixed 
− loss of corneal and laryngeal reflexes 
− pupils dilate and loss of light reflex 
− intercostal paralysis, shallow abdominal respiration 
Stage 4. Stage 4 anaesthesia, also known as "overdose", is the stage 
where too much medication has been given relative to the amount of 
surgical stimulation and the patient has severe brain stem or medullary 
depression. This results in a cessation of respiration and potential 
cardiovascular collapse. This stage is lethal without cardiovascular and 
respiratory support. 
 
American society of anesthesiologists (ASA) patient physical status 
classification: 
ASA I – a normal healthy patient.  
ASA II – a patient with mild systemic disease.  
ASA III – a patient with severe systemic disease.  
ASA IV – a patient with severe systemic disease that is a constant threat 
to life.  
ASA V – a moribund patient who is not expected to survive without the 
operation. 
ASA VI – a declared brain-dead patient whose organs are being removed 
for donor purposes. 
 
Neuroleptanalgesia – a form of analgesia achieved by the 
concurrent administration of a neuroleptic such as droperidol andan 
analgesic such as fentanyl. Anxiety, motor activity and sensitivity to 
painful stimuli are reduced; the person is quiet and indifferent to 
surroundings and is able torespond to commands. If nitrous oxide with 





Conscious sedation is – a technique in which the use of a drug or 
drugs produces a state of depression of the central nervous system enabling 
treatment to be carried out, but during which verbal contact with the patient 
is maintained throughout the period of sedation. 
The drugs and techniques used to provide conscious sedation for 
dental treatment should carry a margin of safety wide enough to render loss 
of consciousness unlikely. 
The level of sedation must be such that the patient remains 
conscious, retains protective reflexes and is able to understand and respond 
to verbal commands. 
Sedation is a useful technique in anxious patients, children and in 
those undergoing more lengthy procedures. Patients often experience a 
sense of disorientation or detachment and may describe the experience as 
similar to being mildly drunk. In some it can induce sexual fantasies and a 
chaperone is essential. 
Sedation is not a substitute for effective local anaesthesia. If local 
anaesthesia is inadequate, the patient will still experience pain and may 
become extremely agitated. Patients do not need to be starved before 
sedation (although a heavy meal is inadvisable) and any routine medication 
should be taken as normal. Patients must have an escort to take them home 
and look after them for 24 hours. Informed consent both for sedation and 
surgery is required, preferably written. 
Sedation can be given in three ways. 
 
Inhalational sedation. This is a relatively safe form of sedation used 
in dentistry although it has little role to play in more extensive surgery. It is 
particularly useful in children and can be helpful in quick procedures such 
as reduction of a dislocated mandible. 
A variable percentage mix of nitrous oxide (N2O) mixed with 
oxygen (O2) is used for this technique. N2O is an extremely potent analge-
sic, rapidly taken up and excreted by the lungs. The N2O/O2 mix has both 
sedative and analgesic effects. The drug is not metabolized within the body 
to any significant extent, thus adding to its safety. This technique does not 
involve the use of injections and this may be an important factor for some 
patients. 
Note that the terms ‘relative analgesia’ and ‘inhalational sedation’ 
both refer to N2O/O2 inhaled techniques. Relative analgesia involves 
titrating the N2O, dose whereas inhalational sedation uses a fixed dose of 
N2O. Both have a fixed minimum inhaled dose of 30% O2. 
The mix of N2O/O2 is used as an adjunct to a local anaesthetic 
technique and is in no way meant to be used as the sole analgesic. With 
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correct patient selection, adequate local anaesthetic use, combined with 
reassurance, many dental procedures may be accomplished. 
Following administration, patients make a quick recovery with no 
lasting effects. 
Historically, when using N2O sedation, long-term exposure was 
thought to lead to vitamin B12 depletion and subacute degeneration of the 
spinal cord. With modern scavenging systems, extensive research has not 
found this to be a major concern. An additional concern is the potential for 
abuse of Diazepam is fairly rapidly absorbed from the gut. As a guide, a 
dose between 0,1 and 0,25 mg/kg of body weight will produce sedation. 
Temazepam may be used, 10 to 20 mg 1 hour before treatment. 
 
Intravenous sedation. In the United Kingdom the only recommended 
intravenous sedation method is the ‘single injection of a single drug’. In 
this country the administration of multiple drugs should be carried out only 
by fully trained anaesthetists and in a hospital setting, with full monitoring 
and resuscitation equipment available. 
The «single drug» in question is a benzodiazepine, usually 
midazolam. The advantages of the benzodiazepines are anterograde 
amnesia, anxiolysis and a degree of muscle relaxation. Midazolam has a 
wide margin of safety and is particularly suited to outpatient sedation. It 
causes minimal respiratory depression, although as patients relax they will 
often «forget» to breathe – vigilance is required. 
Doses of midazolam for any individual patient are difficult to 
predict. Most patients reach an adequate degree of sedation with 10 mg or 
less. Bear in mind that the onset time may be delayed in elderly patients 
because of a slowed circulation time; patience will avoid inadvertent 
overdose. 
GDC guidelines state that the patient’s pulse, respiratory rate and O2 
saturation must be monitored during the procedure. Noninvasive blood 
pressure recordings must be made at regular intervals and a defibrillator 
should be available in the procedure room. All staff involved must be pro-
ficient in cardiopulmonary resuscitation in the event of medical 
emergencies (regulations mandate a ‘second appropriate person’). 
Skills need to be acquired in venipuncture to carry out intravenous 
sedation. 
Flumazenil, a specific benzodiazepine reversal agent, must be 
available. It rapidly reverses all the effects of the benzodiazepines at a dose 
of 200 μg intravenously over 15 seconds, followed by 100 μg at 60-second 
intervals until reversal occurs. Bear in mind that flumazenil has a shorter 
duration of action, so multiple doses may be required. 
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Children may react with the opposite effect; paradoxical stimulation 
and agitation are well described following intravenous sedation. This 
method is therefore not recommended in the outpatient paediatric 
population. Both rectally and orally administered benzodiazepines are 
popular in paediatric wards for minor procedures such as suture removal. 
 
Oral sedation. This is useful in mildly anxious patients and can be 
administered at home before the appointment. The advantage is 
acceptability to both patient and surgeon. However, it is essential that 
monitoring be used during any procedure if the patient has had oral 
sedation. 
The disadvantage is that the surgeon has to rely on a compliant 
patient to self-administer the medication before coming to surgery, within 
an allotted period of time, for the sedative to be of benefit. This does 
require a motivated, cooperative patient. 
Drugs administered orally take 30 to 60 minutes for any clinical 
effect to be seen. The dose required to produce sedation is unpredictable 
and absorption of drugs from the gastrointestinal tract is also variable. The 
effects are therefore variable in depth and duration. 
There is the potential for complications should multiple doses be 
administered outside of a monitored environment. It is the responsibility of 
the prescriber to ensure that all the rules and regulations relating to sedation 
are applied and strictly followed. 
Diazepam is fairly rapidly absorbed from the gut. As a guide, a dose 
between 0,1 and 0,25 mg/kg of body weight will produce sedation. 
Temazepam may be used, 10 to 20 mg 1 hour before treatment. 
 
Transcutaneous nerve stimulation. This technique is thought to 
work via the «gate control» theory. Rubbing or massaging a painful area, or 
the application of a small electrical current to the skin, closes the ‘gate’ at 
the spinal cord level and prevents pain fibres from conducting impulses to 
the brain. Transcutaneous electrical nerve stimulation (TENS) and some 
types of acupuncture are also thought to promote endogenous opioid 
release in the brain. In the maxillofacial region this can be effective in 
postherpetic neuralgia and other forms of deep-seated facial pain. 
TENS is contraindicated in patients with pacemakers and should be 
avoided over the carotid sinus. 
 
Hypnosis. This is thought to produce a state of altered consciousness 
and relaxation. Hypnosis is generally believed to be an altered state of 
92 
 
consciousness. Sleep is the best-known altered state. The aim of hypnosis is 
to teach people to cope with the situation to the best of their ability. 
It has been suggested that in a hypnotic state, patients do not act 
against their own consciences and always cooperate voluntarily. Always 
have a chaperone. 
Induction of the hypnotic state can be performed verbally by the 
surgeon, visually or by the patients themselves. Multiple sessions can 
prepare patients to autohypnotize or respond to posthypnotic suggestion by 
using key words or procedures. 
 
Acupuncture. Traditionally acupuncture is a holistic approach to the 
management of disease as well as maintenance of health. It involves 
insertion of needles into various parts of the body and should be regarded 
as a supplement to conventional treatment. 
It has value in control of postoperative pain and in the management 
of myofascial pain dysfunction and facial pain. Its value as a sole analgesic 
for operative treatment is questionable; however, it may play a role in 
reducing anxiety preoperatively. 
The United Kingdom and German-speaking countries are fairly 
similar in this area. The United States is a little different. 
 
Analgesia. Dental procedures can be painful and a sound knowledge 
of good analgesic prescribing is essential. The principles are simple: give 
appropriate drugs, in sufficient dose, on a regular basis, at sufficient time 
intervals. Where possible, use of smaller doses of a combination of drugs 
will have a synergistic effect, while minimizing side effects. When oral 
analgesics are combined with effective local anaesthetic techniques, the 
results can be very rewarding. 
There are numerous approaches to this end. The simplest is set out in 
the World Health Organization analgesic ladder on the next page. Devised 
by the World Health Organization (WHO), it outlines a systematic 
approach to pain control that will satisfy the needs of the majority of 
patients. 
 
Simple analgesics. Simple analgesics (e.g. paracetamol) are useful 
for mild pain. Minimal side effects at therapeutic doses make this an 
attractive option. Hepatotoxicity is a problem only at toxic doses. 
Paracetamol has antipyretic and analgesic properties. It is a useful analgesic 
if nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated. 
Doses: adult dose – 1 g every 4 to 6 hours. Maximum daily dose – 4 
g; Paediatrics – dependent on age, consult recent formulary. 
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Nonsteroidal anti-inflammatory drugs. NSAIDs (e.g. aspirin, 
diclofenac, ibuprofen, ketorolac) have both anti-inflammatory and 
analgesic effects; therefore, they are useful particularly when inflammation 
is the primary cause of the pain. Following oral surgical procedures 
involving the teeth and bones (e.g. wisdom teeth removal, apicectomies), 
NSAIDs can be given orally, i.m. or rectally. 
These drugs are contraindicated in patients with peptic ulcer disease, 
renal impairment and coagulation disorders and in patients who have had a 
previous hypersensitivity reaction to aspirin or NSAIDs. 
A note about asthmatic patients and NSAIDs – These drugs are not 
absolutely contraindicated in asthma. There is, however, a higher chance of 
allergy and an increased chance of exacerbation of asthma symptoms. 
Side effects include gastrointestinal upset, bleeding, hypersensitivity 
reactions and wheezing. Use with caution in elderly patients – Long-term 
use can result in severe gastrointestinal haemorrhage. 
Doses. Adult dose – Ibuprofen 400 to 600 mg three times daily. Take 
with food to reduce chances of gastrointestinal upset. Maximum daily dose 
– 2.4 g. 
Diclofenac 50 mg three times daily. Take with food. 
Child dose – dependent on weight, consult recent formulary. Avoid 
aspirin in children with recent flu-like illness – Potentially lethal Reye’s 
syndrome may result. 
Minor opioids. These drugs (e.g. codeine, tramadol, dihydrocodeine) 
are effective for mild to moderate pain. Given orally or i.m. They can be 
given in combination with paracetamol. Side effects include nausea, 
constipation and confusion, especially in elderly patients. 
Doses. Codeine – 30 to 60 mg every 4 to 6 hours to a maximum of 
240 mg daily. 
Tramadol – 50 to 100 mg every 4 to 6 hours; said to be less likely to 
interfere with pupillary response in head injury. 
Compound analgesic (Co-Codamol [codeine and paracetamol]) 
This drug is used for mild to moderate pain relief or pyrexia. 
Presentations: 8/500 – 8 mg codeine phosphate, 500 mg paracetamol. 
(If Co-Codamol is prescribed with no stated strength, this will be 
dispensed.) Given orally, constipation and rebound ‘analgesic headache’ 
are the main complications. 
Adult dose – 1 to 2 tablets every 4 to 6 hours. Maximum daily – 8 
tablets. 
Child dose – dependent on age. 
30/500 – 30 mg codeine phosphate, 500 mg paracetamol. 
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Dose – 1 to 2 tablets every 4 hours. Maximum daily – 8 tablets. Not 
recommended for children. 
60/1000 – 60 mg codeine phosphate, 1 g paracetamol. 
Dose – 1 tablet every 4 hours. Maximum daily – 4 tablets. 
Opioids (e.g. morphine, diamorphine). These are the most potent of 
the analgesics. The opioids are seldom used after office procedures. The 
role is analgesia in the postoperative period after major surgery. 
Routes of administration – options include oral (Oramorph), i.m., 
subcutaneous and intravenous administration and patient-controlled analge-
sia (PCA). Because of the side effect profile of the opioids, they should be 
administered only in an inpatient setting, where respiratory monitoring is 
available. 
Side effects – Nausea and vomiting, constipation, sedation, 
confusion and respiratory depression. Prescription of naloxone, a specific 
opioid antagonist and an antiemetic for use alongside the opioid is humane. 
Consider addition of a laxative, especially in elderly patients or if long-
term use is anticipated. 
 
Cryotherapy. This is the therapeutic use of extreme cold, achieved 
by using N2O or liquid nitrogen to freeze tissues. Cell death and 
subsequent tissue necrosis result in analgesia. 
Intractable or recurrent pain from nerve infiltration (e.g. malignancy 
or physiological conditions such as trigeminal neuralgia) may be treated by 
cryotherapy. 
The diagnosis must be established beforehand and this is most easily 
done by a nerve block. In such cases the nerve (e.g. inferior alveolar, 
infraorbital) can then be exposed and frozen. 
Procedure. Informed consent must be gained. In particular, patients 
must be warned of postoperative oedema and ulceration, which may be 
quite severe. 
A local anaesthetic should be used to anaesthetize the area, followed 
by selection of appropriate probe tip. A lubricant jelly (such as KY) should 
be applied to the area to improve contact between probe and tissue. Freeze 
for 1 minute; thaw for 1 minute is the usual cycle. 
During thawing, be careful not to pull the probe from the tissue 
because this will result in damage to tissue. At least two cycles are used. 
One may need to overlap ice zones. 
Follow up to check symptoms. 
The duration of paraesthesia varies, but there is usually an analgesic 
period after the paraesthesia resolves. If necessary, cryotherapy can be 
repeated at a later date. 
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TOPIC: INDICATIONS AND CONTRAINDICATIONS FOR 
TOOTH EXTRACTION 
 
Extraction of teeth is one of the most common surgical procedures 
worldwide. It has a psychological impact on the patient, because the patient 
will be losing a tooth, and the associations the patient will have with such a 
procedure. The patient will also face another problem in that the loss of a 
tooth often requires a later replacement of the missing tooth. For this reason 
patient information and consent is very important. Moreover, extraction of 
teeth incorporates basic principles from physics, mechanics, and surgery, 
and the clinician should therefore fully understand and master the 
techniques of extraction. 
 
 Indications for extraction. Although teeth in principle should be 
treated and maintained in the oral cavity as long as possible, provided they 
fulfill functional and esthetic criteria, it is sometimes inevitable that teeth 
have to be removed for various reasons. General indications for extractions, 
are discussed under their respective headings; however, the decision to 
extract has to be made individually for each case.  
Caries. When the tooth is subjected to severe caries with extensive 
loss of tooth substance that will not permit restorative procedures, it may 
sometimes be necessary to extract the tooth.  
Periodontal disease. Periodontal disease should be treated as first 
alternative, but there are situations where severe periodontal disease can be 
an indication for extraction, especially when the prognosis is poor for 
periodontal treatment. Severe bone and attachment loss and irreversible 
tooth hypermobility may be an indication for extraction. Long-standing, 
progressive periodontitis will result in alveolar bone loss. If implant 
treatment is going to be performed after extraction it is important not to 
wait too long before severely periodontally affected teeth are extracted. The 
severity of periodontal disease, long-term prognosis, and even cost/benefit 
aspects should be considered before making the decision. Pulp disease 
when endodontic treatment is not possible or has failed Irreversible 
pulpitis, pulp necrosis or internal resorption of the root canal where 
endodontic procedures are not possible or have failed are sometimes other 
indications for tooth extraction. This could be because of obliterated root 
canals, canals that are not accessible due to root anatomy, or when a patient 
chooses not to undergo such treatment. Pathologic lesions in relation to 
teeth Pathologic lesions associated with teeth, i.e. apical or juxtaradicular 
periodontitis, can usually be solved by endodontic treatment. If endodontic 
procedures are not possible, then extraction can be considered. If teeth 
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compromise the surgical treatment of other pathologic lesions found in the 
tissues surrounding them, then extraction may be considered, e.g. in the 
treatment of osteomyelitis, or benign and malignant tumors of the jaw. 
Crown and root fractures. Crown, crown-root, and root fractures 
after trauma can most often be successfully treated and extraction avoided. 
However, there are other situations where fractures of the crown and root 
do not allow successful restorative therapy and extraction is the only 
alternative.  
Malposition of teeth. Although malposition of teeth is not an 
indication for extraction, there are situations where malposition is 
associated with other conditions such as trauma to soft tissue or blockage 
of eruption of adjacent teeth. Another situation is when there is elongation 
of teeth due to the missing antagonist and where prosthetic rehabilitation is 
considered in the opposing jaw. The elongated tooth may then be 
considered for extraction. 
Impacted teeth. Impacted teeth do not always reach functional 
occlusion, often because of lack of space. These teeth should be 
investigated and considered for extraction if they present a potential for the 
development of pathology in the future. These could include the risk for 
root resorption of adjacent teeth, loss of bone around adjacent roots or 
development of other pathologic conditions such as cysts. Impacted third 
molars are the most common teeth considered for extraction. However, 
there must always be an indication if third molars are going to be removed 
and prophylactic removal of impacted third molars without pathology or 
symptom is not justified today.  
Supernumerary teeth. Supernumerary teeth that are potential 
sources for future pathology should sometimes be removed. However, 
supernumerary teeth without pathology do not have to be routinely 
removed. Orthodontic indications Extraction of teeth is sometimes required 
to create space in order to carry out planned orthodontic treatment. The 
most common teeth for extraction on orthodontic indications are premolars. 
The decision on which tooth/teeth are to be extracted is made by the 
orthodontist.  
Before prosthetic procedures. Before prosthetic reconstructions is 
carried out it is sometimes necessary to extract teeth. Teeth could interfere 
with the proper placement of a fixed or removable prosthetic appliance and 
may then be extracted. For example, in the case of rehabilitation of a jaw 
with implants where there are only one or two incisors remaining that have 
a dubious prognosis, in some situations it may be better to be radical and 




Before other surgical procedures. Sometimes teeth have to be 
removed prior to other surgical procedures. The most common indication in 
this regard is the removal of impacted molars prior to LeFort-I and sagittal 
split osteotomies. This is done if the teeth lie in the line of the planned 
osteotomiesor increase the risk for other complications such as undesired 
fractures.  
Before radiation therapy. Careful consideration should be given to 
patients who are to undergo radiation therapy due to tumors in the head and 
neck region. These extractions should preferably be carried out before 
radiation treatment is starting. Teeth associated with pathologic conditions 
such as periapical periodontitis should be considered either for swift 
endodontic procedures or extraction. A radical approach by extracting 
rather than choosing doubtful restorative treatment with less chance of 
successful outcome is recommended to avoid later complications in the 
irradiated bone. There is a high risk of osteoradionecrosis if extractions 
have to be carried out after radiation therapy, especially with high doses of 
radiation (>60 Gray). This risk persists throughout the life of the patient.  
Before bisphosphonate therapy. Patients treated with 
bisphosphonates, especially those treated for malignancies with intravenous 
administration of bisphosphonates, run a high risk of osteonecrosis if 
extraction is carried out after bisphosphonate treatment has started. Like in 
irradiated patients, this risk persists throughout the life of the patient. For 
this reason dental examination and appropriate treatment shall always be 
taken into consideration when such bisphosphonate treatment is planned. 
Extractions should be carried out before bisphosphonate therapy is started. 
Teeth associated with pathologic conditions such as periapical periodontitis 
should be considered either for swift endodontic procedures or extraction. 
A radical approach by extracting rather than choosing doubtful restorative 
treatment with less chance of successful outcome is recommended to avoid 
later complications. There is a high risk of osteonecrosis if extractions have 
to be carried out after intravenous bisphosphonate therapy is started. 
Patients on oral bisphosphonates, usually osteoporosis patients, are not 
subjected to the same high risk of osteonecrosis. Teeth in bone fracture 
lines Sometimes teeth in the line of a jaw fracture should be considered for 
extraction in order to prevent infection. Tooth luxation can almost always 
be treated by repositioning and fixation, but where there is severe luxation 
of teeth associated with complex jaw fractures, where teeth are in the line 





Other reasons for extraction. There are other situations where 
extraction may be chosen, even when the extraction may be on doubtful 
indications. In these situations it is especially important to discuss 
alternative treatment and inform the patient preoperatively so the surgeon 
and patient agree on the choice of treatment. Extractions can sometimes be 
performed due to economic reasons. Patients might choose to extract a 
tooth rather than incur the costs of, for example, having endodontic 
treatment or a more expensive restorative procedure. Extractions can 
sometimes also be performed due to esthetic reasons. For example, the 
patient could choose to extract an upper malformed lateral incisor and have 
it replaced with an implant. Furthermore, a patient could choose to extract 
protrusive teeth in the upper front and have them replaced by an implant-
supported prosthesis as an alternative to undergoing orthodontic or 
orthognathic surgical correction. Malformed or severely discolored teeth 
could also be considered for extraction due to esthetic reasons where the 
patients choose extraction and prosthetic reconstruction over other 
procedures such as veneers and crowns. Teeth could sometimes also be 
extracted due to difficulty in maintaining adequate oral hygiene. Most 
commonly, the third molars are extracted due the recurrence of 
pericoronitis and difficulties in maintaining oral hygiene. 
 
Contraindications for extraction 
The surgeon should also consider the contraindications for extracting 
the tooth, for example with consideration to the patient’s general health or 
local conditions in the region of extraction. Contraindications for 
extractions are often relative and can be changed after treating or adjusting 
the underlying reason for the contraindication. 
 
Systemic contraindications. These constitute all general health 
factors and mental factors which have influence on the patient’s ability to 
withstand the surgical procedure. Severe dental anxiety is a relative 
contraindication to extraction in local anesthesia and in some cases patients 
can be treated in general anesthesia. One should pay extra attention to 
patients on medication such as anticoagulant drugs, cancer medication, 
glucocorticoids, immunosuppressants and bisphosphonates. Patients with 
hemophilia or other coagulopathies should first have their disorders 
controlled before extraction. In general, most uncontrolled metabolic 
diseases, such as diabetes, constitute a relative contraindication until they 
are brought under control. Similarly, patients with severe uncontrolled 
hypertension and cardiac diseases should ideally be treated for these 
conditions first before extractions are carried out. Ongoing radio- and/or 
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chemotherapy is also a relative contraindication. In all cases, one should be 
aware of the medications, especially those drugs that affect the immune 
system, delay or impair the healing process, or could interact with 
medication administered to manage an extraction. Some cancer 
medications, e.g. bisphosphonates, can also cause necrosis of the jaws after 
extractions. 
 
Local contraindications. The most common local contraindication 
is an ongoing acute inflammatory or infectious process. The acute 
infection/inflammation should first be treated before proceeding with the 
extraction, depending on the location of the acute process. Extraction of a 
third lower molar during an ongoing acute pericoronitis could lead to a life-
threatening postoperative infection. Local treatment of the pericoronitis is 
preferred and extraction may be carried out later. However, there are also 
situations where an acute abscess is best drained by extraction of the tooth 
even in an acute phase. Therefore, an acute infectious and inflammatory 
process should not be considered as an absolute contraindication for 
extraction. The surgeon should, however, bear in mind that there could be 
other problems, such as severe pain, swelling, reduced mouth opening, and 
anxiety, which could make extractions associated with other acute 
conditions suboptimal. In such cases extractions should be deferred until 
the acute symptoms have subsided. One of the most important 
contraindications to extraction is radiation therapy, past and present, 
involving the jaws. Delayed healing, dehiscence, and necrosis of the bone 
are often complications due to extractions performed in irradiated bone. 
Finally, teeth within the area of a malignant tumor should not be removed 




TOPIC: TOOLS AND METHODS FOR TOOTH 
EXTRACTION 
 
A tooth or root may be removed with either the closed or the open 
technique. The closed technique is also known as the simple technique or 
forceps technique, while the open technique is also known as a surgical 
extraction or flap technique. The simple technique is that which is used 
most often in everyday practice. In contrast, the surgical technique is 
employed only in cases where the tooth or root extraction is not possible 
with the simple technique. The basic requirements for a successful outcome 
in simple tooth extraction are as follows: 
− informing and reassuring the patient, so that stress and fear levels are 
minimized, and so to ensure desirable cooperation during the procedure. 
− knowing tooth anatomy well, which can be variable 
− detailed clinical and radiographic examinations, since these provide 
important information pertaining to procedure planning and selecting the 
appropriate technique. 
− preparation of the patient, which includes: rinsing the oral cavity with 
various antiseptic solutions, and correct positioning of the dental chair. 
 
Patient Position 
To ensure adequate visualization and comfort during the various 
manipulations required for the tooth extraction, the dental chair must 
always be positioned correctly. For the extraction of a maxillary tooth, the 
patient’s mouth must be at the same height as the dentist’s shoulder and the 
angle between the dental chair and the horizontal (floor) must be 
approximately 120°. Also, the occlusal surface of the maxillary teeth must 
be at a 45° angle compared to horizontal when the mouth is open. During 
mandibular extractions, the chair is positioned lower, so that the angle 
between the chair and the horizontal is about 110°. Furthermore, the 
occlusal surface of the mandibular teeth must be parallel to the horizontal 
when the patient’s mouth is open. The position of right-handed dentists 
during extraction using forceps is in front of and to the right of the patient; 
left-handed dentists should be in front of and to the left of the patient. For 
the extraction of anterior mandibular teeth right-handed dentists should be 
positioned in front of the patient, or behind them and to their right; left-







Forceps for tooth extraction 
The forceps design: 
1. Cheeks. 
2. Lock. 
3. Handles (jaws) 
 
Characteristic of the angle. 
In the forceps to remove the upper teeth: 
− cheeks axis coincides with the axis handles, making a straight line. 
− the angle formed by the axis of the cheeks and the axis handles close 
to two right angles. 
− axis cheeks and handles axis are parallel or nearly parallel. 
In the forceps to remove the lower teeth: 
− cheeks axis and the axis of the handles forms a right angle or 
approaching straight angle. 
 
Feature curve handles: 
− To remove the front (incisors and canines) upper teeth are straight 
forceps  handles are in the same plane with the cheeks. 
− To remove the top small and large root teeth (premolars and molars) 
are tongs with an S-shaped cheeks and handles – S-shaped forceps. Due to 
this bending pliers can freely impose on the tooth side, and thus prevents 
the lower jaw dislocating movements. 
− To remove the upper third molars – special bayonet forceps having a 
bayonet bend, which allows you to seamlessly bring them to the third 
molar. 
 
Feature convergence cheeks: 
− To remove the roots of the teeth on the upper jaw – or bayonet 
forceps with convergent cheeks (at the closing of the forceps handles, their 
cheeks converge – is the hallmark of forceps for removing roots of teeth). 
− To remove the roots of the teeth on the lower jaw – coronoid forceps 
with convergent cheeks. 
 
Feature of direction: 
There is only the S-shaped tongs for removing molars in the upper 
jaw. These pliers have a spike on one of the cheeks, the other cheek – 
smooth. Spike enters the bifurcation between the two buccal roots. If a 
spike on the right cheek – is to remove the left molars, and vice versa. To 
identify correctly the forceps must be placed on the palm of his right hand 
swell up pens. 
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All other tongs are designed to operate as a right-hand side of the 
jaw, and on the left. 
 
Feature width cheeks: 
Choosing the right forceps depends on the group membership of a 
tooth in accordance with the crown width of the tooth. The tongs for 
removing incisors, canines, and premolars cheeks are narrower than – to 
remove molars. Narrower cheeks have forceps for removing roots of teeth. 
To remove the teeth on the lower jaw are coronoid forceps: 
• the cheeks, bent on the edge – smooth, without thorns – to remove 
the incisors, canines and premolars; 
• the cheeks, bent on edge – with a spike on each cheek, which is 
designed for entry into the bifurcation between the two roots – a 
front and a distal – to remove molars in the lower jaw; 
• cheeks, curved forceps on a plane – with a spike on each cheek. It is 
intended for removal of lower third molars with limited mouth 
opening. 
 
Elevators for tooth extraction 
Use elevators, failure the roots removal of teeth with forceps,  
Mode of elevator’s action – the lever of the first kind, consists of: 
1. Cheeks, which ends in a slightly concave groove with a thinned end. 
The concave cheeks face to the deleted root. The convex part of the cheeks 
rests on the wall of the cavity or a nearby root. 
2. Intermediate part, where the second doctor’s finger is located while 
using elevator. 
3. Handles, that the doctor grasps his right hand. 
  
Straight elevator: to remove the single-root teeth in the upper jaw, 
upper jaw teeth, positioned outside the arc. Sometimes straight elevator is 
used for removal of lower third molar roots and lower molars. 
The corner or side elevators: to remove the roots of the teeth on the 
lower jaw, especially the molars. 
Unlike straight elevator: cheek bent on edge and forms with the 
longitudinal axis of the elevator angle 60-800. 
In some sorts of elevators – also connecting part has a bend. 
In the operating position of the elevator cheek facing the concave 
part  or otherwise that depends on the point force application. 
T-shaped or bayonet elevator (Lecluse key) to remove the third 
molar of the lower jaw with the stable first and second molars. Lecluse key 
comprises cheeks connected by a bayonet coupling link with a massive 
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handle is perpendicular to the elevator axis. Cheeks, thinned to an end, one 
side is flat, the other convex. 
 
Separation of tooth from soft tissues 
Severing soft tissue attachment 
 The first step in removing a tooth using the simple technique is to 
sever or loosen the soft tissue attachment surrounding the tooth. Two 
instruments are required to sever the soft tissue attachment: the straight and 
curved desmotomes. The straight desmotome is used for the six maxillary 
anterior teeth, while the curved desmotome is used for the rest of the 
maxillary teeth and all the mandibular teeth. The desmotome is held in the 
dominant hand, with a pen grip and, after being positioned at the bottom of 
the gingival sulcus, it is used to sever the periodontal ligament. This is 
accomplished in one continuous motion, beginning at the distal surface of 
the tooth and moving toward the mesial surface, first buccally and then 
lingually or palatally. While severing the soft tissue attachment, the index 
finger and thumb of the nondominant hand are positioned buccally and 
palatally or the index finger and middle finger are placed buccally and 
lingually, to protect the soft tissues from injury (tongue, cheeks and palate). 
More specifically for right-handed dentists, in the right maxilla, from the 
canine and posterior to the canine teeth (teeth 13–18), the index finger is 
placed palatally and the thumb buccally, while for the rest of the teeth 
(anterior teeth and teeth on the left side, teeth 12–28), the index finger is 
positioned buccally and the thumb palatally. In the mandible, the fingers 
are positioned differently. The fingers usually used are the index finger and 
middle finger of the nondominant hand. More specifically, from the left 
third molar until the right lateral incisor (teeth 38–42), the index finger is 
placed buccally and the middle finger lingually, while for the rest of the 
teeth of the right side (teeth 43–48), the index finger is positioned lingually 
and the middle finger buccally. For left-handed dentists, from the canine 
and posterior to the canine teeth (teeth 23–28) in the left maxilla, the index 
finger is placed palatally and the thumb buccally, while for the rest of the 
teeth (anterior teeth and teeth on the right side, teeth 22–18), the index 
finger is positioned buccally and the thumb palatally. In the mandible, the 
fingers are positioned differently. The fingers usually used are the index 
finger and middle finger of the nondominant hand. More specifically, from 
the right third molar until the left lateral incisor (teeth 48–32), the index 
finger is placed buccally and the middle finger lingually, while for the rest 
of the teeth of the left side (teeth 33–38), the index finger is positioned 




Reflecting soft tissues  
Reflecting the gingiva surrounding the tooth is accomplished with 
two instruments called Chompret elevators. Depending on the shape of the 
blade, the Chompret elevator is either straight or curved. These elevators 
are used to push or slightly reflect the gingiva around an intact tooth, to 
allow the extraction forceps to grasp the tooth beneath the cervical line of 
the tooth as apically as possible. Some people suggest that reflecting the 
soft tissues is not necessary since severing them is sufficient, while others 
consider that reflecting is a more appropriate procedure compared to 
severing the soft tissue attachment. The fact remains that severing the soft 
tissue attachment is a less traumatic procedure compared to reflecting. 
Chompret elevators are also used to expose destroyed teeth that are covered 
by hyperplastic gingivae, enabling positioning of the appropriate 
instrument for their removal. Reflecting (positioning of fingers and 
movements) is done in exactly the same way as severing the soft tissue 
attachment, with a slightly different motion, which is applied with slight 
pressure and in an outward direction. Chompret elevators may also be used 
as dental elevators to remove roots and broken root tips. It is worth noting 
that in the case of an intact tooth, the Freer periosteal elevator, being a very 
narrow instrument and easy to handle, is considered more suitable for 
reflecting the soft tissue attachment compared to the previously mentioned 
instruments. 
Extraction technique using tooth forceps  
The extraction technique using tooth forceps is based on certain 
guidelines to ensure that the tooth is extracted with maximum skill. These 
guidelines involve the correct way to hold the forceps and the tooth itself, 
the forces applied to the tooth, and the direction of movement during the 
extraction. The extraction forceps are held in the dominant hand, while the 
thumb is simultaneously placed between the handles directly behind the 
hinge, so that pressure applied to the tooth is controlled.The nondominant 
hand also plays an important role in the extraction procedure. More 
specifically: 
− It reflects the soft tissues of the cheeks, lips, and tongue, so that there 
is adequate visualization of the surgical field. 
− It supports the alveolar process of the maxilla and aids in stabilizing 
the patient’s head. It also controls the expansion of the alveolar bone by 
way of feel, as well as luxation of the tooth during the various maneuvers. 
− It supports and stabilizes the mandible, counteracting the forces 




After reflecting of the gingiva, the beaks of the forceps are 
positioned at the cervical line of the tooth, parallel to its long axis, without 
grasping bone or gingivae at the same time. The initial extraction 
movements applied are very gentle. More specifically, the dentist applies 
slow steady pressure to move the tooth buccally at first, and then palatally 
or lingually. Movements must become greater gradually and the buccal 
pressure is greater than the corresponding palatal or lingual pressure, 
because the labial or buccal bone is thinner and more elastic compared to 
that of the palate. If anatomy of the root permits (single, conical roots), 
rotational force may be applied in addition to buccopalatal or buccolingual 
pressure. These movements expand the alveolar bone and also sever all the 
periodontal fibers. Slight traction is also employed at the same time, 
facilitating the tooth extraction. During the final extraction phase, traction 
is not permitted, because there is risk of damage due to sudden removal of 
the tooth and the risk of the forceps knocking the teeth of the opposite arch. 
To avoid such a possibility, the final extraction movement must be labial or 
buccal, and in a curved direction that is outwards and upwards for the 
maxilla, and outwards and downwards for the mandible. Before the tooth is 
delivered from the socket, the soft tissue between the tooth and the gingiva 
must be examined for a possible attachment. If this is the case, the gingiva 
must be completely severed from the tooth, because there is a risk of 
greatly tearing the tissues. 
Procedural steps: 
1. Separation – separation of circular ligament from the neck of the tooth 
and the gums of the alveolar bone. 
The basic rule: thoroyghness of the work. 
2. Forceps on the tooth. 
The basic rule: the axis cheeks forceps should coincide with the axis 
of the tooth. 
3. Promoting cheeks forceps. When removing teeth preserved crown, 
cheeks forceps to promote the neck of the tooth. When bone resorption 
around the tooth is permissible to promote extractor deeper in the upper 
part of the root. When you remove the roots of teeth impose forceps on the 
edge of the alveoli.  
The basic rule: the axis cheeks forceps must coincide with the axis of 
the tooth. 
4. Retention or interlocking of forceps. Forceps and the tooth should be 
«one». Tooth and forceps at the same time form a common arm. 
5. The dislocation of the tooth. There is a gap periodontal fibers, 




There are two ways of dislocation: 
Luxation – oscillating (pendulum) movement in the vestibular-oral 
direction; 
Rotation – rotational motion around the axis of the tooth to 20-280 in 
one direction and then in another direction. Rotation is possible while 
dislocation 11th, 12th, 13th, 21st, 22nd, 23rd and the severed roots 14th, 24th, 
17th, 18th, 26th, 27th, 28th. 
Basic rules: 
− The first sprained movement should start in the direction of least 
resistance (where the cavity wall is thinner).  Vestibular wall of the alveolar 
bone is usually thinner than the palate. So the first sprained movement by 
removing the teeth and roots of teeth of the upper jaw should be done in the 
vestibular side (outside). The exceptions are 16th and 26th teeth, as at the 
level of the teeth passes chine alveolar crest, thickening the outer wall. 
Therefore, if you remove these teeth – the first sprained movement is 
carried out in the palatal side. When you remove the lower teeth presence 
of the external oblique line in the area of molars results in that the removal 
of these teeth need to make the first move in the oral side. 
− The first sprained movement makes weak, should gradually increase 
the amplitude of the oscillation. 
6. Removing the tooth from the cavity. Produced when the 
connection with the tissues of the tooth completely lost. It carried out 
smoothly, without jerks. 
7. Cavity curettage. 
The basic rule: curette spoon size should fit well. You should know 
the presence of the maxillary sinus on upper jaw. 
8. Provide full clot formation and convergence cavity edges using 
gauze. 
The basic rule: the clot must be complete, i.e. not extend beyond the 
cavity (not to be loose, overlapping the edge of the cavity). 
 
Tooth extraction on mandible 
The position of the patient in the chair: the operative field is to be at 
the level of the elbow lowered doctor's hands. The patient's head is in a 
vertical position, and by removing the left molars and premolars slightly 
rotated right. 
The position of the doctor to the patient: 
− The right and in front by removing all groups of teeth in the lower 
jaw on the left and the right incisors and canines, and molars on the right 
while removing with forceps, curved in the plane. 
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− The right and rear of the patient in removing premolars and molars of 
the mandible on the right with coronoid shaped forceps, curved along the 
edge, and elevators. 
Using forceps: 
− For the removal of 31st, 32nd, 41st, 42nd  teeth  use forceps, curved 
along the edge of a narrow cheeks, thornless. 
− For the removal of 33rd, 34th, 35th, 44th, 45th teeth using coronoid 
forceps curved along the edge, with widen cheeks, without thorns. 
− For the removal of 36th, 37th, 46th, 47th teeth used coronoid forceps, 
bent on the edge, with thorns on both cheeks. 
− For the removal of  38th and 48th used the tooth coronoid forceps, 
bent on the edge, with thorns on both cheeks (normal opening of the 
mouth). 
− For the removal of 38th and 48th while limiting the opening of the 
mouth using coronoid forceps curved in the plane. 
− To remove the roots of all the groups of teeth in the lower jaw are 
used coronoid forceps, bent on the edge, with narrow converging cheeks. 
According to indications the elevators are used. 
 
Using elevators: 
− When removing 38th and 48th used straight elevators. Bearing point 
are located near the 37th and 38th. 
− For the removal of the distal right and left mesial roots of the molars 
used a corner pull elevator. 
− For the removal of the distal left root and  right mesial roots of the 
molars used a corner push elevator. 
 
Tooth dislocation. First dislocating (luxation) movement while 
removing all groups of teeth in the lower jaw with the exception of 37th, 
38th, 47th and 48th spend in the vestibular side (in the direction of less 
resistance); 37th, 38th, 47th, 48th – in the oral (lingual) side. 
Exclusion of dislocation when the 2nd  and 3rd  molars of the 
mandible is due to thickening of the vestibular wall by the external oblique 
line. 
 
Tooth extraction on maxilla 
Extraction of maxillary central incisors  
Extraction forceps for six anterior maxillary teeth or maxillary 
universal forceps. In order to extract maxillary central incisors, righthanded 
dentists must be positioned in front of and to the right of the patient, and 
left-handed dentists in front of and to the left of the patient. The index 
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finger of the nondominant hand is then placed labially, and the thumb 
palatally, firmly holding the alveolar process next to the tooth to be 
extracted. The beaks of the forceps are adapted to the tooth, and the beaks 
must be parallel to the long axis of the tooth. The initial extraction 
movements are gentle, first in a labial direction, and then palatal. After the 
initial force is applied to the tooth, motions gradually become greater and 
the final extraction force is applied labially. Because the root of the central 
incisor is conical in shape, its removal may also be achieved using 
rotational forces. More specifically, the tooth is rotated first in one 
direction and immediately afterwards in the other direction, until the 
periodontal fibers are completely severed. The tooth is then delivered from 
the socket using slight traction. 
 
Extraction of maxillary lateral incisors 
Extraction forceps for six anterior maxillary teeth or maxillary 
universal forceps. In order to extract maxillary lateral incisors, righthanded 
dentists must be positioned in front of and to the right of the patient, and 
left-handed dentists in front of and to the left of the patient. The fingers of 
the nondominant hand are placed in exactly the same way as for the central 
incisors. The extraction movements for removal of the lateral incisor are 
labial and palatal. Because the lateral incisor has a thin root and there is 
usually curvature of the root tip distally, rotational force is not allowed. 
Slight rotational motions may be employed only in the final stage, with 
simultaneous traction of the tooth from the socket. 
 
Extraction of maxillary canines 
Extraction forceps for six anterior maxillary teeth or maxillary 
universal forceps. Maxillary canines present some degree of difficulty due 
to their firm anchorage in alveolar bone, and their long roots and frequent 
curvature of the root tip. Also, the labial surface of the tooth’s root is 
covered by thin alveolar bone, and if due consideration is not given during 
movements, there is a risk of fracturing the alveolar process. In order to 
extract maxillary canines, right-handed dentists must be positioned in front 
of and to the right (left-handed dentists should be in front of and to the left) 
of the patient, whose head should be turned towards the dentist. For the 
right-handed dentist, the fingers of the nondominant hand are placed as 
follows: for the right side, the thumb is placed labially and the index finger 
palatally, while for the left side, the index finger is placed labially and the 
thumb palatally. For the left-handed dentist, the fingers of the nondominant 
hand are placed as follows: for the right side, the thumb is placed palatally 
and the index finger labially, while for the left side, the index finger is 
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placed palatally and the thumb labially. The extraction movements are 
labial and palatal, with gradually increasing intensity. Because the canine 
has a flattened root and the root tip is usually curved distally, rotational 
motions are not permitted, or if they are used, they must be done so very 
gently and with alternating buccopalatal pressure. The final extraction 
movement is labial. 
 
Extraction of maxillary premolars 
Maxillary universal forceps. In order to extract maxillary premolars, 
the dentist should be positioned in front of and to the right (or to the left for 
left-handed dentists) of the patient. For right-handed dentists, the fingers of 
the nondominant hand are placed as follows: for the right side, the index 
finger is placed palatally and the thumb buccally, while for the left side, the 
index finger is placed buccally and the thumb palatally. For left-handed 
dentists, the fingers of the nondominant hand are placed as follows: for the 
right side, the index finger is placed buccally and the thumb palatally, 
while for the left side, the index finger is placed palatally and the thumb 
buccally. As for the first premolar, because it usually has two roots, buccal 
and palatal pressure should be gentle and slight. If movements are vigorous 
and abrupt, there is a risk of fracturing the root tips. If one of the root tips 
does break, it may be removed easily, since they are not very curved and 
the tooth has already been mobilized during the extraction attempt. 
Rotational motions are not allowed due to the tooth’s anatomy. Extraction 
of the second premolar is easier, because the tooth has one root. 
Movements are the same as those for the first premolar. The final 
movement for both teeth is buccal. 
 
Extraction of maxillary first and second molars 
Maxillary right molar forceps, maxillary left molar forceps. In order 
to extract maxillary molars, the dentist must be positioned in front of and to 
the right (or to the left, for left-handed dentists) of the patient. The fingers 
of the nondominant hand are placed in exactly the same way as for 
maxillary premolars. The appropriate forceps are chosen, depending on the 
tooth to be extracted. The right and left maxillary molar forceps differ in 
that their buccal beaks have a pointed end at the center, which adapts to the 
root bifurcation. The maxillary first molar has three diverging roots: the 
palatal, which is the largest and most widely divergent toward the palate, 
and the two buccal roots, which are often curved distally. The tooth is 
firmly anchored in the alveolar bone and its buccal surface is reinforced by 
the extension of the zygomatic process. This tooth therefore requires the 
application of strong force during its extraction, which may cause fracture 
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of the crown or root tips. To avoid this from happening, initial movements 
must be gentle, with buccopalatal pressure and an increasing range of 
motion, especially buccally, where resistance is less. The final extraction 
movement is a buccal upwards curved motion, following the direction of 
the palatal root. Because the root tips are close to the maxillary sinus, their 
removal requires careful consideration, due to the risk of oroantral 
communication. Extraction of the maxillary second molar may be 
accomplished in the same way as for the maxillary first molar, because the 
teeth have similar anatomy. Extracting the second molar, however, is 
considered to be easier than extracting the first molar, because there is less 
resistance from the buccal alveolar process and relatively little divergence 
of the roots. Quite often the roots of this tooth are fused together in a 
conical shape. In this case, extraction of the tooth is even easier. 
 
Extraction of maxillary third molar 
Maxillary third molar forceps. In order to extract maxillary third 
molars, the dentist must be positioned in front of and to the right (or to the 
left, for left-handed dentists) of the patient. The fingers of the nondominant 
hand are placed in exactly the same way as for maxillary premolar 
extraction. The maxillary third molar is the smallest of all molars and 
varies greatly in size, number of roots, and root morphology. It has three to 
eight roots. It most commonly has three roots just like the other maxillary 
molars, but smaller and converging. They are usually fused together in a 
conical shape, curved distally. Extraction of the tooth depends on its 
location, as well as on the number and shape of the roots. If the third molar 
has erupted completely and its roots are fused (conical shape), its extraction 
does not usually present any difficulty and it may be removed with only 
buccal pressure. The risk of fracturing the palatal alveolar process is 
avoided this way, which would otherwise occur if force were applied 
palatally (the palatal bone is thinner and lower than the buccal bone). When 
the tooth has three or more roots, though, its extraction is accomplished by 
applying buccal pressure and very gentle palatal pressure. The final 
extraction movement must always be buccal. Root anatomy of the third 
molar permitting, extraction is easily accomplished using the straight 
elevator. The elevator is positioned between the second and third molars 
and the tooth is luxated according to the direction of its roots. 
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TOPIC: SURGICAL TOOTH EXTRACTION 
 
The management of impacted teeth is probably the most common 
problem in oral and maxillofacial surgery worldwide. Teeth that fail to 
erupt are usually the teeth which erupt last in a certain region where there is 
not enough space or because of crowding of teeth. The most common teeth 
which are impacted are mandibular and maxillary third molars followed by 
maxillary canines and mandibular premolars. An impacted tooth is one 
which is prevented from completely erupting into a normal functional 
position. This may be due to lack of space, obstruction by another tooth, or 
an abnormal eruption path. The tooth may be soft tissue impacted or hard 
tissue impacted and may be unerupted or partially erupted. Impaction per 
itself is not an indication for removal, it is only a description of the position 
of the tooth. However, impacted teeth may sometimes give rise to 
complications if they are left in place, and over several decades there have 
been recommendations that impacted teeth should be removed, even if they 
are asymptomatic.  
In the last 20 years, however, there has been much discussion and 
controversy regarding the need for prophylactic treatment of asymptomatic 
impacted teeth and there is now evidence that asymptomatic impacted teeth 
do not have to be removed. This discussion of prophylactic third molar 
surgery has been stimulated by research in medical decisionmaking, public 
health analysis, cost-effectiveness studies and by incorporating patient 
preferences in the decision-making process. It is well known in the practice 
of medicine that there is also a geographical and cultural variation in 
treatment indications and this variation can also be expected in the 
management of the third molar problem. Since surgery is sometimes 
associated with complications, one must always balance the risk of 
complications caused by leaving the impacted tooth in place against the 
risk for complications and discomfort associated with surgery. The main 
complications related to third molar surgery are alveolar osteitis 
(fibrinolytic alveolitis, dry socket) infection and temporary or permanent 
nerve injury. Nerve injuries often cause temporary and permanent 
neuropathic pain or altered sensation in and around the mouth, resulting in 
significant difficulties for the patient with regard to eating, drinking, 
speaking, kissing, shaving, applying makeup etc. A nerve injury is one of 
the main causes of litigation in dentistry. Prevention of these injuries must 
therefore be taken into consideration before surgical removal of impacted 
teeth. The patient should always be advised of the risk of inferior alveolar 
nerve injury. It is probably easier for a patient to accept a permanent 
complication or disability of an intervention if it was properly based on a 
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therapeutic indication than if surgery was performed on prevention and 
prophylaxis. Patient information about risks and complications is very 
important and the patient should always be part of the decision. 
While many impacted third mandibular molars that cause problems 
are removed, impacted canines and premolars may often be guided to erupt 
spontaneously or by using orthodontic traction. Some impacted teeth, 
especially premolars, can be used as autotransplants to another region. 
Management of impacted third molars Indications for third molar 
removal. 
There should always be an appropriate indication for third molar 
removal. Indications can be local or for medical reasons. 
 
Local therapeutic indications 
 • Recurrent or severe pericoronitis; 
 • Periodontal disease with a pocket depth of 5mm or more distal to the 
second molar;  
• non-restorable caries in the third molar;  
• Resorption of the third molar or adjacent tooth;  
• Caries in the second molar where the third molar removal would render 
restoration possible or more simple;  
• Apical periodontitis;  
• Cysts or tumors associated with the third molar (or adjacent tooth);  
• When required prior to orthognatic surgery;  
• Removal of third molar in a fracture line;  
• When a third molar may be considered for autogenous transplantation. 
Medical conditions that require a serious consideration of prophylactic 
third molar removal Prior to:  
• radiation therapy for head and neck malignancies;  
• organ transplantation;  
• chemotherapy;  
• bisphosphonate therapy. 
 
Contraindications for third molar removal  
There are situations when third molars should not be removed.  
Summarizing our current knowledge from the literature, published in 
reviews and guidelines, it is recommended that:  
• third molar buds in young people should not be enucleated;  
• asymptomatic pathology free third molars totally covered by bone should 
not be removed; 
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• routine removal of pathology free third molars totally or partially covered 
by soft tissue is not recommended but specific medical and local conditions 
may prove a prophylactic approach appropriate;  
• third molar surgery is contraindicated in patients whose medical history or 
conditions expose the patient to an unacceptable risk to their health.  
 
Presurgical assessment of third molars  
In addition to a thorough history-taking, clinical and radiologic 
assessment should always be combined before considering removal of a 
third molar. Clinical assessment Clinical assessment should be carried out 
with the aim of assessing the status of the patient, the oral and maxillofacial 
region, the third molars and the adjacent teeth (eruption status, caries, 
periodontal status, occlusion). 
 
Radiological assessment  
Radiological examination is a complement to the clinical 
examination and is necessary in order to make decisions related to the 
procedure. A radiological evaluation will give information about anatomy 
of the impacted tooth, the region and the relation of structures. Usually a 
pair of periapical radiographs taken in different projections is enough and 
can be supplemented by a panoramic radiograph when more than one third 
molar requires assessment. If the initial radiographs suggest a close 
relationship between the roots of the lower third molar and the inferior 
alveolar nerve (IAN) canal, cone-beam computer tomography (CBCT) 
scanning can be used to give more detailed information of the aImportant 
factors to consider. 
 
The following local factors are important to take into 
consideration when planning third molar surgery.  
Application depth. 
The alveolar bone level and tooth position will dictate the application 
point depth. The depth of application and the point of elevation will dictate 
the amount of bone removal that is required to gain access to the optimal 
application point. This factor is the most predictive of difficulty of surgery. 
Another way to describe depth of impaction is Pell and Gregory 
classification, which assesses the relationship of the tooth to occlusal plane 
(classified as A, B, C) and relationship of the tooth to the anterior border of 
ramus (classified as 1, 2, 3). This classification may be used to describe the 
depth of impaction of the tooth but has been found to be less reliable in 





The distinction between vertical, mesoangular, horizontal, and disto-
angular orientation may affect the surgical approach, in particular with 
regard to the requirements for bone removal in order to gain access to point 
of application. The incidence and estimated degree of difficulty for the 
different angulations are: 
 • vertical impaction: 40% of all impacted mandibular third molars 
and usually the least difficult to remove.  
• mesoangular impaction: 45% – can be of moderate difficulty;  
• horizontal impaction: 10% – are generally of intermediate 
difficulty;  
• distoangular: 5% – the most difficult to extract and frequently 
underestimated. 
The application point and necessary bone removal is not only 
dictated by the angulation of the tooth but also root morphology and 
proximity to adjacent structures (adjacent tooth, antrum and nerve). In 
association with identifying the tooth angulation, the potential space for 
application points must be identified. Often distoangular lower third molars 
are in close proximity to the adjacent second molar and have limited space 
for mesial application point. Several examples of radiographs of third 
molars illustrating angulation of teeth and a summary of potential 
application points for bone removal and planned sectioning. 
  
The crown size and condition  
The crown width of the third molar can be an important factor in 
making surgery more difficult. If the tooth is impacted and the crown is 
wide, sectioning of the crown will be required to minimize bone removal 
thus reducing potential pain and swelling for the patient. If the third molar 
is carious or heavily restored, or indeed non-vital, this may render the tooth 
more brittle on elevation thus impacting on surgical difficulty. 
 
Root number and morphology  
More complex root morphology is associated with increased 
difficulty of surgery. Identification of such hooks is important, as they may 
fracture during removal of the tooth and a decision is then required as to 
whether to attempt their removal. Hooked, dancing or bent roots may 
provide a “challenge” to routine elevation. Even after sectioning of the 
crown and roots, if the root morphology is complex the roots will often 
require further sectioning and patience is often required to identify the 
“sweet spot” with which the resistant root will comply with elevation. 
Occasionally lower third molar roots can perforate the lingual plate and this 
115 
 
is often not evident until part way through surgery. Every effort must be 
made to ensure these roots do not get lost through the perforated lingual 
plate, one of the rare indications to raise a lingual flap for third molar 
surgery. 
Pathology associated with third molars Cystic lesions are the most 
common pathology associated with mandibular third molars. If the cystic 
lesion is associated with the crown of the tooth, the first differential 
diagnosis should be dentigerous cyst followed by odontogenic keratocystic 
tumor or ameloblastoma. Odontogenic keratocystic tumors are more likely 
to be associated with missing teeth. Surgical removal of third molars in 
association with pathology may be facilitated. However, the surgeon must 
ensure the pathology is correctly diagnosed and treated accordingly. 
 
Removal without using a flap  
In some cases, when the molar is erupted, a third molar can be 
removed using forceps or elevator without raising a flap.  
Surgical flaps 
Impacted third molars are extracted by first raising buccal triangular 
or envelope flap to gain access to the tooth. The flap should be a full 
thickness mucoperiosteal flap and, as pointed out in other another chapter, 
consideration must always be taken to the anatomy and sensitive structures 
in the region of the flap. 
Bone removal  
In the maxilla the overlying bone is thin and the maxillary bone is 
cancellous and elastic so extraction is usually accomplished by removing 
additional bone rather than by sectioning the tooth. For maxillary third 
molars, bone removal is done primarily on the lateral aspect of the tooth 
down to the cervical line to expose the crown. In the mandible an air-driven 
or electric hand piece with round or fissure burs is used. A fissure bur is be 
used to get clean sections for tooth splitting for elevation. For mandibular 
teeth, bone on the occlusal and buccal aspects of the impacted tooth is 
removed beyond the cervical line down to the roots of the tooth. It is 
advisable not to remove bone on the lingual and distal aspects due to the 
likelihood of damage to the lingual nerve.  
Sectioning the tooth 
Tooth sectioning is important and saves operative time. When 
sectioning the crown from the root a fissure bur allows the surgeon to get a 
narrow clean section into the dental pulp then extend the slot within the 
confines of the tooth. At no point should the bur breach the mesial, distal or 
lingual surfaces of the tooth. Thus one achieves a “partial” section of the 
tooth covering about 40% of the split surface. After this section has been 
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made the crown can be fractured with the help of an elevator in the slot. 
Depending on the depth of application point and the angulation, the crown 
or root will need to be sectioned. When sectioning the roots the surgeon 
can use the dental pulp chambers to estimate where to split the roots. Again 
at no point should the drill cut extend through the lingual aspect of the 
roots. Drilling a small hole large enough to engage the tip of a curved 
Warwick James elevator is useful in gaining a “purchase point” to elevate 
roots. 
Coronectomy  
Coronectomy (also known as partial tooth removal, partial 
odontectomy or intentional root retention) is a technique of partial root 
removal which should be considered when radiographic imaging suggests 
an intimate relationship between the roots of the lower third molar and the 
IAN and there is a high risk of nerve injury if too much bone has to be 
removed. In such cases only the crown is removed and the root is retained. 
In the years after coronectomy subsequent root migration can be seen 
towards the superior border of the mandible. Later root removal may be 
required but only in 2–6% of cases. Roots may require removal when they 
erupt later and become infected but sometimes the roots have then migrated 












Etiology and prevalence. 
Postoperative bleeding is a side-effect of dentoalveolar procedures. 
In healthy patients, postoperative bleeding is typically minimal and self-
limited by the clotting processes. It is important to distinguish active 
bleeding from surgical site oozing. Patients will often complain of 
excessive bleeding because they have noticed blood in their saliva. Oozing 
should resolve within 36–72 hours postoperatively, should respond to 
pressure, and is generally a nuisance for the patient. In contrast, patients 
with an active bleed will often complain of their mouth filling with blood 
immediately after removing a gauze dressing or other local pressure 
measure. 
Risk factors and prevention 
Among the most important steps in the management of excessive 
postoperative bleeding is recognition of the at-risk patient. During the 
preoperative assessment, a detailed history should be obtained, including a 
history of disorders associated with coagulation, e.g. hemophilia, von 
Willebrand disease, use of medications such as antiplatelet agents like 
aspirin and clopidogrel (Plavix), vitamin K antagonists like warfarin 
(Coumadin), or heparin or its derivatives, e.g. enoxaparin (Lovenox) or 
fondaparinux (Arixtra), an individual or family history of bleeding with 
surgical procedures, excessive bleeding upon loss of deciduous teeth, and, 
in females, a history of menorrhagia. 
As the average age of oral surgical patients increases due to 
prolonged life, practitioners will encounter a greater number of 
anticoagulated patients. Appropriate adjuvant therapy, such as 
discontinuation of anticoagulant medications, factor infusions, or use of 
clot-stabilizing medications, should be considered in patients with risk 
factors for bleeding or known bleeding diatheses. Of note, patients taking 
clopidogrel, aspirin and other non-steroidal anti-inflammatory medication 
do not need to stop their medications prior to routine dentoalveolar 
procedures. Patients on warfarin pose a common and special problem for 
the dentist. The underlying medical problem, e.g. long-standing atrial 
fibrillation, deep vein thrombosis, prosthetic heart valve, or myocardial 
infarction, often prohibits discontinuing the anticoagulant. An acceptable, 
but uncommon, management strategy is to hospitalize the patient, 
discontinue the warfarin, and maintain the patient on a heparin bridge until 
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the INR (international normalized ratio) returns to the normal range. An 
alternative option is to discontinue the warfarin 3 days preoperatively. 
Care should be taken in considering the type of dentoalveolar surgery 
being performed. Many minor oral surgical procedures (such as single 
tooth extraction) can be done while the patient is anticoagulated, based on 
the coagulation profile. In general, for patients on warfarin, an INR <2.5 is 
generally acceptable if extraction of multiple (more than four) teeth is 
required. For extraction of one to three teeth, with no posterior teeth or 
surgical extractions, an INR of <3.0 is acceptable. Keeping this in mind for 
the patient who may need multiple extractions, staged visits may be most 
appropriate so discontinuation of the anticoagulants can be avoided. 
Newer anticoagulants such as the oral factor Xa inhibitors 
(rivaroxaban and apixaban) and the oral thrombin inhibitor (dabigatran 
etexilate) have more rapid onset than warfarin, have fixed dosing, are not 
affected by food, have fewer interactions, and do not require monitoring. 
Despite the cost differential, they are therefore rapidly becoming the 
anticoagulants of choice for patients requiring anticoagulation and 
generally do not require any adjustment for routine dental extractions. 
Treatment 
Excessive postoperative bleeding can be prevented intraoperatively 
by appropriate tissue management and local measures. In general, careful 
removal of granulated/infected tissue, minimal manipulation of surgical 
flaps to avoid tearing, use of local anesthetic with vasoconstrictor, primary 
wound closure, and the application of topical agents, such as absorbable 
gelatin sponge, oxidized regenerated cellulose fabric, or chitosan bandage, 
can limit most postoperative bleeding. Direct pressure with gauze in the 
immediate postoperative setting is an important method of limiting 
bleeding as the initial clot forms. Patients should be instructed to continue 
to apply pressure to the wound until bleeding has stopped. 
Bleeding that persists after the initial phase of clot formation should 
be treated first with local measures, starting with direct pressure to the 
surgical site. Careful examination of the operative site with illumination 
and magnification and good suction can be invaluable to identify the source 
of bleeding. It is not uncommon to identify an incompletely formed clot, a 
“liver clot”, that is mobile and continues to aggravate the site. Careful 
removal of the clot is critical to control the bleeding successfully. Use of 
local vasoconstricting agents, such as local anesthetics with a 
vasoconstrictor such as epinephrine, is appropriate once the source of 
bleeding has been identified. If the vasoconstrictor is applied to the area 
prior to identification of the bleeding vessel, identification will be 
complicated. The wound may need to be repacked with a local hemostatic 
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agent and sutured. Arterial bleeds that cannot be controlled with local 
measures should be treated with ligation or electrocautery. If bleeding 
persists, embolization, proximal vessel ligation, or other endovascular 
procedures may be required. 
 
PAIN 
Etiology and prevalence 
As with bleeding, postoperative pain is a side-effect of operative 
intervention. Pain associated with routine dentoalveolar procedures usually 
begins with the resolution of local anesthesia (6–12 hours) and typically 
peaks between 24 and 48 hours postoperatively. 
Risk factors and prevention 
Prevention of pain via intraoperative measures and adequate 
postoperative pain control measures is essential. Intraoperatively, 
minimizing tissue trauma and careful tissue manipulation will decrease 
inflammation and thus decrease pain. There is evidence that the 
administration of preoperative non-steroidal anti-inflammatory medications 
(salicylates, cyclooxygenase (COX)-2 inhibitors) can reduce the severity of 
postoperative pain. Postoperatively, the use of nonsteroidal medications, as 
well as narcotic preparations with acetaminophen (APAP) (hydrocodone, 
oxycodone, tramadol) are useful for treatment of moderate to severe 
postoperative pain. In addition, the use of long-acting local anesthetics, e.g. 
0.5% bupivacaine with 1:200 000 epinephrine, can be beneficial in 
delaying the onset of pain, which may allow the patient to start 
postoperative analgesics prior to the onset of pain. 
 
SWELLING 
Etiology and prevalence 
Edema following the surgical removal of teeth and other routine 
dentoalveolar procedures is an expected finding during the postoperative 
course. The onset of swelling is typically between 12 and 24 hours 
following the procedure, with a peak swelling noted 48–72 hours 
postoperatively. Swelling typically begins to subside at 4 days 
postoperatively, with most patients experiencing resolution of surgical 
edema within 1 week postoperatively. 
Prevention and treatment 
It is important to inform patients of this time course and that swelling 
is an anticipated postoperative finding. In the early postoperative period, 
the use of ice may help with the management of swelling. In addition, 
patients should be told to sleep with the head of their bed elevated and not 
to sleep on their side, so as to avoid dependent swelling. Finally, 
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perioperative steroids may be used to prevent swelling in patients 
undergoing significantly invasive procedures (e.g. third molar extraction). 
While the use of perioperative steroids may produce moderate decreases in 
swelling, these medications are typically short in action. 
 
SURGICAL SITE INFECTION 
Etiology and prevalence 
Because the oral cavity is home to a wide variety of bacterial flora, 
any intraoral wound will be exposed to a broad spectrum of aerobic, 
anaerobic, and facultative organisms with pathogenic potential. As such, 
postoperative infections should be primary among concerns for the 
practitioner when performing oral surgical procedures. Though the routine 
use of antibiotics for prevention of postoperative infections is still debated, 
there are several measures that can be implemented to reduce the likelihood 
of postoperative wound infection. 
Prevention 
Prevention of postoperative infection begins with identification of 
the patient at risk. A number of studies have demonstrated that the 
incidence of postoperative inflammatory complications increases with age, 
smoking, pre-existing infection/pathology in the surgical area, oral 
contraceptive use, and lack of surgical experience. When dealing with 
impacted teeth, mandibular third molars have been shown to have a higher 
rate of postoperative infections than maxillary teeth. 
As with other common complications, careful tissue management, 
debridement/curettage of necrotic/ infected tissue, and thorough irrigation 
of the wound site will help to reduce the bacterial inocula within the wound 
site and reduce the possibility of infection. 
Treatment 
Patients presenting with infections will typically complain of 
persistent pain and swelling that is not improving with time, a foul taste, 
drainage from the wound, and limitation of jaw motion (trismus). Fever is 
variable and depends on the magnitude of the infection. Early recognition 
of an infectious process, typically a cellulitis, requires prompt treatment 
with an empiric course of antibiotics with broad-spectrum coverage for 
Gram-positive and anaerobic organisms. If the symptoms have persisted for 
more than 48–72 hours after the procedure, an abscess, or pus pocket, may 
have formed, in which case incision and drainage may be indicated, with 
collection of exudate for culture and sensitivity testing to guide antibiotic 
therapy. Prompt recognition and treatment are necessary to prevent the 
spread of infection into the submandibular, sublingual, submental, 
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retropharyngeal spaces and spaces of the deep neck, which can result in 
airway compromise and the necessity for emergency airway management. 
 
ALVEOLAR OSTEITIS 
Prevalence and etiology 
Among the most common complications associated with oral 
surgical procedures, specifically the removal of impacted teeth, is alveolar 
osteitis (AO), or “dry socket”. The reported incidence is as high as 30% in 
some studies, though there exists a wide variation in reported incidence due 
to inconsistent diagnostic criteria. This condition, which was classically 
thought to be infectious in nature, is now understood to be associated with 
malformation, disruption, or other loss of a newly formed blood clot from 
an extraction socket. Patients presenting with AO will usually complain of 
a severe throbbing, radiating pain, often associated with a malodor from the 
surgical site. Trismus is an associated sign, related more to pain than 
swelling. Recognition of AO is based on the presence of new-onset severe 
pain, typically 3–5 days postoperatively, at which point pain and swelling 
associated with the operation should be beginning to subside. The lack of 
constitutional symptoms (fever), significant swelling, or intraoral discharge 
may help to distinguish AO from a surgical site infection. This distinction 
is important, since antibiotic treatment will not resolve AO. Physical exam 
findings may include a crypt-like socket with exposed bone and 
erythematous soft-tissue margins, food debris, or other detritus in the 
socket and extreme tenderness to palpation. Radiographic examination 
should also be obtained to rule out the presence of a retained tooth structure 
or other surgical site complication, such as alveolar fracture. 
Prevention 
Preoperatively, there are a number of risk factors that have been 
identified that should alert the vigilant practitioner of the patient at risk. As 
with postoperative infections, age, oral contraceptive use, surgical 
experience, smoking, and mandibular surgery have been associated with 
AO. In addition, poor oral hygiene and pre-existing infections have been 
shown to increase the risk for AO. Intraoperatively, thorough lavage of the 
surgical site is associated with a decreased incidence of AO. The use of 
topical medicaments and antibiotics, clot stabilizers (Gelfoam®), platelet-
rich plasma, and medicated mouthrinses have also been suggested for 
prevention of AO. 
Treatment 
As the condition is self-limiting, the treatment is supportive, with 
pain control being the primary goal. Treatment typically consists of gentle 
irrigation of the wound area with warm saline and application of medicated 
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packing to the area, e.g. eugenol dressings, and aggressive use of oral 




Prevalence and etiology 
While rare, fractures of the dentoalveolar process or mandible should 
be considered in the differential diagnosis of persistent pain or swelling 
after dentoalveolar procedures. Fractures are the result of using excessive 
force during tooth extraction. If unrecognized and untreated, such fractures 
can lead to malocclusion, malunion, infection, and paresthesia. 
Prevention 
Preoperatively, there are few risk factors for fracture that have been 
identified. There is some evidence to suggest that age is a risk factor for 
fractures, presumably because of the loss of bone density, elasticity, and 
strength which are common findings in elderly patients. Atrophic 
mandibles or mandibles with large intrabony lesions are at risk for fracture. 
Treatment 
Recognition of the fracture is the most important management. 
Intraoperatively, recognition of an alveolar process or mandibular fracture 
can result from observing a mobile alveolar or mandibular segment or 
malocclusion. Postoperatively, any patient complaining of malocclusion, 
pain and swelling disproportionate to the procedure, tooth displacement or 
mobility, or persistent numbness should be evaluated for a possible 
fracture. 
Once a fracture is identified, typically with the aid of imaging 
studies, e.g. periapical or panoramic radiographs or computed tomography 
(CT), treatment is guided by the nature of the fracture and functional 
limitation. Treatment ranges from dietary modifications (blenderized diet) 
and early immobilization to reduction and fixation of the fracture. 
 
ROOT FRACTURE 
Prevalence and etiology 
Root tip fractures are common after tooth extraction, especially in 
posterior, multirooted teeth. Fracture of the roots, or root tips, is typically 
due to excessive forces applied during extraction with inadequate 
separation of the roots from the extraction socket and is commonly 
unavoidable due to the root anatomy and bone quality. When such forces 
are applied, the torque generated will typically cause a fracture at the 
junction between that portion of the root still attached to the socket and that 




The prevention of root fractures is primarily based on use of proper 
surgical technique, minimizing excessive forces, and carefully ensuring 
that teeth are adequately elevated and mobilized prior to luxation. 
Recognition of teeth at risk for root fracture is also an important 
preventative measure. Multirooted posterior teeth, roots that are curved, 
canines or other anterior teeth that have root dilacerations, or teeth with 
widely spaced thin roots, all have an increased risk for fracture. Inadvertent 
root fractures can be avoided by operative planning and prudent sectioning 
of a tooth prior to elevation and removal. 
Treatment 
The most important step in treating a fractured root or retained root 
tip is recognition that such an incident has occurred. Once the tooth has 
been removed, it should be carefully inspected to confirm that the roots 
were removed completely. Reconstitute the fragments of a sectioned tooth 
to confirm complete removal. 
If a root fracture is noted, the socket should be irrigated thoroughly 
and an attempt should be made to directly visualize the retained root/root 
tip. For teeth without preoperative evidence of periapical pathology or 
infection, small root tips (<3 mm) can be left in place without adverse 
effects. In fact, for posterior teeth, the risk of causing damage to the 
maxillary sinus or inferior alveolar nerve may often outweigh the risk of 
leaving the fragment in place, and sometimes this is carried out deliberately 
in the technique known as coronectomy. 
If there is associated pathology with the tooth preoperatively, the 
root fragment should be removed. Once the fragment is directly visualized, 
root tip picks/elevators should be used to carefully separate the fragment 
from the alveolar socket, with special care taken not to apply apical 
pressure to the fragment. This gentle manipulation should be done until the 
root is mobilized, at which point it can be removed. 
 
ROOT OR TOOTH DISPLACEMENT 
Prevalence and etiology 
Displacement of root tips or tooth fragments is an uncommon but 
distressing complication nonetheless. Given the proximity of various 
fascial spaces to maxillary and mandibular third molars, displacement of 
tooth fragments can occur into the infratemporal fossa and maxillary sinus 
or submandibular space and inferior alveolar canal, respectively. 
Prevention 
Displacement of tooth fragments into these fascial spaces can often 
be prevented by using careful surgical technique. For example, when 
124 
 
elevating an impacted maxillary third molar, the use of a periosteal elevator 
posterior to the distal aspect of the crown can serve as a barrier to 
displacement into the infratemporal fossa. In the event of displacement into 
the infratemporal fossa, a minimal attempt should be made to visualize the 
fragment and remove it. If this attempt is unsuccessful, the wound should 
be closed and the patient should be given a course of antibiotics. Future 
exploration of the region should be anticipated and CT, plain film imaging 
or both should be obtained to aid in localization and surgical treatment 
planning. 
Careful examination of preoperative radiographs can be useful in 
evaluating the association between the roots of impacted maxillary third 
molars and the maxillary sinus. In older patients, or those with significant 
periodontal disease, pneumatization of the maxillary alveolus can increase 
the likelihood of an association between the roots of the teeth and the 
maxillary sinus. In these cases, careful attention must be directed to 
avoiding excessive apical pressure to the teeth during the process of 
extracting teeth. 
Treatment 
In the event that a root fragment or tooth is displaced into the 
maxillary sinus, the first step in treatment is localization of the fragment 
and prevention of further displacement. Typically this can be achieved by 
seating the patient in the upright position and obtaining periapical 
radiographs of the region of interest. In the event that a root or fragment is 
visualized, various methods can be used for retrieval. The simplest method 
is forcing positive pressure through the sinus to displace the root – this can 
be accomplished by closing the nostrils and having the patient attempt to 
exhale through the nose. Alternative methods include attempting to remove 
the fragment using a thin suction tip or packing the socket with iodoform 
gauze and removing the gauze in a smooth stroke, hoping that the fragment 
will be caught in the gauze. In the event that such measures prove 
unsuccessful, the maxillary sinus can be explored to directly visualize and 
remove the fragment, either endoscopically or with open surgery involving 
a Caldwell–Luc incision. This can be done as a simultaneous procedure or 
at a future visit. If done at a future visit, the patient should be placed on 
sinus precautions, antibiotics and nasal decongestants. 
Displacement of mandibular teeth into either the submandibular 
space or inferior alveolar canal is a rare occurrence. However, given the 
vital structures in these regions, any suspicion of displacement must be 
evaluated fully. Visualizing any fragments is best accomplished 
immediately using periapical and Panorex-type films, with occlusal films in 
addition for submandibular space invasion. These will be supplemented by 
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cone-beam CT scans as time allows. Once the fragment is identified, a 
gentle attempt should be made to remove the fragment from the inferior 
alveolar nerve (IAN) canal or the submandibular space, but care should be 
taken not to compromise the spaces and further displace the tooth. In the 
event that the fragment cannot be easily removed, delayed removal may be 
indicated and the patient should be placed on antibiotics. For fragments in 
the IAN canal, if the patient does not demonstrate any signs of infection or 
paresthesia in the postoperative course, the fragment may be left without 
concern. For fragments in the submandibular space, exploration of the 
region with lingual dissection and separation of the mylohyoid muscle from 
the mandible is indicated approximately 6 weeks after the initial operation. 
This delay allows for tissue fibrosis to occur around the displaced 
fragment, thereby stabilizing its position. This procedure can be carried out 




Prevalence and etiology 
Following extraction of maxillary posterior teeth, oroantral (sinus) 
communications are common, commonly unrecognized, and do not need 
treatment. Persistent, symptomatic oroantral communications are 
uncommon with a frequency of <1%. Oroantral communications may result 
from excessive manipulation of the operative site or poor technique. It 
should be readily acknowledged that communications typically result from 
intimate anatomic associations between the roots of the teeth and the floor 
of the maxillary sinus and may be unavoidable. 
Prevention 
As with displacement of teeth into the maxillary sinus, prevention of 
oroantral communications starts with identification of the patient at risk. 
Evaluation of preoperative radiographs for any evidence of encroachment 
of the roots upon the floor of the sinus should alert the surgeon to the 
likelihood of this complication. Upon removal of the tooth, the socket 
should be curetted gently, avoiding the apical areas. If the tooth is not 
removed completely, judicious exploration should be undertaken, so as not 
to: (1) displace the remnant into the sinus; or (2) perforate the sinus floor 
while attempting to remove the fragment. A self-limiting oroantral 
communication may be an unavoidable side-effect of tooth removal due to 
the anatomic relationship between the roots and the sinus. Informing the 
patient of a likelihood of an oroantral communication prior to tooth 





Diagnosis of a sinus communication is often made by having the 
patient force air through the nasal cavity while the nares are closed. If a 
large communication exists, air bubbles should be visible within the socket. 
This method may prove ineffective for small communications. 
In the event that a communication is discovered, either by tactile 
sensation or forced air maneuver, the size of the defect and patient 
complaint guide treatment. As a general principle, any patient with a 
communication should be placed on sinus precautions, antibiotics, and 
nasal decongestants. 
Most oroantral communications heal spontaneously with little 
intervention. At the time of the procedure, primary closure of the extraction 
socket is not indicated. The patient should be placed on broadspectrum 
antibiotics, e.g. amoxycillin or clindamycin, and sinus precautions. Monitor 
the patient closely over the postoperative period to confirm closure of the 
oroantral communication. If an oroantal fistula develops, standard 
procedures to produce a layered closure of the wound and management of 
the sinus are indicated. Clinicians should remember that the size of the 
visible fistula is much smaller than the actual bony defect. 
 
THIRD MOLAR SURGERY COMPLICATIONS 
 
Injury to adjacent teeth/wrong tooth extraction 
The most common injury to an adjacent tooth is loosening or fracture 
of a large restoration. Other injuries can include tooth loosening due to 
inappropriate use of elevators, crown fracture due to caries, and inadvertent 
extraction of an adjacent tooth. The incidence of injury to an adjacent 
second molar when performing third molar surgery is between 0.3% and 
0.4%. Limited data exist regarding inadvertent extraction of an adjacent 
tooth specifically during third molar surgery; however, the overall 
incidence of wrong tooth extraction ranges from 0.026% to 0.047%. 
Adjacent teeth with large restorations, caries, or recurrent decay pose 
a risk for inadvertent injury. Evaluation of adjacent teeth both clinically 
and radiographically should be completed prior to beginning a procedure, 
and patients should be made aware of the possibility of injury. If an 
adjacent tooth poses a high risk for injury, attempts should be made to 
avoid luxation with elevators adjacent to the tooth or consideration should 
be given to not using an elevator at all. To avoid injury to the opposing 
dentition during extraction, excessive traction forces should be avoided. If 
a tooth suddenly releases, this can result in instrument damage to opposing 
cusps. Also, placing a finger or suction tip in between the forceps and 
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opposing dentition can prevent contact with the instrument or absorb some 
of the blow. Wrong tooth removal should never occur if adequate attention 
is given to planning and appropriate time out. The tooth to be extracted 
should be marked on the radiograph and confirmed with both the patient 
and the assistant in terms the patient can understand. Referrals should be 
contacted if confusion exists as to the correct procedure. 
If an injury occurs, it should be promptly treated and all parties 
involved notified. A fractured tooth or restoration can be temporized and 
the referring practitioner notified. Loosened or avulsed crowns can be 
recemented if no recurrent decay exists or temporarily cemented if caries 
are noted. If an adjacent tooth is loosened it should be repositioned and 
stabilized. Often, this requires only minimal repositioning, and the tooth 
can be left alone. If significant loosening has occurred, stabilization for 10–
14 days with the least rigid method of stabilization should be used to avoid 
risk of ankylosis or root resorption. Extraction of the wrong tooth, if 
immediately noted, can be treated as an avulsion. The tooth should be 
implanted back into the extraction site and stabilized. If the tooth is being 
extracted for orthodontic reasons, the remaining teeth should not be 
extracted and a call should be placed to the referring orthodontist. 
Occasionally, modification of the treatment plan can be done to utilize the 
tooth that should have been removed and treatment can proceed with the 
new plan. If the original tooth planned for extraction needs to be removed, 
the health and stability of the accidentally extracted tooth should be 
confirmed prior to proceeding with further extractions. When the error goes 
unnoticed at the time of extraction, the tooth can obviously no longer be 
replanted. It is important to document thoroughly any case of wrong tooth 
extraction and inform all parties involved. According to data from the Oral 
and Maxillofacial Surgery National Insurance Company (OMSNIC), 46% 
of all wrong-site tooth extraction claims are settled with an indemnity 
payment. Thus, documentation and communication with both the patient 
and referring dentist are important to avoid litigation. 
 
Injury to adjacent osseous structures 
During the process of third molar extraction, and more specifically 
maxillary third molar extraction, the surrounding bone is at risk for 
inadvertent fracture. The most likely places for bone to fracture during 
removal of maxillary third molars are the buccal cortical plate and 
maxillary tuberosity. The incidence of maxillary tuberosity fracture in 
association with third molar extraction is approximately 0.6% and is most 
often caused by excessive force with forceps or elevators. The combination 
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of Type IV bone, no distal support, and often significant space involvement 
by maxillary sinus contribute to the potential for tuberosity fracture. 
Maxillary tuberosity fracture or buccal cortical plate fracture can 
compromise future prosthetic rehabilitation as the maxillary tuberosity is an 
important anatomical retention point for complete dentures. Buccal plate 
fracture can lead to soft tissue tearing and irregular remaining alveolar 
bone. To avoid these complications the surgeon should ensure appropriate 
force application and remove bone in a controlled fashion when excessive 
force is necessary for extraction. In addition, placement of a periosteal 
elevator distal to the third molar to elevate the tooth and separate it from 
the periodontal ligament and tuberosity can assist the surgeon in avoiding a 
tuberosity fracture. 
When a fracture of the buccal cortical plate occurs, the surgeon 
should asses the stability, size, and soft tissue attachment of the fractured 
segment. If the surgeon has been supporting the alveolus with finger 
pressure during extraction, early cortical plate fracture can be assessed. At 
this point, the cortical plate should be dissected free from the tooth with an 
elevator or other sharp instrument while the tooth is stabilized with forceps. 
Once the bone and soft tissue are dissected free, the tooth is extracted and 
the tissues approximated and secured with sutures. If a soft tissue flap is 
reflected from bone, the blood supply to the segment has been 
compromised, and that segment will become necrotic if not removed. 
Maxillary tuberosity fractures should be treated in a similar manner. Once 
recognized, the fractured segment should be dissected free from the tooth. 
Using a handpiece, the bone segment can be separated from the tooth and 
the roots sectioned to allow for atraumatic extraction. If adequate soft 
tissue attachment remains, the tuberosity is stabilized through good soft 
tissue closure with sutures. In the event that the tuberosity cannot be 
dissected free from the tooth, the reason for extraction should be revisited. 
If asymptomatic, the tooth and attached tuberosity segment can be fixated 
for 6–8 weeks via an arch bar or orthodontic fixation followed by surgical 
extraction with controlled bone removal and tooth sectioning on a later 
date. If symptomatic, the tooth must be extracted and in doing so, the 
tuberosity will be removed. The remaining bone should be smoothened and 
soft tissues approximated with sutures. The overall goal of treatment in a 




The occurrence of temporomandibular joint (TMJ) injury as a result 
of third molar surgery is not supported in the literature. In a study by 
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Threlfall, patients with diagnosed anterior disk displacement were no more 
likely than the control group to have had prior third molar surgery. Also, 
only 9.5% of patients with anterior disk displacement reported third molar 
extractions within the past 5 years. Complaints of limited opening are most 
often due to trauma from injections, inflammation of the muscles of 
mastication, and/or the body’s own protective mechanism to limit function 
and further trauma. 
Injury may occur if excessive force is used, a bite block is not in 
place when extracting lower third molars, or the patient’s mouth is opened 
excessively. This transient injury often resolves with soft diet, moist heat, 
jaw rest, and NSAID use. An acutely “stuck disc” can be treated effectively 
with arthrocentesis when observed. 
It is important to evaluate all patients undergoing third molar surgery 
for preoperative joint disease or myofacial pain and thoroughly document 
all such history. Clicks, pops, crepitus, opening and excursive movements, 
and any tenderness of the muscles of mastication should be noted. If prior 
TMJ dysfunction is present, contemplation for surgical extraction of teeth 
to avoid trauma to the joint should be made. 
 
Aspiration/ingestion 
The incidence of foreign body aspiration or ingestion is likely 
underreported in the literature. Approximately 92.5% of objects are 
ingested while the remaining 7.5% are aspirated. Patients who undergo the 
surgical removal of third molars are often sedated, which results in their 
gag and cough reflexes being obtunded. A pharyngeal curtain should be 
utilized in all patients to prevent aspiration or ingestion during surgery. If 
the patient is not coughing or in any respiratory distress, it is likely the 
tooth has been ingested and prompt referral to an emergency room for 
abdominal and chest radiographs to confirm the location of the object 
should be made. Coughing that continues or leads to respiratory distress 
should alert the surgeon to probable aspiration. An attempt to suction the 
object from the oral pharynx should be made and ACLS protocols 
activated. The Heimlich maneuver should be used to attempt to dislodge 
the object. If a patient becomes cyanotic or unconscious, an attempt at 
retrieval under direct laryngoscopy can be made. If this fails, 
cricothyrotomy may be necessary to secure the airway. An object that 
passes through the vocal chords will most likely end up in the right main 
stem bronchus or right lung, and the patient should be transported to the 
emergency room and arrangement for bronchoscopy and object retrieval 





The incidence of neurologic complications as a result of third molar 
surgery ranges from 0.4% to 11%. Injury to the inferior alveolar nerve 
(IAN) is associated with spontaneous recovery in 96% of cases and 
spontaneous recovery of lingual nerve injury is approximately 87%. 
Sensory deficits that last longer than 1 year are likely to be permanent; 
recovery of sensation should begin within the first 8 weeks following 
surgery. According to the AAOMS white paper on third molars, the 
incidence of IAN injury 1 to 7 days postoperatively is 1–5% and persistent 
alteration in sensation after 6 months ranges from 0.0% to 0.9%. Lingual 
nerve injury 1 day after surgery was reported in 0.4–1.5% of patients, with 
persistent sensory alteration at 6 months in 0.0–0.5% of patients. The use of 
lingual retraction increased the incidence of temporary paresthesia; 
however, the incidence of persistent findings remained the same. In a study 
by Tay et al., 192 inferior alveolar nerves in 170 patients were exposed 
during third molar surgery. Twenty percent reported paresthesia at the 1 
week follow-up, and 6% had persistent paresthesia at 1 year. 
An increased risk of IAN injury is associated with increased age, 
complete bony impaction, horizontal angulation, sectioning of the tooth 
multiple times, bone removal, surgeon’s experience, and duration of 
surgery. Additionally, Rood et al. has described several radiographic 
predictors of potential nerve injury. These include diversion of the IAN 
canal, darkening of the root, and interruption of the white line. One in three 
patients with canal diversion, and one in four patients with darkening of the 
root or interruption of the white line, exhibited impairment of sensation. 
These signs are highly sensitive but not highly specific for risk of injury, 
and the absence of all signs has a strong negative predictive value. 
Therefore, patients without any significant indicators of injury are unlikely 
to have injury, patients with an injury are likely to have at least one of the 
predictors, and patients without injury commonly have predictors of injury 
radiographically. Other reported radiographic indicators such as deflected 
roots, narrowing of the root, dark bifid roots, and narrowing of the canal 
were statistically unrelated to nerve injury. 
Lingual nerve injury is associated with distoangular inclination, 
lingual orientation, and perforation of the lingual cortex. Often, flap 
reflection, tooth sectioning with extension into the lingual plate, or lingual 
plate fracture are the cause of injury. Due to the nerve’s variable position, 
care must be taken when incisions are made and flaps reflected. Miloro et 
al. reported 10% of lingual nerves positioned superior to the lingual crest 
and 25% in direct contact with the bone. The mean vertical distance from 
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the crest is 2.75 mm and the mean horizontal distance from the lingual 
plate is 2.53 mm. 
Injury to the lingual or inferior alveolar nerve due to local anesthetic 
injection occurs in approximately 1 in 785,000 cases with 79% affecting 
the lingual nerve and 21% the IAN. The highest incidence is associated 
with prilocaine or articaine injection. The majority of cases (85%) resolve 
within 8 weeks and of the remaining 15%, one-third will eventually 
resolve. Unfortunately, patients with persistent paresthesia are not 
candidates for microneurosurgical repair. 
All patients who report paresthesia should be followed closely for 
resolution and appropriate objective testing should be performed. The 
clinical neurosensory test should be performed to determine the degree of 
impairment and whether microneurosurgical intervention is necessary. 
Mechanoceptive testing begins with Level A testing. It comprises brush 
stroke directional discrimination and two-point discrimination. It is 
important to test both normal and abnormal areas, map out the area of 
impaired sensation by marking directly on the patient’s skin, and 
photograph the markings for future reference. Two-point discrimination 
can be tested using a Boley gauge or the noncotton end of a cotton tip. 
Testing should be completed in 2-mm increments until the patient can no 
longer discern two separate points. Normally, the IAN tests to 4 mm and 
the lingual nerve to 3 mm. Level B testing involves contact detection and 
Level C pin-prick and thermal discrimination. The indications for repair are 
complete anesthesia beyond 1–2 months, profound hypoesthesia with no 
improvement after 3 months, early dysesthesia, and a clinically observed 
Sunderland V transection. Referral to a surgeon proficient in 
microneurosurgery should be made if any of the above criteria are met or if 
unfamiliar with nerve testing and possible treatment protocols. 
Bony sequestra and lingual plate exposure are potential 
complications of low significance but require thorough and prompt 
attention. Small bony sequestra will spontaneously extrude through the soft 
tissues and usually cause only temporary discomfort. Reassuring the patient 
or parent that there is no remaining tooth in the area, the usual concern at 
presentation, and removing the loose bone is all that is required. The injury 
to the soft tissues is resolved within few days, and the patient is instructed 
to avoid trauma from chewing in the area until this occurs. Exposure of the 
lingual plate or a portion of the mylohoid ridge is not uncommon since the 
overlying mucosa in this area is excitingly thin. The common complaints 
will be pain upon swallowing and sharp bone detected in the area. 
Application of topical anesthetic to allow for a bone file or fine rongeurs to 
gently smooth or remove any sharp bone is all that is required. The patient 
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is instructed to avoid further injury to the area with certain foods such as 
popcorn or potato chips and is reassured that the area will spontaneously 




The incidence of osteomyelitis as a result of third molar extraction is 
not reported in the literature however it is a known complication of 
infection, fracture, and/or extraction in medically compromised patients. 
Osteomyelitis is an inflammation of the bone marrow and is most common 
in the mandible due to its dependence on blood supply from the inferior 
alveolar artery and poorly vascularized thick cortical bone. Because the 
maxilla has a rich vascular supply from multiple vessels it is less likely to 
develop osteomyelitis. The presence of bacteria within the marrow space 
leads to inflammation and edema with subsequent compression of blood 
vessels and a decrease in blood supply. This decrease in blood flow results 
in ischemia, bone necrosis, and proliferation of bacteria. Purulence and 
bacteria can spread within the marrow via Haversian and Volkmann’s 
canals and extend into cortical bone. Once the cortical bone and periosteum 
are involved, the blood supply is further compromised and perforation of 
soft tissues can occur resulting in fistula formation. Predisposing factors in 
the development of osteomyelitis involve suppression of host defenses in 
some form. Diabetes, alcoholism, autoimmune disease, radiation therapy, 
chemotherapy, steroid use, osteopetrosis, myeloproliferative diseases, and 
malnutrition can contribute to the development of osteomyelitis. 
The classification of osteomyelitis offered by Hudson is commonly 
cited in the literature and essentially breaks down into acute and chronic 
forms based on disease presence greater than 1 month. 
Patients with osteomyelitis will often present with complaints of a 
dull and deep pain, swelling and erythema of overlying tissues, paresthesia 
of the inferior alveolar nerve, trismus, adenopathy, fistula, fever, and 
malaise. In patients with chronic osteomyelitis, signs of acute infection 
such as fever are often not present; however, fistulas, both intra- and 
extraorally, are more common. Radiographs typically demonstrate a “moth-
eaten” appearance of bony sequestrum. CT scanning can assist in the 
demarcation of lesion extent although it should be noted that 30–50% 
demineralization of bone is necessary before radiographic changes. In 
chronic osteomyelitis there may be radiopacity due to an osteitis-type 
reaction and proliferation of bone. A laboratory workup will demonstrate 
leukocytosis in acute forms, elevated erythrocyte sedimentation rate (ESR) 
and C-reactive protein (CPR). Further laboratory evaluation of ESR and 
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CRP levels during treatment can assist in assessment of healing. Culture 
specimens will often reveal bacteria traditionally responsible for 
odontogenic infections such as Bacteroides, Peptostreptococci, 
Fusobacterium, and Streptococci. Occasionally, less common odontogenic 
bacteria are present. These include Lactobacillus, Eubacterium, Klebsiella, 
Acinetobacter, and Pseudomonas aeruginosa. Osteomyelitis of the jaws is 
different from osteomyelitis of other bones in that Staphylococci are not the 
predominant bacteria. 
The treatment of osteomyelitis is combination of surgical and 
medical management. Treatment of systemic diseases must be considered 
along with medical consultation when appropriate. Empiric antibiotics 
should be administered while awaiting final culture results. 
Penicillin/metronidazole or clindamycin are excellent first-line antibiotics. 
In chronic cases, sequestrectomy, decortication, and saucerization are 
necessary and extend to vital, bleeding bone. Removal of the cortex with 
placement of periosteum directly on the marrow space assists with blood 
flow. After aggressive debridement, that may lead to further weakening of 
the mandible, fixation may need to be employed to prevent fracture or for 
stabilization of a known fracture. External fixation, rigid internal fixation, 
or intermaxillary fixation may be used with the fixation type dependent on 
the surgeon’s preference and degree of success of surgical debridement. 
Other methods of treatment have been proposed such as local antibiotic 
administration with both resorbable and nonresorbable carriers and 
hyperbaric oxygen. Polymethylmethacrylate beads impregnated with 
gentamycin have been discussed in the orthopedic literature; however, 
results can be disappointing due to inadequate local release and 
subinhibitory antibiotic levels. Also, a second surgery is necessary to 
remove the beads. Hyperbaric oxygen (HBO) has not been demonstrated to 
have a significant effect on outcome based on the limited available 
literature. Esterhai et al. studied the use of HBO on 28 patients with chronic 
refractory osteomyelitis and this controlled trial concluded that HBO had 






TOPIC: FEATURES OF LOCAL ANESTHESIA, TOOTH 
EXTRACTION AND MEDICALLY COMPLEX PATIENTS 
 
The first step in managing the patient with medical problems is 
acquiring a thorough health history; the second step is for the clinician to 
fully understand the significance of the disease that may be endorsed by the 
patient. Each identified condition can affect dental care in a unique manner. 
For example, medication prescribed for a medical condition might produce 
a problem during the administration of a local anesthetic, or it could 
interact with pain medication prescribed post intervention. The dental 
clinician needs to understand the potential complications that can occur as a 
consequence of dental treatment of a medically compromised patient and 
when pretreatment or post-treatment medication or emergency care is 
indicated. 
Certain medically compromised patients should only be treated in a 
hospital setting where emergency issues, should they arise, can be 
immediately addressed and promptly attended to in a controlled manner. 
For example, the patient with a significant bleeding problem or 
thrombocytopenia arising as a primary condition or secondary to 
medication, radiation, or leukemia is best managed in an in-patient 
environment where replacement of platelets can be provided before the 
procedure or afterwards if spontaneous bleeding occurs. 
Dental management of the medically compromised patient requires 
acquisition of a complete health history of the patient. This should include 
documentation via questionnaire as well as a verbal history. A 
comprehensive health history questionnaire should include questions about 
the patients cardiovascular, hematologic, neural and sensory, 
gastrointestinal, respiratory, dermal, mucocutaneous, and musculoskeletal, 
endocrine, and urinary systems as well as questions related to sexually 
transmitted diseases, drug use (eg, alcohol, tobacco), allergies, x-ray 
exposure or treatment, medications, and hospitalizations. Preferably an oral 
history should also be obtained as a review of systems (ROS). This oral 
ROS often elucidates information that is only touched on by a 
questionnaire. 
The dental history should also include questions related to current 
oral conditions such as periodontal disease or oral ulceration and past 
dental treatment and potential complications from prior intervention 






Cardiovascular diseases  
Local anesthetic agents themselves can affect the cardiovascular 
system, especially at higher doses. Cardiovascular manifestations are 
usually depressant and are characterized by bradycardia, hypotension, and 
cardiovascular collapse, potentially leading to cardiac arrest. The initial 
signs and symptoms of depressed cardiovascular function commonly result 
from vasovagal reactions (dizziness and fainting), particularly if the patient 
is in an upright position. Cardiovascular diseases constituting 
contraindications to the use of local anesthetics in general, and to the use of 
vasoconstrictors in local anesthetics in particular, are often discussed in 
terms of absolute as opposed to relative contraindications. Absolute 
contraindications for the use of local anesthetics with or without 
vasoconstrictors in patients with cardiovascular diseases exist only if the 
patients condition is determined, by the dentists review of the health 
history, to be medically unstable to the degree of posing undue risk to the 
patients safety. Dental care should be deferred in these patients until their 
medical conditions have been stabilized under the care of their physicians. 
For patients with stabilized cardiovascular diseases, dental treatment may 
usually be delivered in near routine fashion, although, as the following 
sections will emphasize, the amount of vasoconstrictor-containing local 
anesthetic used may need to be limited and the patient carefully monitored.  
Hypertension  
It is estimated that more than 50 million people in the United States 
have high blood pressure or are taking antihypertensive medications. 
Because lack of compliance is a major problem in medical treatment of 
hypertensive patients, the dental practitioner is wise to measure blood 
pressure and evaluate the patients status at every visit. The decision 
regarding whether or not a local anesthetic agent containing vasoconstrictor 
should be administered to a patient with hypertension or other 
cardiovascular disease is a common concern amongst dental practitioners. 
A rational approach to this question is to recall the effects and mechanism 
of action of the vasoconstrictors. One of the primary effects, and 
advantages, of vasoconstrictors in dental local anesthetics is to delay the 
absorption of the anesthetic into the systemic circulation. This increases the 
depth and the duration of anesthesia while decreasing the risk of toxic 
reaction. Additionally, the vasoconstrictor provides local hemostasis. 
Epinephrine and levonordefrin (neocobefrin) are the two vasoconstrictor 
agents commonly used in dental local anesthetic formulations. Although 
they do have slightly differing cardiac effects, they carry the same 
precautions for their use. There are no absolute contraindications to the use 
of vasoconstrictors in dental local anesthetics, since epinephrine is an 
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endogenously produced neurotransmitter. In 1964, the American Heart 
Association and the American Dental Association concluded a joint 
conference by stating that "the typical concentrations of vasoconstrictors 
contained in local anesthetics are not contraindicated with cardiovascular 
disease so long as preliminary aspiration is practiced, the agent is injected 
slowly, and the smallest effective dose is administered. It has long been 
recommended that the total dosage of epinephrine be limited to 0.04 mg in 
cardiac risk patients. This equates to approximately two cartridges of 
1:100,000 epinephrine-containing local anesthetic. Levonordefrin is 
considered to be roughly one-fifth as effective a vasoconstrictor as 
epinephrine and is therefore used in a 1:20,000 concentration. In this 
concentration, levonordefrin is considered to carry the same clinical risks 
as 1:100,000 epinephrine. The results of a number of studies11-17 indicate 
that the use of one to two 1.8 ml cartridges of local anesthetic containing a 
vasoconstrictor is of little clinical significance for most patients with 
hypertension or other cardiovascular diseases, and that the benefits of 
maintaining adequate anesthesia for the duration of the procedure far 
outweighs the risks. However, the use of more than two cartridges of local 
anesthetic with a vasoconstrictor should be considered a relative rather than 
an absolute contraindication. If, after administering one to two cartridges of 
vasoconstrictor-containing local anesthetic with careful preliminary 
aspiration and slow injection, the patient exhibits no signs or symptoms of 
cardiac alteration, additional vasoconstrictorcontaining local anesthetic 
may be used, if necessary, or local anesthetic without epinephrine can be 
used. Some practitioners prefer to achieve initial anesthesia with a 
nonvasoconstrictor-containing anesthetic agent such as 3 percent 
mepivacaine or 4 percent prilocaine plain and then use a small amount of 
local anesthetic with vasoconstrictor to supplement cases of inadequate 
anesthesia. While this is a viable protocol, a safer choice is to use a 
minimal amount of vasoconstrictor-containing local anesthetic first and 
then supplement as necessary with nonvasoconstrictor-containing agents. 
The advantage of using the epinephrine-containing anesthetic first is that it 
will minimize blood flow in the injection site, thereby holding the local 
anesthetic in place, optimizing the anesthetic effect while minimizing the 
rate of plasma uptake and potential toxicity. Since nonvasoconstrictor-
containing local anesthetics produce localized vasodilation, addition of a 
vasoconstrictor-containing agent after first injecting with a 
nonvasoconstrictor-containing local anesthetic can be expected to produce 
increased cardiovascular alterations. The goal should always be to 
minimize the dosage of local anesthetic with or without vasoconstrictor; 
but if additional vasoconstrictor will provide improved pain control for the 
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dental procedure, it is not contraindicated. If a patient has severe 
uncontrolled hypertension, elective dental treatment should be delayed until 
his or her physician can get the blood pressure under control. But if 
emergency dental treatment is needed, the clinician may elect to sedate the 
patient with valium and use one to two cartridges of local anesthetic with a 
vasoconstrictor. This dose will have minimal physiologic effect and will 
provide prolonged anesthesia. The greater risk in such a scenario is that 
without the epinephrine the anesthesia will wear off too soon and the 
endogenous epinephrine produced by the patient, because of pain from the 
dental procedure, will be much greater and more detrimental than the small 
amount of epinephrine in the dental anesthetic cartridge. Another concern 
for the dental practitioner is the possibility of an adverse interaction 
between the local anesthetic agent and a patients antihypertensive 
medication, particularly the adrenergic blocking agents. The nonselective 
beta-adrenergic drugs, such as propranolol (Inderal), pose the greatest risk 
of adverse interaction. In these patients, an injection of vasoconstrictor-
containing local anesthetic may produce a marked peripheral 
vasoconstriction, which could potentially result in a dangerous increase in 
blood pressure due to the pre-existing medication-induced inhibition of the 
compensatory skeletal muscle vasodilation. This compensatory skeletal 
muscle vasodilation normally acts to balance the peripheral 
vasoconstriction effects in nonmedicated patients. The cardioselective beta 
blockers (Lopressor, Tenormin) carry less risk of adverse reactions. Both 
classes of beta blockers may increase serum levels of anesthetic solutions 
due to competitive reduction of hepatic clearance. Though these 
considerations are theoretically important, there is still little risk of a 
problem if the total dose of anesthetic, with 1:100,000 epinephrine or its 
equivalent, is limited to one to two 1.8 ml cartridges. Other 
antihypertensive medications, such as the central sympatholytic drugs, for 
example Clonidine and Methyldopa (Aldomet), and the peripheral 
adrenergic antagonists such as Reserpine as well as the direct vasodilators, 
may potentiate adrenergic receptor sensitivity to sympathomimetics, 
resulting in a magnified systemic response to vasoconstrictor-containing 
anesthetics. However, once again, these medications pose no significant 
risk as long as the vasoconstrictor-containing anesthetic is limited to one to 
two 1.8 ml cartridges. An additional reminder to inject vasoconstrictor-
containing local anesthetics slowly is appropriate due to the increased risk 
of injection site ischemia resulting from the potentiated localized 





Angina pectoris and post-myocardial infarction  
Patients with stable angina without a history of infarction generally 
have a significantly lower risk of adverse reactions to dental anesthetics 
than do patients with unstable angina or a history of recent (less than six 
months prior) myocardial infarction. Stress and anxiety reduction play a 
crucial role in management of these patients, and excellent pain control 
throughout the dental procedure is essential. The use of local anesthetics 
containing a vasoconstrictor is recommended as part of the stress reduction 
protocol for these patients. The dosage of the vasoconstrictor should be 
limited to that contained in one to two 1.8 ml cartridges of vasoconstrictor-
containing anesthetic. For patients with unstable angina, recent myocardial 
infarction (less than six months), or recent coronary artery bypass graft 
surgery (less than three months), elective dental treatment should be 
postponed. If emergency treatment is required, stress-reduction protocols 
with antianxiety agents are appropriate, and the above limitation of one to 
two cartridges of vasoconstrictor-containing anesthetic must be strictly 
observed.  
Cardiac dysrhythmia  
Proper identification of patients with an existing cardiac 
dysrhythmia, commonly called arrhythmias, or those patients who may be 
prone to developing dysrhythmia, is essential and requires a physician 
consult to determine the current status. Patients with coronary 
atherosclerotic heart disease, ischemic heart disease, or congestive heart 
failure are susceptible to stress-induced cardiac dysrhythmias. Stressand 
anxiety-reduction protocols are again of paramount importance. Local 
anesthetic agents containing vasoconstrictors are appropriate for 
maintenance of adequate pain control during dental procedures. Elective 
dentistry should be avoided in patients with severe or refractory 
dysrhythmias until their physician can get the problem under control. Once 
again, it is reasonable and safe to limit the total dose of local anesthetic to 
no more than two 1.8 ml cartridges per appointment. The use of periodontal 
ligament or intraosseous injections using a vasoconstrictor-containing local 
anesthetic is not recommended in these patients. Congestive Heart Failure 
Patients who are under physician care and well-controlled with no 
complications can be treated relatively routinely. Limitation of 
vasoconstrictor dosage to two 1.8 ml cartridges of 
vasoconstrictorcontaining anesthetic is advised. Patients taking digitalis 
glycosides, such as digoxin, should be carefully monitored if 





Cerebrovascular accident  
Atherosclerosis, hypertensive vascular disease, and cardiac pathoses 
such as myocardial infarction and atrial fibrillation are commonly 
associated with the occurrence of strokes. A patient who has suffered a 
stroke is at greater risk for having another one than is a patient who has 
never had one. It is recommended that dental treatment be deferred for six 
months following a stroke because of the increased risk of recurrent strokes 
during this period. After six months, dental procedures may be provided 
with the use of vasoconstrictor-containing local anesthetics where required 
for adequate pain control. If the stroke patient has associated cardiovascular 
problems, the dosage of local anesthetic with vasoconstrictor should be 
minimized in accordance with the guidelines for their specific 
cardiovascular disease 
 
Pulmonary disease  
The most common pulmonary diseases encountered in the dental 
office are asthma, tuberculosis, and chronic obstructive pulmonary disease, 
which includes chronic bronchitis and emphysema. While the status of 
tuberculosis infection in a patient is of the utmost concern to dental 
practitioners, and the patients infection must be under control before 
elective dentistry is done, it poses no implications with regard to the use of 
dental local anesthetics.  
Asthma  
Dental management of asthmatic patients is primarily aimed at 
prevention of an acute asthma attack. Knowing that stress may be a 
precipitating factor in asthma attacks, adherence to stress-reduction 
protocols is again essential and implies the judicious use of local 
anesthetics containing vasoconstrictors when the planned procedure 
requires extended depth and duration of anesthesia. However, caution has 
been recommended based upon Food and Drug Administration warnings 
that drugs containing sulfites can be a cause of allergic reactions in 
susceptible individuals. Studies suggest that sodium metabisulfite, which is 
used as an antioxidant agent in dental local anesthetic solutions containing 
vasoconstrictors to prevent the breakdown of the vasoconstrictor, may 
induce allergic, or extrinsic, asthma attacks. Data on the incidence of this 
problem occurring is limited, and suspicion is that it is probably not a 
common reaction even in sulfite-sensitive patients since the amount of 
metabisulfite in dental anesthetics is quite small. Indications are that more 
than 96 percent of asthmatics are not sensitive to sulfites at all; and those 
who are sensitive are usually severe, steroiddependent asthmatics. As 
Perusse and colleagues conclude, we believe local anesthetic with 
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vasoconstrictor can be used safely for nonsteroid-dependent asthma 
patients. However, until we know more about the sulfite sensitivity 
threshold, we recommend avoiding local anesthetic with vasoconstrictors in 
corticosteroid-dependent asthma patients on account of a higher risk of 
sulfite allergy and the possibility that an accidental intravascular injection 
might cause a severe and immediate asthmatic reaction in the sensitive 
patient. 
Chronic obstructive pulmonary disease  
The two most common forms of chronic obstructive pulmonary 
disease, characterized by chronic irreversible obstruction of ventilation of 
the lungs, are chronic bronchitis and emphysema. Patients with chronic 
obstructive pulmonary disease already have decreased respiratory function, 
making it mandatory that the dental practitioner take every precaution to 
avoid further respiratory depression. There are no containdications to the 
use of therapeutic doses of local anesthetics in these patients. However, any 
patient with chronic obstructive pulmonary disease who also suffers from 
coronary heart disease and/or hypertension must be managed in accordance 
with the guidelines provided for those diseases. 
 
Renal disease  
In general, drugs excreted by the kidney, such as dental local 
anesthetics, may not be metabolized and cleared from the blood stream as 
quickly as normal in the presence of renal disease. Total anesthetic dosage 
may need to be reduced and the interval of time between subsequent 
injections may need to be extended. Though this is a consideration, it is not 
a factor in most dental procedures provided the total local anesthetic dosage 
is kept to a safe minimum.  
 
Hepatic disease  
For patients with known liver function impairment, drugs 
metabolized by the liver should be avoided if possible, or the dosage at 
least decreased. Since all of the amide local anesthetics are primarily 
metabolized in the liver, the presence of liver disease and the status of liver 
function are important to the dentist. A history of hepatitis infection is not 
uncommon in most dental office patient pools. In completely recovered 
patients, local anesthetics may be administered routinely. However, 
patients with chronic active hepatitis or with carrier status of the hepatitis 
antigen must be medically evaluated for impaired liver function. Local 
anesthetics may be used in these patients, but it is recommended that the 
dose be kept to a minimum. In patients with more advanced cirrhotic 
disease, metabolism of local anesthetics may be significantly slowed, 
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leading to increased plasma levels and greater risk of toxicity reactions. 
Total anesthetic dosage may need to be reduced and the interval of time 
between subsequent injections may need to be extended. In these cases, 
initial injection with rapid-onset anesthetics such as lidocaine or 
mepivacaine followed by injection with a long-acting anesthetic like 
etidocaine or bupivacaine may be the best protocol for limiting total 
anesthetic dosage while achieving adequate pain control duration. 
Cimetidine (Tagamet) has been shown to significantly reduce the metabolic 
clearance of amide local anesthetics through the liver. However, the 
probability of cimetidine and therapeutic doses of local anesthetic 
interacting to produce a toxic level of local anesthetic in the blood stream is 
unlikely and unreported. Other histamine H2 -receptor antagonist drugs 
such as ranitidine (Zantac) or famotidine (Pepcid) do not share cimetidines 
metabolic inhibition of liver enzymes.  
 
Pancreatic disease  
Diabetes  
Patients with either Type I insulin-dependent diabetes mellitus or 
Type II non-insulin-dependent diabetes mellitus, can generally receive 
local anesthetics without special precautions if control of their disease is 
well-managed. Consultation with a patients physician, as well as frank 
discussion with the patient, can determine the current status and what, if 
any, precautions are needed. Stress-reduction protocols, including excellent 
pain control, are of paramount importance and use of local anesthetics with 
vasoconstrictors is recommended when appropriate as long as the dosage is 
kept to the minimum needed. Special caution should be used for patients 
with Type I diabetes who are being treated with large doses of insulin. 
Some of these patients, so-called brittle diabetics, experience dramatic 
swings between hyperglycemia and hypoglycemia ;and the use of 
vasoconstrictors should be minimized due to the potential for 
vasoconstrictor-enhanced hypoglycemia. 
 
Adrenal disease  
Adrenal insufficiency  
No alteration of local anesthetic use is required for patients with 
adrenal insufficiency. Of greatest concern for treatment of these patients is 
the maintenance of good anesthesia during the dental procedure and good 







The cardinal symptom of this tumor of the adrenal medulla or of the 
sympathetic paravertebral ganglia is hypertension due to the increased 
secretion of endogenous epinephrine from these tissues. These patients are 
also prone to cardiac dysrhythmias. Due to the risk of potentiating 
cardiovascular problems, the use of vasoconstrictor-containing local 
anesthetics is contraindicated in these patients. No elective dental treatment 
should be rendered until the disease is medically corrected. 
 
Thyroid disease  
Hyperthyroidism  
The use of epinephrine or other vasoconstrictors in local anesthetics 
should be avoided, or at least minimized to one to two cartridges, in the 
untreated or poorly controlled hyperthyroid patient. Hypertension and 
cardiac abnormalities, especially dysrhythmias, are common in the 
presence of excessive thyroid hormones. However, the well-managed or 
euthyroid patient presents no problem and may be given normal 
concentrations of vasoconstrictors.  
Hypothyroidism  
In general, the patient with mild symptoms of untreated 
hypothyroidism is not in danger when receiving dental treatment. However, 
patients with mild to severe hypothyroidism may have exaggerated 
responses to local anesthetics due to the central nervous system depressant 
effects. Dosage should be kept to a minimum in mild hypothyroid patients, 
and dental treatment is best deferred in severe hypothyroidism until the 
patients condition can be corrected by his or her physician. 
 
Musculoskeletal diseases  
Malignant hyperthermia  
This rare, but potentially fatal, muscle disease was at one time 
believed to be induced by administration of amide local anesthetics. 
However, leading authorities, including the Malignant Hyperthermia 
Association of the United States, do not advise any special precautions for 
the use of amide anesthetics in patients susceptible to malignant 
hyperthermia. 
 
Blood dyscrasias  
Sickle cell anemia  
Profound anesthesia as part of a proper stress reduction protocol is 
essential in management of these patients. The use of vasoconstrictor-
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containing local anesthetics is considered safe as long as the dosage is 
limited to one to two cartridges.  
Methemoglobinemia  
Methemoglobin is hemoglobin that has been oxidized and can no 
longer bind and transport oxygen. While present in everyone, it normally 
makes up less than 1 percent of the circulating red blood cells. Increases in 
methemoglobin levels can be induced by administration of local anesthetic 
solutions, particularly prilocaine (Citanest), usually when in combination 
with other medications that also increase the methemoglobin level. 
Examples of common medications that may produce this interaction are 
Cipro, Bactrim, Septra, Dapsone, Macrodantin, Macrobid, Isordil, Nardil, 
and nitroglycerin.32 Patients with methemoglobinemia or taking 
medications associated with this disease may be safely treated with local 
anesthetic injections, with or without vasoconstrictors; however, the dosage 
should be minimized and the use of prilocaine should be avoided.  
 
Drug interactions  
Antipsychotic drugs (Phenothiazines)  
There are no contraindications for use of any local anesthetics, with 
or without vasoconstrictors, in patients taking lithium for bipolar disease. 
For bipolar patients taking a phenothiazine type of drug such as 
chlorpromazine (Thorazine) or risperidone (Risperdal), fluctuations in 
blood pressure are common. Local anesthetics with vasoconstrictors used 
in normal amounts usually will produce no adverse effects.33 However, 
consultation with the patients physician is recommended before dental 
treatment, and the patient should be carefully monitored for possible 
hypotensive episodes during the appointment. 
Cocaine  
The main concern in patients abusing cocaine is the significant 
danger of myocardial ischemia, cardiac dysrhythmias, and hypertension. 
Patients high on cocaine should not be treated in the dental office for a 
minimum of six hours following the last administration of cocaine,34 
although the longer the time since the last use of the drug the better, with 
some researchers recommending deferral of dental treatment for 24 to 72 
hours. 
Tricyclic antidepressants  
Although use of tricyclic antidepressant drugs such as imipramine 
(Tofranil) and amitriptyline (Elavil) is decreasing, they are still prescribed 
to significant numbers of patients. One to two cartridges of epinephrine-
containing local anesthetic can be safely used in patients taking these 
drugs, however, these patients should be carefully observed at all times for 
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signs of hypertension due to enhanced sympathomimetic effects. 
Levonordefrin-containing local anesthetics are not recommended due to a 
greater tendency toward hypertension producing receptor potentiation than 
is seen with epinephrine. 
Monoamine oxidase inhibitors  
Dentists have long been cautioned about potential interactions of 
drugs of this class, for example the antidepressant phenelzine (Nardil), the 
Parkinsons disease drug selegiline (Eldapryl), and the antimicrobial 
furazolidone (Furoxone), relative to vasoconstrictor-containing local 
anesthetics. These cautions were based upon a fear of induction of severe 
hypertension due to interaction of vasoconstrictor-containing anesthetics 
with the MAO inhibitors. However, both animal and human studies have 
failed to yield evidence of such an interaction. Vasoconstrictor-containing 
local anesthetics may be used without special precautions in patients taking 
MAO inhibitor drugs.  
Antianxiety drugs  
Diazepam (Valium), one of the most widely prescribed drugs in the 
United States, is a potent central nervous system depressant. Dosage of all 
local anesthetic agents should be kept to the minimum necessary for good 
pain control in patients taking benzodiazepine antianxiety drugs due to 
their additive depressive effects. 
Thus, local anesthetics, with or without vasoconstrictors, may be 
safely used in most medically complex patients. Observance of simple 
safety guidelines should be universal for administration of local anesthetics 
to all patients:  Aspirate carefully before injecting to reduce the risk of 
unintentional intravascular injection;  Inject slowly, a maximum rate of one 
minute per carpule is widely recommended, and monitor the patient both 
during and after the injection for unusual reactions;  Select the anesthetic 
agent and whether to use it with or without a vasoconstrictor based upon 
the duration of anesthesia appropriate for the planned procedure; and  Use 
the minimum amount of anesthetic solution that is needed to achieve an 
adequate level of anesthesia to keep the patient comfortable throughout the 
dental procedure. Adherence to these simple guidelines will reduce the risk 
of adverse reactions to the local anesthetic agents themselves or to the 
vasoconstrictors contained in local anesthetics. A further safety guideline 
useful for the majority of medically complex patients is to reduce the 
amount of local anesthetic containing a vasoconstrictor to no more than two 
1,8 ml cartridges. If additional anesthetic volume is need to maintain 
adequate pain control for the procedure, nonvasoconstrictor anesthetics can 




ТOPIC: COMPLICATIONS ASSOCIATED WITH TOOTH 
EXTRACTION. EMERGENCY MEDICAL CARE 
 
Syncope. 
Syncope, one of the most common anesthetic complications, 
typically occurs in the preoperative setting, but may be observed 
occasionally postoperatively as well. Syncope is defined as transient loss of 
consciousness with spontaneous return to consciousness. It is usually 
related to patient’s anxiety in the preoperative setting and is most 
frequently observed upon venipuncture for placement of an intravenous 
line. Syncope responds well to placing the patient in the Trendelenberg 
position, as this places the patient’s head lower than the thoracic cavity and 
speeds blood return to the brain. Supplemental oxygen is beneficial and 
should always be given; it is also useful in cases of near-syncope. 
Ammonia smelling salts may also be helpful and are usually applied in 
situations where Trendelenberg positioning and supplemental oxygen does 
not result in a rapid return to consciousness. In the postoperative period, 
patients may experience syncope due to vasovagal response or transient 
orthostatic hypotension when rising too quickly from a seated or supine 
position. This complication may be prevented by assisting all patients when 
they stand or begin walking, since syncope under these circumstances 
carries the additional risk of injury from falling. Management consists of 
patient positioning, supplemental oxygen and ammonia salts if needed. Any 
period of unexpected patient unconsciousness that lasts for several minutes 
is not considered true syncope. If a loss of consciousness episode lasts 
more than a few minutes, other causes should be investigated without 
delay, including the possibility of hypoglycemia, hypotension, dehydration, 
partial seizure, oversedation, or cerebrovascular accident. 
Vasovagal syncope. 
Before you faint due to vasovagal syncope, you may experience 
some of the following: 
• Pale skin 
• Lightheadedness 
• Tunnel vision — your field of vision narrows so that you see 
only what's in front of you 
• Nausea 
• Feeling warm 
• A cold, clammy sweat 
• Yawning 




During a vasovagal syncope episode, bystanders may notice: 
• Jerky, abnormal movements 
• A slow, weak pulse 
• Dilated pupils 
Recovery after a vasovagal episode generally begins in less than a 
minute. However, if you stand up too soon after fainting – within about 15 
to 30 minutes – you're at risk of fainting again. 
Fainting can be a sign of a more serious condition, such as a heart or 
brain disorder. You may want to consult your doctor after a fainting spell, 
especially if you never had one before. 
Causes 
Vasovagal syncope occurs when the part of your nervous system that 
regulates heart rate and blood pressure malfunctions in response to a 
trigger, such as the sight of blood. 
Your heart rate slows, and the blood vessels in your legs widen 
(dilate.) This allows blood to pool in your legs, which lowers your blood 
pressure. Combined, the drop in blood pressure and slowed heart rate 
quickly reduce blood flow to your brain, and you faint. 
Sometimes there is no classical vasovagal syncope trigger, but 
common triggers include: 
• Standing for long periods of time 
• Heat exposure 
• Seeing blood 
• Having blood drawn 
• Fear of bodily injury 
• Straining, such as to have a bowel movement 
Diagnosing vasovagal syncope often involves ruling out other 
possible causes of your fainting – particularly heart-related problems. 
These tests may include: 
• Electrocardiogram. This test records the electrical signals your 
heart produces. It can detect irregular heart rhythms and other cardiac 
problems. You may need to wear a portable monitor for at least a day or as 
long as a month. 
• Echocardiogram. This test uses ultrasound imaging to view the 
heart and look for conditions, such as valve problems, that can cause 
fainting. 
• Exercise stress test. This test studies heart rhythms during 
exercise. It's usually conducted while you walk or jog on a treadmill. 
• Blood tests. Your doctor may look for conditions, such as 




Tilt table test 
If no heart problems appear to cause your fainting, your doctor may 
suggest you undergo a tilt table test.  
For a tilt table test: 
• You lie flat on your back on a table. 
• The table changes position, tilting you upward at various 
angles. 
• A technician monitors your heart rhythms and blood pressure 
to see if the postural changes affect them. 
In most cases of vasovagal syncope, treatment is unnecessary. Your 
doctor may help you identify your fainting triggers and discuss ways you 
might avoid them. 
However, if you experience vasovagal syncope often enough to 
interfere with your quality of life, your doctor may suggest trying one or 
more of the following remedies. 
Medications 
A drug called fludrocortisone acetate that is normally used to treat 
low blood pressure may be helpful in preventing vasovagal syncope. 
Selective serotonin inhibitors may also be used. 
 
Therapies 
Your doctor may recommend ways to decrease the pooling of blood 
in your legs. These may include foot exercises, wearing compression 
stockings or tensing your leg muscles when standing. 
You may need to increase salt in your diet if you don't usually have 
high blood pressure. Avoid prolonged standing – especially in hot, crowded 
places – and drink plenty of fluids. 
Surgery 
Very rarely, inserting an electrical pacemaker to regulate the 
heartbeat may help some people with vasovagal syncope who haven't been 
helped by other treatments. 
Oversedation 
Oversedation is a relatively common event observed during 
ambulatory anesthesia that can rapidly develop in a potential complication 
of variable severity. It initially manifests as lack of adequate patient 
response to appropriate stimuli. For example, a patient who previously 
responded to loud verbal or forceful physical stimuli may suddenly fail to 
respond. In cases of profound oversedation, a patient may fail to respond to 
increasingly painful stimuli, and when the plane of general anesthesia is 
reached, the patient will have lost protective airway responses. If allowed 
to progress without intervention, oversedation can rapidly advance to 
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airway obstruction, hypopnea, or apnea leading to hypoxemia. In severe 
cases, respiratory depression can lead to respiratory arrest and depression 
of cardiac output will be observed. Oversedation in ambulatory anesthesia 
takes two forms: unintended deep sedation or general anesthesia during the 
procedure, or prolonged or delayed awakening in the postoperative period. 
Intraoperatively, oversedation is produced by too high a dose of an 
anesthetic drug or a dose of anesthetic that is administered too quickly. 
Patient factors often figure prominently in cases of oversedation, as patients 
who are very sensitive to the effects of an anesthetic or who have greatly 
decreased elimination kinetics will have a narrowed therapeutic range 
compared to an “average” patient. It can be quite difficult to titrate 
anesthetic drugs in such a patient, with the result that oversedation is more 
likely to occur. Age is an important factor in a patient’s response to 
anesthesia. Sensitivity to anesthetic drugs and alterations in the dosages are 
required to achieve specified levels of sedation with extremes of age. While 
this may seem self-evident in the elderly, research shows that the reduction 
in required anesthetic dose begins as early as age 40 to 45. For each decade 
past the age of 40, there is an observed 10% reduction in the dose of 
fentanyl required while for propofol, the dose reduction is about 8%. The 
pediatric population in particular has a markedly idiopathic response to 
anesthetic drugs, and titration of sedation can be more challenging in this 
age group. Ironically, patients with very high anxiety levels may be prone 
to oversedation because they typically require a high initial dose of 
anesthetic to achieve sedation, but often markedly less medication to 
maintain a given level of anesthesia. Failure to reduce the dosage of 
anesthesia adequately after the initial induction bolus in these patients can 
result in oversedation. Oversedation may be caused when boluses of a drug 
are given too quickly or too close together. This typically occurs during an 
anesthetic procedure when a patient begins to awaken or become agitated 
and additional medications are administered to rapidly deepen the 
anesthesia. Since all anesthetic drugs take some period of time to exert their 
effect, failure to wait for the drug to take effect can result in the observation 
that the dose was insufficient and the administration of an additional bolus. 
Subsequently, when the additional boluses have had time to take effect, the 
patient may be in a deeper plane of anesthesia than was intended. This can 
be partially prevented by the spacing of additional drug boluses and 
knowing the time to effective onset of the anesthetic drugs utilized. Not all 
pharmacologic agents demonstrate first order kinetics however, and rate of 
drug onset can be increased or decreased depending on the patient’s plasma 
drug level. Oversedation can sometimes result when the level of surgical 
stimulation is rapidly or dramatically decreased. Since surgical stimulation 
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tends to counteract the sedative effects of anesthetic drugs, a higher dose of 
anesthesia is typically required for more stimulating surgical procedures. A 
patient who is at an appropriate level of anesthesia may quickly become 
over-sedated if stimulation is decreased or discontinued. In situations 
where changes in the level of surgical stimulation can be predicted, 
allowing time for the anesthetic drug to wear off or decreasing the rate of 
infusion can effectively prevent most oversedation in these cases. 
Oversedation is a relatively common complication of ambulatory 
anesthesia which can rapidly develop in severity. It initially manifests as 
lack of adequate patient response to appropriate stimuli. For example, a 
patient who previously responded to loud verbal or forceful physical 
stimuli may suddenly fail to respond. In cases of profound oversedation, a 
patient may fail to respond to increasingly painful stimuli, and when the 
plane of general anesthesia is reached the patient will have lost protective 
airway responses. If allowed to progress without intervention, oversedation 
can rapidly progress to airway obstruction, hypopnea, or apnea leading to 
hypoxemia. In severe cases, respiratory depression can lead to respiratory 
arrest and depression of cardiac output will be observed. Management of 
mild oversedation may consist of briefly interrupting the administration of 
anesthetic drugs and observing the patient for a return to the desired level 
of anesthesia. If any degree of respiratory obstruction or depression is 
noted, maneuvers aimed at opening the airway such as a chin lift or jaw 
thrust should be performed as well. Given the rapid redistribution and short 
duration of effects of many anesthetic drugs, mild oversedation is self-
correcting with supportive measures within a matter of a few minutes. 
Although not a mainstay of treatment, administration of reversal agents 
may be considered as an adjunctive therapy for oversedation. Few drugs 
used in ambulatory anesthesia have a reversal agent, but naloxone is able to 
reverse the effects of opioid agonist drugs and flumazenil is an effective 
antagonist of the benzodiazepine class of drugs. These reversal agents can 
be effective in reversing the effects of oversedation due to drug 
overdosage, but they reverse all actions of a drug including desirable 
effects such as analgesia, hypnosis, and anxiolysis. They may be 
considered for the treatment of oversedation and prolonged awakening in 
the postoperative period and are generally well tolerated. Research has not 
supported the routine use of reversal agents to speed recovery from 








Seizure activity, both partial type and tonic–clonic seizures, 
represents abnormal CNS excitation. Because anesthetic drugs act by 
causing depression of the CNS, seizure activity during an anesthetic 
procedure is unlikely to occur. In patients with seizure disorders, however, 
seizures may occur in the preoperative and postoperative periods. 
Management of seizures involves positioning the patient to avoid injury 
and loosening tight or restrictive clothing as much as possible. Most 
seizures will terminate after a few minutes and require no other treatment, 
though benzodiazepines such as midazolam, lorazepam, or diazepam may 
be given intravenously or intramuscularly to terminate seizure activity. 
Since patients will typically become hypoxic during the clonic phase of a 
tonic–clonic seizure, supplemental oxygen may be beneficial in the 
immediate postictal period. 
 
Cardiopulmonary complications. 
Respiratory depression and respiratory arrest. 
The effects of anesthetic drugs are the most common cause of 
respiratory depression in ambulatory anesthesia. An overdose of anesthesia 
will produce respiratory depression in virtually all cases, and this may 
progress to full respiratory arrest if not promptly corrected. Even typical 
doses of anesthetic drugs will cause some degree of respiratory depression 
in a proportion of patients. Primary respiratory depression, caused by the 
provision of anesthesia itself, refers to a deficit in ventilation or 
oxygenation or both. Respiratory depression may take the form of 
mechanical obstruction, caused by collapse of the oropharyngeal soft 
tissues or occlusion of the airway by the tongue or secretions. Central 
respiratory depression, characterized by hypopnea or apnea can also occur 
either separately or concurrently. Typically, mechanical obstruction occurs 
more frequently and at lower anesthetic doses than central apnea does, and 
it occurs to some extent in susceptible persons. Obese patients, those with 
short thick necks, mandibular retrognathia, and patients with obstructive 
sleep apnea are among the most susceptible groups. In severe cases, this 
may render these patients unsuitable for ambulatory anesthetic procedures. 
In most other cases, patient positioning can play a role in airway 
obstruction. Respiratory obstruction due to mechanical airway obstruction 
can be managed by careful suctioning, repositioning of the tongue in a 
forward position, and either a chin lift or jaw thrust maneuver. If necessary, 
the level of anesthesia may be lessened, as increasing levels of sedation 
contribute to the degree of airway impediment. Rarely, an oral or nasal 
airway may be needed to overcome the obstruction in the posterior pharynx 
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and stent the airway open. Supplemental oxygen can be helpful to decrease 
any oxygen desaturation associated with mild to moderate obstruction, 
although oxygen by itself does not alleviate the mechanics of obstruction. 
Respiratory depression may also be “central,” characterized by a decreased 
respiratory rate or periods of apnea. Narcotic drugs are most often 
implicated because of their effects on the medullary respiratory center of 
the brainstem that results in decrease respiratory drive and response to 
hypercapnia. At moderate levels of narcotic effect, the decreased 
respiratory rate is accompanied by a compensatory increase in tidal volume 
that prevents oxygen desaturation. At higher levels of narcotic sedation, 
respiratory depression can progress to apnea and respiratory arrest. A brief 
period of respiratory support in the form of supplemental oxygen via a face 
mask with cessation of anesthetic drug administration may be all that is 
necessary in terms of management—particularly with short-acting drugs in 
a patient with good respiratory reserve. Whenever there is desaturation in a 
setting of frank apnea, however, the patient’s ventilation should be assisted 
by a positive pressure face mask until spontaneous respiration resumes. 
Occasionally, mask ventilation with or without the placement of an oral or 
nasal airway will not be sufficient to overcome airway obstruction and 
provide oxygenation. In these cases, other means of establishingan airway 
and achieving effective ventilation should be employed. These include 
laryngeal mask airway (LMA) insertion or endotracheal intubation for 
administration of positive pressure ventilation with high oxygen flow. 
Because endotracheal intubation is a technically complex procedure and 
requires specialized equipment, it is subject to high rates of failure, 
especially in emergency situations. Intubation should only be considered in 
a patient who is hypoxemic and cannot be effectively mask ventilated. An 
LMA can be successfully used for the support of ventilation as an 
alternative to endotracheal intubation and has several advantages over the 
traditional endotracheal tube (ET). LMAs are quickly and easily inserted 
without the need for specialized equipment. Use of an LMA poses no risk 
of inadvertent intubation of the esophagus or mainstem bronchus or injury 
to the vocal cords. Airway stimulation is minimal and removal of the LMA 
can be easily accomplished once spontaneous respirations return. 
Regardless of the method used for airway establishment early recognition, 
preparedness, familiarity with the available equipment, and skill 
maintenance for their effective use are critical. In addition to respiratory 
depression or arrest caused by anesthetic drugs, other causes of respiratory 
complications include stroke or myocardial infarction. The signs and 
symptoms of stroke or acute coronary syndrome can be significantly 
masked in a patient undergoing ambulatory anesthesia, and respiratory 
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depression or arrest may initially be diagnosed as a case of oversedation. 
Any respiratory complication that does not respond to moderate 
interventions or progresses to a need for airway establishment and support 
of ventilation should be investigated for additional contributing factors or 
underlying conditions. 
 
Laryngospasm, Bronchospasm, and Acute Asthma. 
A second group of respiratory complications that may arise in the 
course of outpatient anesthesia includes reactive airway conditions such as 
laryngospasm, bronchospasm, and acute asthma. One analysis of 
complications in ambulatory anesthesia identified laryngospasm, stridor, 
and obstruction as the most frequently observed adverse events, accounting 
for 40% of complications. Acute asthma attacks are more frequent 
preoperatively and may be associated with patient anxiety. Laryngospasm 
and bronchospasm typically result from the combination of airway 
irritation and anesthetic sedation. Acute asthma and bronchospasm are 
manifested clinically by audible wheezing (more prominent during 
expiration), tachypnea, shortness of breath, and are usually accompanied by 
decreasing oxygen saturation. They represent a hyperreactive process of the 
large airways that results in bronchoconstriction and obstruction to airflow. 
A number of factors may precipitate an asthma attack or bronchospasm, but 
in an oral surgical setting anything that causes airway irritation may be the 
predominant etiologic factor. Some examples include the production of 
aerosols during a procedure or decreased clearance of secretions that can 
irritate the airway and stimulate coughing. Laryngospasm, by contrast, is an 
acute upper airway obstruction that presents with stridor (incomplete 
laryngospasm) or failure of ventilation (complete laryngospasm with total 
closure of the glottis). Obstruction of the upper airway due to foreign body 
aspiration may also present with acute stridor and should be ruled out 
clinically. Laryngospasm results in reflexive closure of the glottis upon 
irritation and is a protective airway reflex. It does not occur in awake 
patients or in patients during general anesthesia, but can occur in a mild or 
moderate stage of sedation. Acute asthma attacks may be managed with 
inhaled beta-2-agonist bronchodilator medications such as albuterol. These 
drugs are typically administered via a metered-dose inhaler (MDI) either 
with or without an additional spacer device. Patients who are awake and 
alert may be allowed to self-administer the inhaled medication, while 
patients who are sedated may need assistance. In sedated patients, the use 
of a spacer may be particularly useful to assist delivery of the drug to the 
lungs and to prevent excess drug deposition in the oropharynx where it is 
has no therapeutic effect. Inhaled bronchodilators are also the first choice 
153 
 
treatment for bronchospasm and are administered similarly. In intubated 
patients these inhaled medications may be administered via ET tube or 
LMA, though the dosage must be greatly increased (up to 10 to 20 puffs) to 
account for the large amount of drug that coats the airway tube and does 
not reach the lungs. Both acute asthma and bronchospasm benefit from 
supplemental oxygen. In severe cases that do not respond to inhaled beta-
agonists, intravenous or subcutaneous epinephrine may be considered as a 
rescue therapy. The adverse effects of epinephrine-particularly tachycardia 
and increased blood pressure-limit its use for reactive airway disease. It 
should be used with extreme caution, if at all, in patients with underlying 
cardiac disease.  
The treatment of laryngospasm differs from that of asthma or 
bronchospasm. Because it occurs in patients who are at “lighter” levels of 
anesthesia, deepening the level of anesthesia will help to abolish the 
protective airway reflex and relax the vocal cords to allow the passage of 
air. Positive pressure ventilation, especially when instituted early in the 
course of the laryngospasm, is frequently successful at “breaking” the 
spasm. If it appears that secretions or bleeding in the oropharynx may be 
contributing factors, a brief period of suctioning with a tonsillar (Yankauer) 
suction may be helpful. Care should be taken that this does not delay 
positive pressure ventilation, however, and that the suction itself does not 
serve to further provoke the laryngospasm reflex. If neither deepening the 
anesthesia nor positive pressure ventilation proves successful, the treatment 
of choice for laryngospasm is the administration of the neuromuscular 
blocking agent succinylcholine. Succinylcholine for the treatment of 
laryngospasm is typically given at a dose of 20–40mg initially, with an 
additional 20–30mg given a minute or two later if the first dose proves 
insufficient. This dose is less than the “standard intubating dose” of 
succinylcholine, but whenever a paralytic agent is given, it is safest to 
assume that complete paralysis may occur and the practitioner should be 
prepared to assist the patient’s ventilation until the drug has adequately 
worn off and the patient is ventilating well without assistance. 
 
Aspiration.  
Aspiration refers to the entry of substances such as blood, saliva, 
gastric contents, or foreign bodies into the lungs via inadvertent inhalation. 
Aspiration occurs due to decreased or absent protective airway reflexes and 
is exacerbated by decreased gastroesophageal tone. Patients with 
neuromuscular degeneration or history of stroke are at increased risk as are 
those undergoing sedation and general anesthesia. Additional risk factors 
include gastroesophageal pathology such as GERD (gastroesophageal 
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reflux disease), hiatal hernia, or achalasia, as well as a history of 
esophageal surgery or gastric bypass. The greatest risk from aspiration 
occurs with gastric contents that are due to complications from pneumonia 
(a chemical pneumonia causing damage to the lungs from the low pH of 
gastric fluids and the presence of peptic enzymes) or acute respiratory 
distress syndrome (ARDS). Either passive regurgitation of stomach 
contents or active vomiting during anesthesia can lead to aspiration. Any 
patient who begins to retch or vomit during an anesthetic procedure should 
be placed with their head lowered to prevent aspiration into the lungs, and 
any vomitus should be suctioned carefully from the mouth and oropharynx. 
Patients known or suspected to have aspirated vomitus should have their 
respiratory status carefully monitored as they may require elective 
intubation with lavage and suctioning of the bronchial tree. The role of 
steroids and antibiotic therapy in these patients has been questioned and 
they are not routinely administered. In the absence of signs indicating 
respiratory compromise, management of aspiration is expectant. In the case 
of aspiration of a foreign body, the surgeon may make a careful attempt to 
visualize and retrieve the object if possible. A laryngoscope and MacGill 
forceps may be helpful in this situation. If the object cannot be visualized 
for removal, the patient’s respiration should be monitored and supported as 
needed and the patient transferred to a hospital. 
 
Acute Vascular Events. 
Acute vascular events are among the most serious perioperative 
complications and include myocardial ischemia, myocardial infarction, and 
cerebrovascular accident (stroke). Due to the high prevalence of 
cardiovascular and atherosclerotic diseases in adults, complications of this 
nature should be anticipated in any office emergency plan. Myocardial 
ischemia and myocardial infarction are most common in the postoperative 
period and can be related to the surgical procedure, the anesthesia, or both. 
In a very anxious patient with a history of ischemic heart disease, the 
preoperative period presents a risk of acute angina. Risk factors for acute 
vascular events include history of heart disease or cerebrovascular disease, 
increasing length and invasiveness of surgery, and significant changes in 
heart rate, respiration, or blood pressure due to anesthetic drugs or surgical 
manipulation. Though profound fluctuations in heart rate, blood pressure, 
or respiration should be avoided in any patient, this is critical for 
individuals with underlying risk factors for acute coronary or 
cerebrovascular complications. In these patients, vital signs should be 
maintained close to baseline to avoid hemodynamic decompensation. Acute 
angina is characterized by a sensation of pain, tightness, or crushing in the 
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substernal region of the chest and may be accompanied by shortness of 
breath, anxiety, and diaphoresis. It can be difficult to differentiate acute 
angina from a panic attack or GERD/acute gastritis unless the patient has a 
history of angina episodes. Acute angina should be treated by discontinuing 
any stimulating procedure, administering a dose of sublingual 
nitroglycerin, applying supplemental oxygen via face mask or nasal 
cannula, and continuous monitoring of vital signs. If the pain does not 
subside completely within 10 minutes, a second dose of nitroglycerin may 
be given. Up to three doses of nitroglycerin have been recommended to 
alleviate symptoms of angina, but the surgeon should take into account the 
patient’s medical history and level of distress in deciding when to call EMS 
(emergency medical services). It is recommended that EMS be notified 
immediately and that emergency medical drugs and supplies be readily 
available [advanced cardiac life support (ACLS) protocol] in cases of 
moderate to severe chest pain lasting 30 minutes or more, when the pain 
appears to be getting worse, if two to three doses of nitroglycerin are not 
sufficient to provide relief, and in any patient who is hemodynamically 
unstable. In situations where a myocardial infarction (MI) is suspected, the 
patient should be given 325mg of aspirin (chewed or crushed is preferable 
as it speeds absorption of the drug), sublingual nitroglycerin, and 
supplemental oxygen. If morphine is available, this should be given as 
well, both for pain relief and because it causes peripheral vasodilation, 
which enhances cardiac output. The patient’s vital signs should be 
monitored continuously until EMS arrives, particularly the ECG 
(arrhythmias may accompany myocardial ischemia and can signal 
imminent cardiac arrest) and blood pressure. If the patient deteriorates to a 
situation of cardiac arrest, the ACLS protocol should commence without 
delay. (NB: Adequate and uninterrupted chest compressions are now 
recognized as a key to successful resuscitation efforts. If the patient is in a 
dental chair without a hard, flat back or which does not recline completely, 
it is preferable to place the patient on the floor so that adequately forceful 
chest compressions can be delivered against a firm supporting surface.) The 
management of a patient where stroke/cerebrovascular accident is 
suspected includes notification of EMS and supportive measures. 
Supplemental oxygen should be given and the patient’s vital signs 
monitored. A brief neurological examination may distinguish true 
cerebrovascular complications from confusion or disorientation that may 
result from anesthetic drugs. Aspirin should not be given to a patient 
suspected of suffering a stroke because intracerebral hemorrhage may be 
present. Patients who develop signs of neurocognitive deficit in the setting 
of severe hypertension (systolic >200, diastolic >110mmHg) should be 
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treated with medication to decrease blood pressure. Of the intravenous 
agents, labetalol (a combination alpha- and beta-blocking agent) is 
frequently preferred for the management of acute severe hypertension (see 
the section on hypotension and hypertension). 
 
Cardiac Arrhythmias.  
Cardiac arrhythmias may arise spontaneously or they may be 
associated with myocardial ischemia, respiratory depression, metabolic 
disorders, or other physiological derangements. Some anesthetic agents can 
cause or contribute to arrhythmias, particularly in susceptible individuals. 
Arrhythmias may be divided based on rate into tachyarrhythmias and 
bradyarrhythmias, or based on location of supraventricular ectopic rhythm 
generation versus ventricular arrhythmias. Some cardiac rhythm 
abnormalities such as premature ventricular contractions (PVC) and 
premature atrial contractions (PAC) occur spontaneously in an otherwise 
normal population and require no intervention. Likewise, certain instances 
of tachycardia (mild, associated with anxiety) and bradycardia (due to 
chronic treatment with beta-blockers, or in a competitive athlete) may be 
within acceptable limits. Any arrhythmia that is symptomatic, that carries a 
risk of conversion to a more dangerous cardiac rhythm, or that is 
accompanied by hemodynamic instability should be promptly addressed, 
however. If the arrhythmia is attributable to an underlying physiologic 
disturbance, efforts should be made to treat the underlying condition. 
Otherwise, the management strategies for cardiac arrhythmias include 
pharmacologic interventions or cardioversion/ defibrillation.  
Tachycardia due to stress, anxiety, or pain usually responds to a 
deepening of anesthesia and additional analgesia. The administration of a 
beta-adrenergic blocking medication can be considered for refractory cases. 
Selective beta-1 medications are preferred so as to avoid undesirable 
bronchoconstriction. Esmolol is a beta blocker with a fast onset and short-
acting duration. Metoprolol is another beta-1-selective medication with a 
longer acting-duration. Both are available for intravenous use and may be 
titrated to effect. In general, beta blockers are best avoided in patients with 
low cardiac output states such as acute MI or acute exacerbation of 
congestive heart failure due to negative inotropic effects. When tachycardia 
is secondary to hypotension, hypovolemia, or fever, it is preferable to treat 
the underlying physiological derangement.  
For cases of paroxysmal supraventricular tachycardia, the drug 
adenosine is typically recommended. Supraventricular tachycardias that do 
not respond to drug therapy or wide-complex tachycardia (ventricular 
tachycardia) should be treated with synchronized/unsynchronized 
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cardioversion (electric shock). Cardioversion is also preferred for 
tachycardia associated with hemodynamic instability. Cardiac rhythms 
associated with cardiac arrest, i.e., ventricular fibrillation or pulseless 
electrical activity, should be treated according to the ACLS protocols. 
 
Hypertension and Hypotension. 
During the course of an anesthetic, both hypertension and 
hypotension may be encountered. Hypertension is typically associated with 
patient anxiety, painful stimulus, or anesthesia that is too light. 
Hypertension may also be seen in the hypertensive patient who neglects to 
take their regular antihypertensive medications the day of the surgical 
procedure. Hypertension may be treated by deepening the anesthesia or by 
judicious use of an antihypertensive medication. Labetalol, a combined 
alpha-adrenergic and beta-adrenergic blocker is often preferred, but 
selective beta-blocking agents such as metoprolol or vasodilating agents 
such as hydralazine may also be used. In patients whose baseline blood 
pressure is elevated (above 120/80), it is important not to decrease blood 
pressure too rapidly or profoundly to avoid inducing a decrease in cardiac 
output. Hypotension may also be encountered in the course of an 
anesthetic. Several commonly used medications such as propofol can 
induce a transient decrease in blood pressure, particularly when given as a 
bolus. In a young patient without underlying cardiac disease, small to 
moderate decreases in blood pressure are usually well tolerated. However, 
because hypotension may also be a sign of low volume status or of 
impending cardiovascular collapse, it should be closely monitored and 
treated aggressively when indicated. In pediatric patients particularly, 
hypotension typically precedes cardiac arrest and is an important warning 
sign. Decreasing the anesthetic depth, increasing the rate of IV fluid 
infusion, or giving a bolus of IV fluids are all appropriate first steps in the 
management of hypotension. If these steps are not corrective, a vasopressor 
medication such as ephedrine or phenylephrine may be given while also 
investigating for any causative factors such as an underlying medical 
condition, anaphylaxis/allergic reaction, or increased vagal stimulation. 
 
Nausea and Vomiting. 
Postoperative nausea and vomiting (PONV) is frequently cited as the 
most common complication of anesthesia, and it is one that patients 
frequently complain about. Many drugs used in ambulatory anesthesia are 
potentially capable of causing nausea and vomiting, particularly the 
halogenated gases (isoflurane, halothane, sevoflurane) and 
anticholinesterases. Narcotic medications such as morphine and fentanyl 
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may also cause nausea and vomiting, as do barbiturates. Benzodiazepine 
medications have not been cited as a cause of PONV, and propofol is 
known to have antiemetic properties. In addition to the effects of the 
anesthetic drugs, there are several patient factors that are known to increase 
the risk of PONV. Female gender, obesity, gastroparesis, past history of 
PONV, and a history of motion sickness may all predispose toward nausea 
and vomiting post anesthesia. Dehydration may also be a factor. Prevention 
is an important consideration given that PONV is a frequent cause of 
delayed discharge to home after ambulatory anesthesia procedures. 
Treatment of nausea and vomiting once it occurs is more difficult and less 
successful than efforts at prophylaxis. Avoiding dehydration and 
hypoglycemia by maintaining a reasonable preoperative fasting period and 
giving IV fluids during surgery will benefit most patients. In addition, 
screening prospective patients to identify those at risk of PONV will allow 
the surgeon to consider pharmacological methods of nausea and vomiting 
prophylaxis. Several effective medications are available that can be given 
by mouth or intravenously prior to the procedure in order to prevent and 
treat nausea and vomiting. 
 
Adrenal Crisis. 
Adrenal crisis is a rare but serious complication of suppressed 
adrenal release of cortisol and can rapidly cause hemodynamic collapse if 
the cortisol deficiency is not promptly diagnosed and rectified. Risk factors 
for acute adrenal crisis include both patient and procedure factors. Surgical 
procedures that are invasive and cause high levels of physiologic stress 
carry the highest risk. Patients most at risk for adrenal crisis are typically 
those with a lengthy history of moderate- to high-dose exogenous 
corticosteroid supplementation, though adrenal crisis has been classically 
associated with Addison’s disease (primary adrenocortical insufficiency). 
Since most procedures that will be performed in an out, patient setting will 
be minimally invasive and of short duration, the risk of adrenal crisis is 
low. Patients should be screened for a history of Addison’s disease or 
corticosteroid use, and preoperative adjunctive corticosteroid 
supplementation should be considered for any patient deemed to be at risk. 
Acutely, the management of adrenal crisis involves intravenous cortisol 
administration and supportive measures. 
 
Immunologic complications. 
Hypersensitivity Reactions Hypersensitivity, or allergic, reactions 
are common in the general population and may be produced in the 
ambulatory anesthesia setting by a variety of common substances. Patients 
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with a history of allergic asthma, atopy, or autoimmune disease may be 
most at risk. Mild reactions include urticaria, flushing, and pruritis, while 
more severe reactions can be characterized by angioedema, wheezing, 
nausea and vomiting, or anaphylaxis. The most common complication is a 
localized skin reaction, frequently to an adhesive tape used to secure an IV 
line, for example. Some of the medications used in ambulatory anesthesia 
(propofol or succinylcholine) have been implicated in allergic reactions, 
but this is generally rare. Likewise, a true allergy to local anesthetic agents 
is very infrequent. Most hypersensitivity reactions will be mild and can be 
managed symptomatically. More serious reactions involving angioedema 
or a skin rash covering the full body require more aggressive management 
such as the use of an antihistamine drug (e.g., diphenhydramine) and 
possibly corticosteroids. Angioedema or other acute allergic facial swelling 
should be carefully monitored for the development of airway compromise – 
an unlikely but possible sequela.  
 
Anaphylactic Reaction. 
Anaphylactic and anaphylactoid reactions result from systemic 
release of mediators from mast cells and basophils. Again, anaphylactoid 
reactions are chemically and clinically indistinguishable from anaphylactic 
reactions except that they are not IgE mediated. These mediators consist of 
preformed substances stored in the granules of mast cells and basophils 
(e.g., histamine, tryptase, heparin, chymase, and cytokines), as well as 
newly synthesized molecules that are principally derived from the 
metabolism of arachadonic acid (e.g., prostaglandins and leukotrienes). 
Anaphylaxis occurs in an individual after reexposure to an antigen to 
which that person has produced a specific IgE antibody. The antigen to 
which one produces an IgE antibody response that leads to an allergic 
reaction is called an allergen. The IgE antibodies produced may recognize 
various epitopes of the allergen. These IgE antibodies then bind to the high-
affinity IgE receptor (FcεRI) on the surface of mast cells and basophils. 
Upon reexposure to the sensitized allergen, the allergen may cross-link the 
mast cell or basophil surface-bound allergen-specific IgE resulting in 
cellular degranulation as well as de novo synthesis of mediators. Histamine 
is thought to be the primary mediator of anaphylactic shock. Many of the 
signs and symptoms of anaphylaxis are attributable to binding of histamine 
to its receptors; binding to H1 receptors mediates pruritis, rhinorrhea, 
tachycardia, and bronchospasm. On the other hand, both H1 and H2 
receptors participate in producing headache, flushing, and hypotension. 
In addition to histamine release, other important mediators and 
pathways play a role in the pathophysiology of anaphylaxis. Metabolites of 
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arachadonic acid, including prostaglandins, principally prostaglandin D2 
(PGD2) and leukotrienes, principally leukotriene C4 (LTC4), are 
elaborated by mast cells and to a lesser extent basophils during anaphylaxis 
and, in addition to histamine, are also thought to be pathophysiologically 
important. PGD2 mediates bronchospasm and vascular dilatation, principle 
manifestations of anaphylaxis. LTC4 is converted into LTD4 and LTE4, 
mediators of hypotension, bronchospasm, and mucous secretion during 
anaphylaxis in addition to acting as chemotactic signals for eosinophils and 
neutrophils. Other pathways active during anaphylaxis are the complement 
system, the kallikrein-kinin system, the clotting cascade, and the 
fibrinolytic system.  
Specific lymphocyte subtypes (CD4+ Th2 T-cells) are central in the 
induction of the IgE response. CD4+ T-cells are segregated into either T-
helper 1 (Th1) or Th2 types, defined by the cytokine profile produced by 
the individual T cell. Th1 cells are important in cellular immunity and 
make interferon gamma. Th2 responses are important in humoral immunity 
and critical for the allergic response. Cytokines produced be Th2 cells 
include interleukin (IL)-4, IL-5, IL-9, and IL-13. Of great importance, IL-4 
is the isotype switch factor for B cells to begin producing IgE. The IgE 
response is thought to be an overly robust immune response in certain 
predisposed (atopic) individuals. Multiple factors influence whether one 
produces a Th2 versus a Th1 response including genetic variables, 
environmental factors, and triggers. The hygiene hypothesis suggests that 
exposure to microbes in infancy leads to "immune deviation" from a Th2 
response, which predominates in utero, to a predominantly Th1 response. 
Lack of this "immune deviation" leads to further perpetuation of the Th2 
response to allergens. Stimuli (microbes) that lead to a Th1 response cause 
IL-12 to be produced by antigen-presenting cells. IL-12 not only 
perpetuates the Th1 response but inhibits IgE production. Furthermore, 
cytokines such as interferon gamma (produced by Th1 cells) and IL-18 
(produced by macrophages) suppress production of IgE. Thus the Th1 
response is considered to be inhibitory to allergy.  
Signs and Symptoms.  
The signs and symptoms are highly variable. These are rapidly 
occurring and progressive. There are four major clinical syndromes 
recognised. 
1. Skin reactions. 
2. Smooth muscles spasm (Gastrointestinal tract, genitourinary tract 
and respiratory tract). 
3. Respiratory distress. 
4. Cardiovascular collapse; and loss of consciousness  
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The clinical signs of allergy: such as urticaria, erythema, pruritis or 
wheezing occur before patient collapses. 
Management Initial Therapy. 
An anaphylactic reaction should be treated immediately with an 
injection of epinephrine (adrenaline). Doses, available by prescription, 
come in an auto-injector that should be kept with you at all times. Two 
injections may be necessary to control symptoms. Here are some tips for 
reducing the risk of anaphylaxis: 
Know your trigger. If you have had anaphylaxis, it is very 
important to know what triggered the reaction. An allergist can review your 
medical history and, if necessary, conduct diagnostic tests. The most 
common triggers are: 
Food: including peanuts, tree nuts such as walnuts and pecans, fish, 
shellfish, cow’s milk and eggs. 
Latex: found in disposable gloves, intravenous tubes, syringes, 
adhesive tapes and catheters. Health care workers, children with spina 
bifida and genitourinary abnormalities and people who work with natural 
latex are at higher-risk for latex-induced anaphylaxis. 
Medication: including penicillin, aspirin and non-steroidal anti-
inflammatory drugs such as ibuprofen, and anesthesia. 
Insect sting: with bees, wasps, hornets, yellow jackets and fire ants 
being the most likely to trigger anaphylaxis. 
Avoid your trigger. Avoidance is the most effective way to prevent 
anaphylaxis. An allergist can work with you to develop specific avoidance 
measures tailored specifically for your age, activities, occupation, hobbies, 
home environment and access to medical care. Here are some general 
avoidance techniques for common triggers: 
Food allergies. Be a label detective and make sure you review all 
food ingredient labels carefully to uncover potential allergens. When eating 
out, ask the restaurant how food is prepared and what ingredients are used. 
If you have a child with a history of anaphylaxis, it’s imperative to make 
sure that school personnel are informed of the child’s condition and a 
treatment plan is provided, including the administration of epinephrine. 
Medications. Make sure all of your doctors are aware of any 
reactions you have had to medications so that they can prescribe safe 
alternatives and alert you to other medications you may need to avoid. If 
there are no alternative medications, you may be a candidate for 
desensitization, a treatment that introduces a small dose of the medication 
you are allergic to. As your body becomes more tolerant to the medication, 
the dosage can be increased over time. While the treatment is effective, it is 
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only temporary and must be repeated if the medication is needed again in 
the future. 
Insect stings. To help prevent stinging insects, avoid walking 
barefoot in grass, drinking from open soft drink cans, wearing bright 
colored clothing with flowery patterns, sweet smelling perfumes, 
hairsprays and lotion during active insect season in late summer and early 
fall. An allergist can also provide a preventative treatment called venom 
immunotherapy (or venom allergy shots) for insect sting allergy. The 
treatment works by introducing gradually increasing doses of purified 
insect venom, and has been shown to be 90 to 98 percent effective in 
preventing future allergic reactions to insect stings. 
Be prepared. Prompt recognition of the signs and symptoms of 
anaphylaxis is critical. If you unexpectedly come into contact with your 
trigger, you should immediately follow the emergency plan outlined by 
your doctor including the self-administration of epinephrine. If there is any 
doubt about the reaction, it is generally better to administer the epinephrine. 
Teachers and other caregivers should be informed of children who are at 
risk for anaphylaxis and know what to do in an allergic emergency. 
Seek treatment. If a severe reaction does occur and epinephrine is 
administered, you should be transported to the nearest emergency facility 
by ambulance for additional monitoring. 
Tell family and friends. Family and friends should be aware of your 
condition, your triggers and know how to recognize anaphylactic 
symptoms. If you carry epinephrine, alert them to where you keep it and 
how to use it. 
Wear identification. Wear and/or carry identification or jewelry 
(bracelet or necklace) noting condition and offending allergens. 
See a specialist. Allergists have the training and expertise to review your 
allergy history, conduct diagnostic tests, review treatment options and teach 
avoidance steps. 
The following steps should be taken rapidly: 
1. Stop the triggering agent/drug.  
2. Administer O2 (100%). 
 3. Position the patient supine with legs slightly elevated.  
4. Give Basic Life Support (BLS) (ABC of Resuscitation).  
5. Call for medical assistance.  
6. Administer epinephrine IM-IV (0.3-0.5 mg of 1:1000 for adults) 
immediately, or subcutaneous (SC) or intravenous (IV). Epinephrine is the 
mainstay of the initial pharmacotherapy.  




Secondary Therapy  
1. Administration of antihistaminic. If the patient shows signs of 
allergy, give antihistaminics such as IV/IM diphenhydramine 1 mg/kg 
(maximum 50 mg).  
2. If the patient continues to deteriorate, administer glucocorticoids, 
such as: IV hydrocortisone sodium succinate 100 mg, or b. IV 
dexamethasone 8 mg.  
3. CPR, if necessary.  
4. Transfer the patient to a nearby hospital with ICU facilities in an 
ambulance, as soon as possible. 
Сomplications of anaphylactic shock 
Anaphylactic shock is extremely serious. It can block your airways 
and prevent you from breathing. It can also stop your heart. This is due to 
the decrease in blood pressure that prevents the heart from receiving 
enough oxygen. 
This can contribute to potential complications such as: 
• brain damage 
• kidney failure 
• cardiogenic shock, a condition that causes your heart to not 
pump enough blood for your body 
• arrhythmias, a heartbeat that is either too fast or too slow 
• heart attacks 
• death 
In some cases, you will experience a worsening of pre-existing 
medical conditions. 
This is especially true for conditions of the respiratory system. For 
example, if you have COPD, you may experience a lack of oxygen that can 
quickly do irreversible damage to the lungs. 
Anaphylactic shock can also permanently worsen symptoms in 
people with multiple sclerosis. 
The sooner you get treatment for anaphylactic shock, the fewer 
complications you are likely to experience.  
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TESTS AND TASKS 
 
TOPIC: TYPES OF LOCAL ANESTHESIA, LOCAL 
ANESTHETIC IN DENTISTRY 
Tests 


















 5. What is the maximum single dose for 2% novocaine solution? 
1) 20-25 ml. 
2) 30-40 ml. 
3) 30-35 ml. 
4) 25-30 ml. 
5) 10-20 ml. 




4) all true 
 7. What are the main types of carpool syringes? 
1) to the side and front-loading 
2) with vertical load 
3) with a front-loading, horizontal 
 8. Which factor affects the onset of anesthetic action? 
1) protein binding 




4) non nervous tissue diffusability 
5)  pKa 





5) all of the above 
 10. Bevel of the carpool needle can be: 
1) simple, complex, super-cut 
2) direct, blunt, sharp 
3) oblique, longitudinal, transverse 
4) short, medium, long, multi bevel 
Answers: 1-1; 2-2; 3-1,3,4; 4-3; 5-1; 6-2; 7-3; 8-4,5; 9-5; 10-1. 
 
Tasks 
Task №1. The child is 3 years old and 12 kg weight.  
What rules for choice the anesthetic and its dose for local anesthesia 
do you know? 
Task №2. Doctor used the amide anesthetic from thiophene group. 
Anesthesia occurs within 0,5-3 min, quickly removed from the body. It is 
used for infiltration and block anesthesia. Rarely cause allergic reactions. It 
does not cross the blood-placenta barrier. 
What kind of anesthetic from amide group in the question? 
Task №3. The patient came to the dentist and warned that one month 
ago he had a heart attack. What is the tactics of the dentist? What is the 
anesthetic of choice? 
Task №4. Lidocaine infiltration anesthesia in the mandible was 
conducted to the patient. His somatic diseases are hypothyroidism and 
tachycardia. The concentration of adrenaline in the cartridge with 
anesthetic is 1:50 000. 
What mistakes were made for the anesthesia? 
Task №5. Pregnant woman turned to oral surgeon for mandibular 
nerve block anesthesia. 
What anesthetic should be used for anesthesia? 







TOPPIC: INFILTRATION ANESTHESIA IN 
MAXILLOFACIAL REGION 
Tests 





2. Contraindications to the use of dicain ™ are: 
1) children under 5 years; 
2) children under 10 years; 
3) severe general status; 
4) all of the above mentioned  is not true. 





4. What are the target for intraosseous spongy anesthesia: 
1) area of projection of apex of tooth 
2) interdental septum 
3) no right answer 
5. The duration of intrapulpal anesthesia is: 
1) 1-2 min; 
2) 2-5 min; 
3) 5-7 min; 
4) 7-10 min. 
6. The topical anesthesia is used for manipulation on: 
1) mucosa; 
2) skin; 
3) hard tissues of the tooth;  
4) pulp. 
7. What are the requirements for topical anesthetic? 
1) deep penetration into the tissue; 
2) lack of irritation; 
3) stability in solutions; 
4) no right answer 
8. Contraindications for intraligamentary anesthesia are: 
1) subgingival calculus; 
2) periodontal inflammation; 
3) cervical caries; 
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4) enamel hypoplasia. 
9. The advantages of infiltration analgesia: 
1) absence of large nerve and vessels in injection area; 
2) large area of anesthesia; 
3) small amount of solution; 
4) rapid pain relief. 
10. The benefits of intraligamentary anesthesia are: 
1) it is painless; 
2) the possibility of dental treatment in 4eh quadrants during one visit; 
3)longer analgesia compared with conduction anesthesia; 
4) all of the above is true. 
11. What amount of anesthetic we can use for intraligamentary anesthesia: 
1) 0,1-0,2 ml; 
2) 0,4-0,5 ml; 
3) 0,5-0,7 ml. 
Answers:1-1,2,3,4; 2-1; 3-1,2,4; 4-1; 5-1; 6-1,2; 7-1,2,3; 8-1,2; 9-1,4; 
10-1,2; 11-1. 
Tasks 
Task №1. Topic anesthesia was used for 16th tooth extraction. 
Decayed tooth had no mobility. Patient fell acute pain during extraction.  
Was anesthesia chosen correctly? When you can use topic anesthesia? 
Task №2. Apical anesthesia with Ultracain™ was used for 13th tooth 
extraction. Patient felt pain at the injection site the next day after 
extraction. What was the reason of the pain? How to avoid it? 
Task №3.  Minimum duration of 11th, 25th and 44th teeth endodontic 
treatment is necessary for the patient. What type of anesthesia is most 
suitable in this case and why? 
Task №4. Intrapulpal injection anesthesia was used for 12th tooth 
endodontic. The patient felt pain during the pulp extirpation. Why this 
anesthesia was not effective enough? 
Task №5. Soft tissue infiltration anesthesia was used for the patient 








TOPIC: MANDIBLE NERVE BLOCK ANESTHESIA 
Tests 
1. The area of innervations of Inferior alveolar nerve 
1) pulps of all mandibular teeth from the last molar up to the central incisor 
in the midline 
2) body of the mandible 
3) inferior portion of the ramus of the mandible 
4) buccal mucoperiosteum, in the region of mandibular anteriors, anterior 
to mandibular second premolar or anterior to the mental foramen 
5) skin of the chin, skin of lower lip, and mucosa of lower lip. 
2. The area of innervations of Long buccal nerve 
1) buccal mucoperiosteum in the region of mandibular molars or buccal 
mucoperiosteum posterior to mental foramen 
2) adjacent part of vestibular mucosa 
3) adjacent part of buccal mucosa 
4) mucosa of retromolar fossa. 
5) skin of the chin 
3. Advantages of mental nerve block:  
1) high success rate. 
2) technically easy. 
3) usually entirely atraumatic. 
4) produces pulpal anesthesia, as well as soft and hard tissue anesthesia 
without lingual anesthesia. It is useful instead of bilateral inferior alveolar 
nerve blocks. 
5) it does not produce lingual anesthesia 
4. Indications for Gow-Gates' mandibular nerve block 
1) surgical procedures on mandibular body and the ramus. 
2) when buccal soft tissue anesthesia from the third molar up to the midline 
is required. 
3) surgical procedures in the tongue and the floor of the mouth. 
4) presence of infection or acute inflammation in the area of injection. 
5) patients who might bite either their lip or the tongue, such as young 
children and mentally challenged adults. 
5. Areas anesthetised at Akinosi mandibular nerve block 
1) all mandibular teeth on the side of injection up to the midline. 
2) body of the mandible  
3) posterior portion of the ramus. 
4) buccal mucoperiosteum  
5) lingual soft tissues and periosteum. 
6. Advantages of Akinosi mandibular nerve block 
1) relatively atraumatic. 
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2) patient need not be able to open his mouth. 
3) difficult to visualise the path of the needle and the depth of insertion. 
4) no bony contact, so the depth of penetration is somewhat arbitrary. 
5) potentially painful if the needle is too close to periosteum. 
7. The average depth of soft tissue penetration during Gow-Gates' 
mandibular nerve block is  
1) 10 mm 
2) 15 mm 
3) 25 mm 
4) 35 mm 
5) 40mm 
Answers: 1 – 1,2,3,4,5; 2 – 1,2,3,4; 3 – 1,2,3,4; 4 – 1,2,3; 5 – 1,2,4,5; 
6 – 1,2; 7 – 3 
Tasks 
Task №1. When performing regional anesthesia in the mandible the 
patients has no feeling in right cheek, half of the lower lip, skin of the chin, 
gums with vestibular side. What type of anesthesia was used? 
Task №2. The patient has difficulty opening the mouth – 
inflammatory contracture. What kind of anesthesia he needs? 
Task №3. In the case of mandibular nerve block anesthesia has not 
come. What mistakes were made during anesthesia? 
Task №4. To remove the 41tooth doctor used pterygomandibular 
nerve block. Complete pain relief is not due. What is the reason? 
Task №5. Infiltration anesthesia in the mandible proved to be 
inefficient. What will you do?  
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TOPIC: MAXILLA NERVE BLOCK ANESTHESIA  
Tests 
1. What nerve is not a part of the maxillary nerve?  
1) zygomatic  
2) inferior alveolar  
3) pterygopalatine  
4) infraorbital 
2. What block do you administer to anesthetize the palatal gingiva of 
the maxillary posterior teeth? 
1) Greater Palatine Block 
2) Buccal Block 
3) Inferior Alveolar Block  
4) Nasopalatine Block  
5) Anterior Superior Alveolar Block  
6) Infraorbital Block 
3. What block do you administer to anesthetize the palatal gingiva of 
the maxillary anterior teeth? 
1) Infraorbital Block 
2) Inferior Alveolar Block  
3) Nasopalatine Block. 
4) Buccal Block 
5) Anterior Superior Alveolar Block  
4. What block do you administer to anesthetize the labial gingiva of 
the maxillary anterior teeth? 
1) Anterior Superior Alveolar Block  
2) Inferior Alveolar Block  
3) Nasopalatine Block. 
4) Buccal Block 
5) Infraorbital Block 
5. What block do you administer to anesthetize the pulpal tissue of the 
maxillary molars? 
1) Anterior Superior Alveolar Block  
2) Inferior Alveolar Block  
3) Nasopalatine Block. 
4) Posterior Superior Alveolar Block (except for the MB root of the 1st 
molar which would be anesthetized by the Middle Superior Alveolar 
Block). 
5) Infraorbital Block 
6. What block do you administer to anesthetize the pulpal tissue of the 
maxillary premolars? 
1) Middle Superior Alveolar Block 
171 
 
2) the Infraorbital Block   
3) Nasopalatine Block. 
4) Buccal Block 
5) the Anterior Middle Superior Alveolar Block. 
7. What block do you administer to anesthetize the pulpal tissue of the 
maxillary anterior teeth? 
1) Anterior Superior Alveolar Block  
2) the Infraorbital Block  
3) the Anterior Middle Superior Alveolar Block. 
4) Buccal Block 
5) the Anterior Middle Superior Alveolar Block. 
Answers: 1 – 2; 2 – 1; 3 – 3; 4 – 1,3,5; 5 – 4; 6 – 1,2,5; 7 – 1,2,3,5 
 
Tasks 
Task №1. I innervate the lingual gingiva of the mandibular teeth from 
the midline all the way posteriorly. Who am I? 
Task №2. I am the maxillary first molar. I was not cared for properly, 
and now I am destroyed and need to be taken out. How can you put me to 
sleep so I don't feel any pain while I am being taken out? Please don't 
forget that I have 3 legs. 
Task №4. We are the maxillary anterior teeth. We have deep pockets 
on our lingual gingiva that need to be cleaned. How can you help us to go 
through the process without pain? 
Task №5. We are number 1, 2, and 3. We need periodontal treatment 
on our buccal gingiva. Which nerve will you anesthetize to block the pain? 
And where do you think you should inject your needle to reach that nerve? 
Task №6. I'm the beautiful right maxillary central incisor. I need a 
cosmetic filling on my lingual face. The doctor tried to put me to sleep but 
I still have some pain. What do you think he forgot to do? 
Task №7. I innervate the pulp tissues of the maxillary incisors and 




TOPIC: LOCAL COMPLICATIONS OF INJECTING 
ANESTHESIA IN MAXILLOFACIAL SURGERY 
Tests 
1. What is the most commonly injured muscle during a maxillary 
posterior injection? 
1) External Lateral pterygoid muscle 
2) Medial Pterygoid muscle 
3) Medium Pterygoid muscle 
4) m. masseter  
5) m. mylohyoideus 
2. What reasons could be for failed anaesthesia? 
1) inaccurate anatomical placement 
2) too little solution 
3) needs more time 
4) inflammation or infection 
5) expired or improperly stored LA 
3. Where could pain from injection come from? 
1) needle puncture (use topical and a steady hand) 
2) pressure of solution (work slower) 
3) temperature of solution (room temp = less pain) 
4) pH of solution  
4. Which technique of local anesthesia produced the greatest number 
of needle breakage? 
1) Greater Palatine Block 
2) Nasopalatine Block  
3) Anterior Superior Alveolar Block  
4) Infraorbital Block 
5) Inferior Alveolar Nerve Block 
5. A prolonged, tetanic spasm of the jaw muscles by which the 






6. What is the cause of facial nerve paralysis? 
1) needle puncture (use topical and a stead hand) 
2) pressure of solution (work slower) 
3) injection into the parotid gland (too far posterior) 
4) Temperature of solution (room temp = less pain) 
5) too little solution 
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7. In what size needle does most breakage occur? 
1) 30-gauge short 
2) 60-gauge short 
3) 40-gauge long 
4)70 -gauge short 
5) 48-gauge long 
Answers: 1 – 1; 2 – 1-5; 3 – 1, 2, 3, 4; 4 – 5; 5 – 2; 6 – 3; 7 – 1 
 
Tasks 
Task №1. How can you avoid broken needles during anesthesia? 
Task №2. What happened if you see blanching patient face after 
anesthesia? 
Task №3. What are some bizzare neurologic symptoms after local 
anesthetic use and why do they occur? 
Task №4. What are the main problems that can occur due to local 
anesthetic cartridge problems? 





TOPIC: GENERAL ANESTHESIA IN MAXILLOFACIAL 
SURGERY 
Tests 
  1. Barbiturates: Properties: 
1) sedative 
2) hypnotic (truth serum) 
3) anticonvulsant 
4) euthanasia agent 
5) general anesthetic: induction and maintenance 
  2. Propofol: Disadvantages 
1) no preservative 
2) hypotension 
3) potent respiratory depressant 
4) pain on injection 
5) myoclonic twitching 







  4. General Anesthesia is 
1) state of controlled and reversible unconsciousness 
2) lack of pain sensation  
3) lack of memory  
  5. General anesthesia is characterized by 
1) lack of pain sensation (analgesia) 
2) lack of memory (amnesia) 
3) relatively depressed reflex responses 





  7. What is endotracheal intubation: 
1) place a breathing tube in patient's airway 
2) place a wire in patient's airway 
 8. Advantages of endotracheal intubation? 
1) allows efficient delivery of gas to animal 
2) improves efficiency of respiration by decreasing dead space  
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3) can deliver O2 and provide positive pressure ventilation if need to assist 
respiration 
4) reduce risk of aspiration 
  9. Sedation is:  
1) a medication given to reduce a client's anxiety and ease induction of 
general anesthesia 
2) relatively depressed reflex responses 
3) state of controlled and reversible unconsciousness 
Answers: 1 – 1-5; 2 – 1-5; 3 – 1-6; 4 – 1; 5 – 1-3; 6 – 1-4; 7 – 1; 8 – 
1-4; 9 – 1. 
 
Tasks 
Task №1. Patient N. is admitted to dental department of hospital. 
Diagnosis is phlegmon of the mouth floor. Swallowing, breathing,  speech 
are difficult. It is required to make primary surgical debridement of 
suppurative focus. What method of anesthesia should you choose? 
Task №2. The patient is indicated to extract tooth 46 because of 
extensive caries. The doctor has chosen phlebonarcosis. Has he made the 
right decision? 
 Task №3. During the ectomy of mandible for osteoblastoclastoma 
multicomponent combined anesthesia with fentanyl, tubocurarine, 
droperidol was used. The patient came suddenly stop breathing in 10 hours 
after the operation. What was the reason? 
 Task №4. Patient M. is scheduled for extraction of impacted 38 
tooth. What method of anesthesia should you choose? 
 Task №5. Within 3 minutes after the use of inhaled ether 
anesthesia the patient lost algesthesia however, the patient stayed 




TOPIC: INDICATIONS AND CONTRAINDICATIONS FOR 
TOOTH EXTRACTION 
Tests 
1. Indications for tooth extraction: 
1) preparation for orthodontic treatment  
2) teeth in the fracture line 
3) teeth which cannot be restored endodontically 
4) fractured teeth 
5) supernumerary, supplementary or malformed teeth 
2. When can you extract the tooth after patient heart attack 
(infarction)? 
1) 1 year later; 
2) 1 month; 
3) after 3-6 months; 
4) 2 months later. 
3. What is an absolute indication for tooth extraction? 
1) impacted teeth; 
2) odontitis of three 3 molars; 
3) spread of periodontal inflammation; 
4) incorrect setting of tooth in the dental arch ; 
5) traumatic oral mucosal lesions from teeth 
4. What trimesters of pregnancy are common relative 
contraindication for tooth extraction? 
1) 1 and 2 trimesters; 
2) 1 and 3 trimesters; 
3) 2 and 3 trimesters 
5. What are the local relative contraindications for surgery tooth 
extraction? 
1) acute infectious diseases of the mouth and throat mucous membrane; 
2) tooth localization in the area of cancer; 
3) deciduous teeth in the area of absence of permanent teeth; 
4) premature removal of deciduous teeth. 
6. What local absolute contraindications for tooth extraction do you 
know? 
1) premature removal of deciduous teeth; 
2) area of the jaw hemangioma; 
3) the tooth location in the area of cancer; 
4) acute infectious diseases of the mouth and throat mucous membrane. 
7. In which clinical cases the tooth extraction can be done if the 
pulp is preserved? 
1) carious lesions; 




3) later stages of the marginal periodontitis; 
4) fracture of the tooth crown. 
8. In which clinical cases the wisdom tooth extraction is indicated? 
1) carious lesion of  wisdom tooth; 
2) wisdom teeth take the wrong position in the jaw; 
3) wrong position  lead to  inflammatory processes in the surrounding 
tissues; 
4) in any cases. 
Answers: 1 – 1,2,3,4,5; 2 – 3; 3 – 3; 4 – 2 ; 5 – 1,3,4; 6 – 2,3; 7 – 4; 
8 – 3. 
 
Tasks 
Task №1. 64 years old patient X. suffered from myocardial 
infarction 2 weeks ago and needs of oral cavity sanitation. What is the 
doctor's tactics? 
Task №2. 21 years old patient X. appealed for help to the dentist for 
removal and further prosthesis of 12th, 11th, 21th, 22th teeth. Complaints 
are aesthetic defects (abnormal dentition, disfiguring smile). After 
examination of the oral cavity doctor revealed acute gingivitis. What will 
be the patient's treatment plan? 
Task №3. A woman at 34th week of pregnancy ask the doctor to 
extract destroyed 26th tooth, acute periodontal inflammation is absent. 
What decision the doctor will be right?  
Task №4. 56 years old patient complains of pain in 47th tooth when 
biting down on food, the tooth is after endodontic treatment. On X-ray: 
big granuloma is in the apex of medial root, instrument’s fragment is in 
the channel. What is your tactic? 
Task №5. The patient ask to remove the destroyed 26th tooth. The 
mucous membrane of the alveolar bone in the area of 23th, 24th, 25th, 26th 
ulcerated. The patient noted an increasing the ulcer during the last month. 




TOPIC: TOOLS AND METHODS FOR TOOTH EXTRACTION 
Tools and methods for tooth extraction in the mandible 
Tests 
1. Features describing forceps for tooth extraction in the lower jaw: 
1) indication of the angle; 
2) indication of bending handles; 
3) indication of the parties; 
4)  cheeks width; 
5) handle width. 
2. What tooth you can extract by using the forceps curved in a plane? 
1) mandibular incisors 
2) mandibular molars 
3) molars of the upper jaw 
3. The level of patient's head for maxillary extraction is: 
1) at the operator's elbow level; 
2) at the operator's shoulder level; 
3) at the operator's eye level. 






6) tooth extraction. 
5. What is the purpose of the surgical squeezes the cavity after tooth 
extraction? 
1) to promote the formation of a blood clot; 
2) to bring together the edges of the hole and give them initial position; 
3) after this action small fragments of bone tooth roots come out. 
6. When the alveolar socket is covered with epithelium after tooth 
extraction? 
1) after 1 month; 
2) after 7th day; 
3) after 14th day. 
7. What is the level of the alveolar socket resorption occurs after the 
removal? 
1) ⅓ of the root length; 
2)  ½ of the root length; 
3) it is not occur. 
8. What forceps is need for the 38th, 48th teeth extraction by 
orthodontic indications? 
1) universal bayonet forceps; 
2) coronoid forceps with diverging cheeks; 
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3) straight elevator; 
4) forceps, curved in the plane. 
9. What is the aim of circular ligament separation during tooth 
extraction? 
1) to avoid the alveolar mucous membrane injury; 
2) to avoid the tongue injury; 
3) to avoid maxillary fracture; 
4) to avoid mandibular fracture. 
10. The tooth was removed with forceps diverging cheeks, bent in a 
plane, with spikes: 
1) upper molar; 
2) lower incisor; 
3) roots of lower molar; 
4) third lower molars with limited mouth opening. 
Answer: 1 – 1,2,3,4; 2 – 3; 3 – 1; 4 – 1,2,3,4,5,6; 5 – 2; 6 – 3; 7 – 1; 8 
– 4; 9 – 1; 10 – 4. 
Tasks 
Task № 1. 35 years old patient complains of pain in the right lower 
jaw and difficulty in opening the mouth for two weeks. The 48th is 
completely destroyed, takes buccal position, right cheek mucosa is 
hyperemic and edematous. There is 1 cm traumatic ulcer. What is tactics of 
the doctor? 
Task № 2. It was necessary to extract the 43th tooth. The doctor 
decided to use coronoid forceps with spikes on both cheeks. Is it right 
decision? 
Task № 3. It was necessary to extract the 37th tooth. The doctor used 
coronoid forceps curved in the plane, without spines; doctor was on the left 
side of the patient and in front of the patient during operation. Is it true 
tactics of the doctor? 
Task № 4. It is necessary to extract the 32th tooth root. Doctor is 
going to use beaked forceps with narrow open cheeks without thorns? Is it 
right decision? 
Task № 5.  35th tooth was extracted because of acute purulent abscess 
of the mandible. What advice should be given to the patient? 
 
Tools and methods for tooth extraction in the maxilla 
Tests 
1. For the extraction of maxillary tooth the patient’s mouth should be: 
1) at the same height as the dentist’s elbow; 
2) at the same height as the dentist’s shoulder; 
3) at the same height as the dentist’s eyes. 
2. For the extraction of anterior mandibulary teeth right-handed 
dentists should be positioned: 
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1) in front of the patient; 
2) behind the patient and on the left side of the patient; 
3) behind the patient and on the right side of the patient. 
3.  For the extraction of mandibulary tooth the patient’s mouth should 
be: 
1) at the same height as the dentist’s elbow; 
2) at the same height as the dentist’s eyes; 
3) at the same height as the dentist’s shoulder. 
4. What is the first step of a tooth extraction by using the simple 
technique? 
1) tooth luxating; 
2) forceps positioning; 
3) separation of round ligament. 
5. The first luxation movement of 16, 26 extraction must be done: 
1) buccaly; 
2) palatally; 
3) it doesn’t matter; 
4) lingually. 





4) it doesn’t matter. 
7. Which forceps should the doctor choose to extract the maxillary 
second molar? 
1) straight forceps; 
2) Bayonet forceps; 
3) S-shaped forceps; 
4) Beak-shaped forceps. 




3) it doesn’t matter; 
4) luxating. 
9. What instruments should the doctor choose to sever the soft tissues 
attachment? 
1) dental probe; 
2) plier; 




5) curved desmotome. 
10. What kind of local anesthesia should be done to remove the upper 
molars? 
1) Inferior Alveolar block; 
2) Posterior Superior Alveolar block; 
3) Nasopalatine block; 
4) Greater Palatine block. 
Answers: 1 – 2; 2 – 1, 3; 3 – 1; 4 – 3; 5 – 2; 6 – 3; 7 – 3; 8 – 2; 9 – 3, 
5; 10 – 2, 4. 
Tasks 
Task 1. The crown of 1.7 tooth was broken off  at the gum line 
during  the tooth extraction. What is the possible cause of the 
complication? 
Task 2. Patient complains of pain and 2.7 tooth mobility. Objectively: 
tooth mobility is the second degree, tooth roots exposed to 1/3 of its length. 
Diagnosis: exacerbation of chronic marginal periodontitis of tooth 27. The 
tooth needs to be extracted. Which instruments should you choose? 
Task 3. It is necessary to extract the 16 tooth. Dentist’s position is 
right in front of patient, the patient’s head is at the same height as the 
dentist’s elbow. What is the dentist’s mistake? 
Task 4. It is necessary to extract the 23 tooth because of extensive 
caries. The doctor use the beak-shaped forceps, with spikes on both cheeks. 
Is it a right decision? 
Task 5. Patient A. 35 y.o. complains of pain in the left part of the 
lower jaw, pain and difficulty while opening the mouth during a 2-week 
period. Objectively – the mouth opens for 2 cm, 38 is full erupted, the 
cheek mucous on the left side is hyperaemic, hydropic, with a traumatic 
ulcer up to 1 cm. What is the doctor’s tactics? Which instruments should be 
used?  
Task 6. A 30-year-old patient needs to have his 26 tooth extracted 
because of exacerbation of chronic periodontitis. Objectively: the crown of 






TOPIC: SURGICAL TOOTH EXTRACTION 
Tests 
1. In which cases doctor should fill the tooth socket by gauze? 
1) after a difficult tooth extraction to the prevention of infection. 
2) there is the perforation of sinus maxillaris 
2. What tools should be used when the roots of the tooth are 
disconnecting? 
1) corner elevator 
2) straight elevator 
3) flat chisel 
3. What is a surgical tooth extraction? 
1) tooth extraction by using elevator ore  tooth has to be cut out of the bone 
with a shearing muco-periosteal flap. 
2) tooth extraction using forceps 
3) apexectomy  
4. What is the purpose of suturing extraction socket? 
1) avoid getting food stuck in the extraction socket 
2) with a view to the correct positioning torn mucosa and (or) hold the 
blood clot. 
3) for accelerating bone formation. 
5. Straight elevator is used to remove teeth of: 
1) upper jaw 
2) mandible 
6. Which elevator is used to remove the 3.7 medial root if the distal 
root is absent? 
1) left side 
2) right side 
 7. What type of anesthesia can be used to removing R2.3? 
1) intraligamentary 
2) infiltration 
3) mandibular nerve block anesthesia 
 8. Which instrument is used for peeling off muco-periosteal flap for 




4) nipper Luer 
 9. Intravenous sedation is rarely used with the tooth surgical 
extraction because it: 
1) does not provide complete pain relief 
2) causes swallowing disorders 
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3) causes possible ingress of blood in the respiratory tract 
4) is very expensive  
 10. The elevator can be used: 
1) only for roots extraction  
2) only for wisdom teeth extraction  
3) for roots and teeth extraction 
Answers: 1 – 1,2; 2 – 1,2,3; 3 – 1; 4 – 1,2,3; 5 – 1,2; 6 – 1; 7 –1,2; 8 – 
2,3; 9 – 2; 10 – 3. 
Tasks 
Task №1. The tooth 4.8 needs to be extracted because of chronic 
granulomatous periodontitis. The top of the crown and root of 1/3 has 
broken off during tooth extraction. What is the tactic of the doctor? What 
tools should you use? 
Task №2. During 2.6 tooth extraction root fracture at the middle third 
occurred. What is the tactic of the doctor?  
Task №3. During 1.1 tooth extraction root fracture at the apical third 
occurred. What are the actions of the doctor? What tools and methods will 
be used in this case? 
Task №4. A 24-year-old woman consulted a dentist about pain in the 
26 tooth. After a physical examination of the patient the exacerbation of 
chronic periodontitis of the 26 tooth was diagnosed. During the tooth 
extraction the coronal part of the tooth was accidentally broken. Further 
manipulations with bayonet forceps failed to extract the tooth roots. What 
actions can be taken for the successful root extraction? 
Task №5. The 3.6 tooth crown was fractured During the  tooth 






TOPIC: COMPLICATIONS ASSOCIATED WITH 
DENTOALVEOLAR SURGERY 
Local complications during the tooth extraction  
Tests 
 1. What types of physical treatment of alveolitis do you know? 
1) microwave therapy 
2) Ultra-violet radiation 
3) helium-neon laser 
 2. When is alveolitis occurrence after tooth extraction? 
1) 10-12 days 
2) 1-2 days 
3) 3-4 days 
4) week later 
 3. What are the reasons of a mandibular fracture during a tooth 
extraction? 
1) rough surgical technique 
2) pathological process in the area of the tooth  
3) rough bringing  together of the edges of the tooth alveoli  
4) alveolar process atrophy 
 4. What are the reasons of primary bleeding from tooth socket during 
tooth extraction: 
1) injury of vessels mucosa 
2) injury of alveoli walls 
3) injury of alveolar artery branches 
4) all answers are correct 
 5. The signs of the maxillary sinus perforation are: 
1) profuse bleeding from the tooth socket; 
2) severe pain; 
3) asymptomatic; 
4) profuse bleeding from the tooth socket, the passage of air from the nose 
to the oral cavity, nose bleeding; 
 6. What is the main reason of the late secondary bleeding? 
1) purulent fusion of blood clot 
2) mucosal lesion 
3) vessel lesion 
 7. What blood tests that need to be done before using of common 
methods to stop bleeding? 
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1) Complete Blood Count 
2) Blood Clotting Test 
3) Iron Test 
4) Blood Chemistry Screen 
 8. What drug can be used for increasing blood fibrinolytic activity? 
1) E-aminocapronic acid (2-3 g 3-5 times a day or 100 ml of 5% solution 
intravenously) 
2) epinephrine solution 
3) tetracycline  
 9. What local complications can occur after tooth extraction? 
1) bleeding from tooth extraction socket; 
2) alveolitis; 
3) local osteomyelitis of the tooth socket; 
4) the root fracture 
 10.  In case of a fracture in the apical third of a root during extraction 
the dentist should: 
1) stop further manipulation to reduce the trauma to surrounding tissues; 
2) remove the tooth in a few days; 
3) to complete the tooth extraction. 
The answers: 1 – 1; 2 – 3; 3 – 1,2; 4 – 1; 5 – 4; 6 – 1; 7 – 1,2; 8 – 1; 9 
– 1,2,3; 10 – 3. 
Tasks 
Task №1. There was a fracture of the tooth root in the apex region 
when removing the tooth 26 on the dislocation stage. What are the reasons 
of this complication, treatment and prevention.  
Task №2. During extraction part of the tooth broke off and inhaled. 
What is the tactic of the doctor? 
Task №3. The patient complains for acute pain in front of the tragus 
of the ear during the 4.8 tooth surgical extraction. After extraction the 
patient could not close his mouth. On palpation of the TMJ the mandibular 
condyles is palpated anterior to the articular eminence. What complication 
occurs? What is the tactic of the doctor. 
Task №4. During the 2.3 tooth extraction profuse bleeding from the 
socket begin. What is the possible cause of bleeding? What is the doctor's 
tactic? 
Task №5. During the 1.7 tooth extraction the doctor noticed air 
bubbles in the blood from the tooth socket. Tooth extraction was 
unremarkable. There was hemorrhagic drainage from the socket. What 





Local complications after tooth extraction 
Tests 




4) prolonged effects of nerve damage 
5) dry socket 
6) sequestrum 
7) infected socket 
8) chronic oaf/root in antrum 
9) osteomyelitis 
10) osteoradionecrosis 
11) bisphosphonate induced osteonecrosis  
12) actinomycosis 
13) bacteraemia/infective endocarditis 
2. What can cause limited mouth opening? 
1) surgery - edema, muscle spasm 
2) bleeding into tissue  
3) damage to TMJ 
4) maxillary sinus perforation 
3. What is often the cause of secondary bleeding? 
1) infection 
2) maxillary sinus perforation 
3) tooth fracture 
4) crown fracture 
5) asthma 
4. How can post operative bleeding be managed?? 
1) pressure 
2) local anaesthetic with vasoconstrictor  
3) haemostatic AIDS e.g. surgicel, bone wax  
4) suture socket  
5) ligation of vessels/diathermy 
5. Name some haemostatic agents? 
1) adrenaline containing local anesthetic 
2) oxidised cellulose 
3) gelatin sponge  
4) thrombin liquid and powder 
5) fibrin foam 
6. Name some systemic haemostatic aids: 
1) vit K 
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2) anti-fibrinolytics e.g. tranexamic acid 
3) missing blood clotting factors  
4) plasma or whole blood 
7. What are the other names for dry socket? 
1) alveolar osteitis  
2) localised osteitis 
3) alveolitis 
4) smooth socket 
8. What are the signs of an Oro-antral fistula? 
1) history of upper molar extraction 
2) non-healing socket 
3) dull throbbing pain 
4) pressure feeling up to eye/sinusitis 
5) runny or blocked nose 
9. What are the symptoms for dry socket? 
1) dull aching pain moderate to severe  
2) usually throbs  
3) radiates to ear  
4) keep awake at night  
5) bad odour  
6) bad taste 
10. What are the major predisposing factors to osteomyelitis? 
1) odontogenic infections 
2) fracture of the mandible 
3) hypertension  
The answers: 1 – 1-13; 2 – 1-3; 3 – 1; 4 – 1-4; 5 – 1-5; 6 – 1-4; 7 – 1-3; 8 – 
1-5; 9 – 1-6; 10 – 1,2. 
Tasks 
Task №1. If you think you have displaced tooth into sinus what 
should you do to see if its right in sinus?  
Task №2. If patient returns with post op haemorrhage, what is your 
management? If large vessel and can't stop, what is difference?  
Task №3. Dental prosthetist examined the patient before treatment. 
24, 25, 26 teeth extraction was performed in the patient 2 months ago. Now 
there is a significant deformation of the alveolar crest bone of the upper jaw 
creating bad conditions for the prosthesis fixation and stabilization. What 
mistakes of teeth extraction surgeon did?  
Task №4. The patient was hospitalized with residual cyst of the 
mandible on the right. From history we found out that 4.6 tooth was 




Task №5. The patient underwent surgery gouging dystopic, impacted 
tooth 48. After 3 days post op the patient complains of numbness, tingling 






TOPIC: FEATURES OF LOCAL ANESTHESIA, TOOTH 
EXTRACTION IN MEDICALLY COMPLEX PATIENTS 
Тests 
1. What are the main skin allergy tests for detection specific 
sensibilization ? 
1) intradermal test 
2) open patch test 
3) application anesthesia 
4) benzidine test 
5) aspiration test 





5) bronchial spasm 
6) cardiac arrest 
7) all answers correct 
3. What is the correct definition of anaphylaxis? 
1) is a serious allergic reaction that is rapid in onset and may cause death 
2) is a method for medical diagnosis of allergies that attempts to provoke a 
small, controlled, allergic response 
3) is a sudden and often unannounced loss of postural tone (going weak), 
often but not necessarily accompanied by loss of consciousness. 
4) is a condition characterized by an abnormal focus of activity in the brain 
that produces severe motor responses or changes in consciousness 
4. Which organ is the target of a mediators direct effect in the 






5. List the diseases in which collapse may be one of the symptoms: 
1) cardiac accident 
2) sepsis 
3) blood loss 
4) anaphylaxis 
5) dehydration 








6) all answers correct 
7. List your actions before emergency surgical treatment of patient with 
a high blood pressure: 
1) no actions provided 
2) intravenous injection of 1% adrenalin 
3) 5-10 ml 2,4% euphyllin solution and10 ml 25% magnesium sulfate 
solution intramuscularly. 
 Answers: 1 – 1,2; 2 – 7; 3 – 1; 4 – 4; 5 –1,3,4; 6 – 6; 7 – 3. 
 
Tasks 
Task № 1.  A 45-years-old patient has complaints for the pain in the 
left cheek. The doctor provided exzamination of patient: 38 have uncorrect 
position, in the soft tissues near the 38 the patient has ulcus size 1,5 cm. 
Patient had infarction 1 month ago. What are indications for tooth 
extraction? Your actions? 
Task № 2. The bronchial allergy patient has complaints for the pain in 
the area of destroyed 27 tooth. 27 destroyed for the gum level, vertical 
percussion is painful, palpation the gum of the apix level is also painful. 
What is the most likely diagnosis? Your actions? What kind of anesthetic 
you must to prepare in this clinical case? 
Task №3. A 55-years-old patient has complaints for the pain in the 
mandible left site. The doctor detected indications for 44 root extracrion. 
The patient suffers hepatic cirrhosis. What kind of anesthetic you must to 
prepare in this clinical case? 
Task №4. The patient has orthodontic indications for extraction of 24 
and 14 teeth. The patient suffers hemophilia A. Your actions? 
Task №5. A 35-years-old patient, 26 – apical chronic periodontitis in 






ТOPIC: COMPLICATIONS ASSOCIATED WITH TOOTH 
EXTRACTION. PROVIDING EMERGENCY MEDICAL CARE 
Тests 
1. The patient had an epileptic seizures during a tooth extraction under 
a local anesthetic. What measures should the doctor take? 
1) to take measures to prevent tongue biting 
2) to continue working 
3) to call in an emergency aid team 
4) to measure blood pressure 
2. What is a severe allergic reaction to foreign material? 
1) bronchial asthma attack 
2) anaphylactic shock 
3) hypertensic crisis 
4) asphyxia 
5) collapse 
  3.What are characterized by severe and uncontrolled muscle spams 
or muscle rigidity? 
1) convulsions 
2) anaphylactic shock 
3) collapse 
4) hypoglycemic coma 
5) bronchial asthma 
4. What is a condition characterized by an abnormal focus of activity 
in the brain that produces severe motor responses or changes in 
consciousness? 
1) Anaphylactic shock 
2) Syncope 
3) Epilepsy 
4) Cardiac infarction 
5. What is cardiogenic shock? 
1) heart is damaged and is unable to deliver sufficient amount of blood to 
the heart and body 
2) convulsions 
3) anaphylactic shock 
6. How do you calculate the dose of prednisolone for patient with 
anaphylactic shock? 
1) 10 mg/kg 
2) 0.1 mg/kg 
















9. What is myocardial infarction? 
1) Necrosis (death) of the myocardium caused by an obstruction in a 
coronary artery;  
2) commonly known as heart attack 
3) allergic reaction 
10. Signs of Shock: 
1) restlessness or irritability,  
2) nausea or vomiting,  
3) rapid breathing or pulse,  
4) pale skin, thirst 
Answers: 1 – 1,3; 2 – 2; 3 – 1; 4 – 3; 5 – 1; 6 – 1; 7 – 1; 8 – 3; 9 – 
1,2;  10 – 1-4. 
Tasks 
Task № 1.  A 45-year-old patient undergoes teeth preparation. 15 
minutes after anesthetization with 4% solution of Ubistesin forte the patient 
developed hyperemia of skin, increased heart rate, headache, syncope. 
Previously the patient had not exhibited such reaction to this anesthetic. 
What complication occurred? 
Task № 2. During the surgical removal of a retention cyst of the 
lower lip a 14-year-old boy complained of sudden weakness, dizziness, 
nausea. Objectively: the skin is covered with cold sweat. Respiration is 
frequent, pulse is weak, AP is decreased (90/60 mm Hg), the hands are 
cold. What is the most likely diagnosis? 
Task №3. During the 14 tooth extraction patient lost consciousness, 
clonic convulsions appears, foam is at the mouth, skin is pale. What 
complication occurs? Your actions? 
Task №4. During the anesthesia the patient complains of acute pains 
in the stomach, dizziness, weakness, nausea, burning and itching of the 
face. Objectively: consciousness is inhibited, the skin of the face and hands 
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is bloodshot, blood pressure is 90/60 mm Hg. What complication occurs? 
Your actions? 
Task №5. During the tooth extraction the patient with diabetes 
complains for trembling, cramps in the limbs, cold, clammy sweat, 
consciousness is inhibited. The patient has not taken any food because of 
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